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Abstract 
The transmissible spongiform encephalopathies (TSEs) are fatal neurodegenerative 
diseases of the CNS in humans and animals, characterised by long incubation periods 
and transmissibility within and between different species. The primary aims of this 
thesis were firstly to analyse the possible role of caspase- independent apoptotic cell 
death pathways in TSEs, and secondly to develop an in vitro model of neuronal loss in 
order to assess the relationship between amyloid fibril structure and neurotoxicity. 
Caspase- independent pathways were analysed in two well characterised murine 
scrapie models (ME7 /CV and 87V/VM). Whole or micro -dissected brain areas from 
terminal stage infected mice were separated into cytosolic and mitochondrial 
fractions, and their protein contents compared by Western blot to normal brain 
injected age- matched control animals. Micro -dissection proved to be a much more 
sensitive technique for the detection of apoptosis -related proteins in vivo. Caspase- 
independent apoptosis inducing factor (AIF) was found to translocate from the inner 
mitochondrial membrane space (IMM) to the cytosol in ME7 /CV animals, but not in 
87V/VM or in normal brain -injected control cohorts. The release of AIF into the 
cytosol is therefore specific to infection with the ME7 murine scrapie strain. 
Furthermore, cytochrome c (cyt c) was released from the IMM in all animals at the 
terminal stage of disease. However, cyt c was not released from the IMM in younger 
animals, indicating that dysfunction of the mitochondria is related to age and not to 
disease. 
A neuronal PC 12 cell system was established to model TSE neurodegeneration in 
vitro. Murine PrP105 -125, homologous to the neurotoxic human PrP106 -126 
synthetic peptide, was developed specifically for this research. Mature amyloid fibrils 
were created containing f3-sheet structures, but different tertiary structures as revealed 
XV 
by electron microscopy, Thioflavin T binding assays and FT -IR techniques. The 
primary structure of the MoPrP105 -125 peptide is critical for conferring the 
neurotoxicity, as a scrambled sequence is not toxic to neurons. Furthermore, the 
research within this thesis shows that the morphology of mature amyloid fibrils does 
not have a significant effect on toxicity, suggesting that the intermediate soluble 
protofibrillar structures may prove to be the more toxic species. 
In conclusion, this research shows that the mechanisms of neuronal loss in two 
tested TSE models can follow different biochemical pathways, which might explain 
differences in the selective targeting of these TSE agents to different CNS neuronal 
populations. These studies also revealed that mitochondrial dysfunction occurred 
within the lifespan of the animals tested in this research, which may contribute to 
neuronal death in the ME7 /CV model. In addition, an in vitro model demonstrated 
that PrP fibril toxicity was principally related to the primary sequence of the fibrils, 
and not to the secondary or tertiary structures of mature fibrils. These results are all 
relevant to the future development of potential therapeutic strategies for TSEs, and 
may also have wider implications for the treatment of other CNS amyloidogenic 
diseases. 
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Chapter 1: Introduction to Transmissible Spongiform 
Encephalopathies (TSEs) 
1.1.1. General TSE background 
The transmissible spongiform encephalopathies (TSEs), or prion diseases, are fatal, 
infectious, non -inflammatory neurodegenerative diseases of the central nervous 
system (CNS) in humans and animals. These conditions have also previously been 
described as sub -acute spongiform encephalopathies, slow viral diseases and 
transmissible dementias. TSEs in humans include Creutzfeldt -Jakob disease (CJD); 
with etiological subtypes of sporadic (sCJD), iatrogenic (iCJD), familial (fCJD) and 
variant (vCJD); Kuru, Fatal Familial Insomnia (FFI) and Gerstmann- Straussler 
Scheinker syndrome (GSS). In animals, TSE diseases include scrapie of sheep and 
goats, Chronic Wasting disease of elk and mule deer (CWD); Transmissible mink 
encephalopathy (TME) and Bovine spongiform encephalopathy (BSE). These 
diseases are unique in that they can present as a result of sporadic, infectious and 
genetic mechanisms; and all are transmissible by natural or experimental means. 
TSEs in humans and animals are differentiated by differences in clinical symptoms, 
incubation period and pathological changes in the brain (Sections 1.1.2. and 1.4.). 
In recent years, new TSEs have emerged following the discovery of BSE in cattle in 
1987 (Wells et al. 1987); a new form of CJD in humans termed vCJD (Will et al. 
1996), and a novel TSE in domestic cats termed feline spongiform encephalopathy 
(FSE) (Wyatt et al. 1990). FSE has also been identified in captive wild cats including 
cheetas and pumas (Peet & Curran 1992; Willoughby et al. 1992). Other novel BSE- 
related TSEs have been identified in a range of ungulates including captive nyala and 
gemsbok (Jeffrey & Wells 1988; Wilesmith et al. 1988), in elands (Fleetwood & 
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Furley 1990), arabian oryx and greater kudu (Kirkwood et al. 1990) and American 
bison (Kirkwood & Cunningham 1999) (Table 1.1). The origin of the BSE agent is 
unknown but it is hypothesised that the practice of rendering cattle and sheep 
carcasses for cattle feed led to the spread of the disease by the consumption of 
contaminated meat and bone meal (MBM) (Wilesmith et al. 1988). In May 1990, 
FSE was identified in domestic cats, generating widespread concern that the BSE 
agent might be transmissible to other species. In 1990, a National Surveillance Unit 
was established in Edinburgh to enhance the surveillance for all forms of CJD. In 
March 1996, this National CJD Surveillance Unit announced the identification of a 
new form of CJD, now termed vCJD (Will et al. 1996). The link between BSE and 
vCJD was first proposed on the basis of epidemiological evidence (Will et al. 1996) 
and subsequently reinforced by the biochemical similarities between PrP' (Section 
1.3.2.) in the brains of BSE and vCJD infected hosts (Hill et al. 1997). Experimental 
murine transmission studies confirmed that the infectious agent in BSE had identical 
incubation periods and indisputable similarities between the distribution and extent of 
vacuolation in the brains of mice inoculated with the vCJD infectious agent (Bruce et 
al. 1997). Similar findings were subsequently reported following the experimental 
transmission of BSE and vCJD in transgenic mice expressing bovine PrP (Scott et al. 
1997; Scott et al. 1999). 





Mechanisms of Pathogenesis 
Unknown, possibly due to somatic mutations or 
spontaneous conversion of PCP` to PrPs` 
fCJD Humans Germ -line mutations in PRNP gene 
iCJD Humans Accidental infection (e.g. from human growth hormone, 
corneal transplant, dura matter grafts) 
vCJD Humans Infection from bovine tissues (possibly by oral ingestion) 
Kuru Humans (Fore tribe, 
Papua New Guinea) 
Infection probably due to cannibalistic rituals 
GSS Humans Germ -line mutations in PRNP gene 
FFI Humans Germ -line mutations in PRNP gene 
Scrapie Sheep and goats Unknown, disease appears to be spread by maternal and /or 
horizontal transmission 
BSE Cattle Ingestion of infected MBM in animal feed 
CWD Mule deer and elk Unknown, disease appears to be spread by horizontal 
transmission 
THE Mink Unknown, probable infection from animal feed containing 
material from infected sheep /cattle 
FSE Domestic and wild cats Ingestion of infected MBM in animal feed 
Exotic Ungulate 
Encephalopathy 
Greater kudu, Nyala, 
Oryx, Eland, Gemsbok, 
American Bison 
Ingestion of infected MBM in animal feed 
Table 1.1 Spectrum of TSE disease in humans and animals 
1.1.2. Natural and experimental scrapie 
Scrapie, which naturally affects sheep and goats has long been recognised, with the 
first definite record in the UK reported in 1732. By 1755, the volume of documented 
cases led the government to ban the mixing of healthy animals with those suspected of 
carrying the infection, as a means to limit the spread of disease. It is now understood 
that the disease was widespread throughout Europe at this time; known as la 
tremblante in France, Traberkrankheit in Germany and rida in Iceland. Scrapie is 
widespread in many sheep -producing regions worldwide including Great Britain and 
many other European Union countries (where it is a notifiable disease), the United 
States of America and Canada. Australia and New Zealand are generally accepted as 
being scrapie -free but flocks are not resistant to infection, as sheep imported into the 
US from New Zealand have succumbed to disease (Hourigan et al. 1979). The lack 
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of scrapie in New Zealand and Australia therefore appears to be due to the lack of 
agent in these countries, reasons for which remain unclear. 
Clinical symptoms of the scrapie appear to vary between outbreaks of infection. The 
clinical course can last from as little as two weeks to six months, with incubation 
periods typically ranging from two to five years. Clinical symptoms begin with the 
social withdrawal of the animal from the flock, nervousness, apprehension, trembling, 
and uncoordinated movements. Throughout the clinical course other symptoms may 
include pruritis (as a result of intensive scratching against inanimate objects), 
emaciation and hyperaesthesia. Fertility appears to be unaffected, as lambs can be 
born to ewes which have entered the clinical phase of disease. Later in the clinical 
course, motor symptoms appear which include head trembling and ataxia. 
Mechanisms of natural scrapie transmission are not fully understood, but it is known 
that infectivity can be passed from an infected ewe to her lambs both pre- and post- 
natally. However, it is also possible for infected ewes to give birth to uninfected, 
healthy offspring. Infectivity can be passed experimentally through both oral and skin 
scarification routes, and it is believed that natural scrapie may be transmitted by these 
mechanisms (Dickinson et al. 1974; Hourigan et al. 1979). Natural scrapie was first 
shown to be transmissible by intraocular inoculations between sheep following 
prolonged incubation periods (Cuille & Chelle 1936). These long incubation periods 
led researchers to propose that the infectious agent was a slow progressive virus. 
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In 1959, (Hadlow 1959) proposed similarities between TSE diseases in animals and 
humans, based upon the neuropathological similarities of scrapie and Kuru, a recently 
identified emerged endemic human TSE in the Fore tribe of Papua New Guinea 
(Gajdusek & Zigas 1957). Subsequently, Klatzo (Klatzo et al. 1959) noted 
neuropathological similarities between Kuru and CJD. Subsequent intracerebral (i.c.) 
inoculation of primates with Kuru brain material resulted in a spongiform 
encephalopathy remarkably similar to Kuru in humans (Gajdusek et al. 1966). 
Further successful inoculations of primates with sCJD and GSS verified the 
transmissibility of these diseases between humans and animals (Gibbs et al. 1969; 
Masters et al. 1981), suggesting common infectious mechanisms. 
Many subsequent experimental transmission studies ensued; Pattison and Millson 
(Pattison & Milson 1961) were the first to recognise the existence of different strains 
of the transmissible agent from a single source of scrapie, resulting in the isolation of 
the clinically distinct isolates termed "drowsy" and "scratching" syndromes in goats. 
These characteristics remained highly consistent on subsequent goat -to -goat passage. 
The successful transmission of scrapie from these experimentally inoculated goats to 
mice (Chandler 1961; Zlotnik & Rennie 1963) and direct transmissions of sheep 
scrapie to mice (Chandler 1961; Zlotnik & Rennie 1962); was a major advance for 
TSE research. Many other models for scrapie research have been described, but the 
murine scrapie models have persisted due to their high reproducibility, relatively 
shorter incubation periods, and basic economical considerations. Approximately 20 
phenotypically distinct experimental strains of the scrapie agent have been identified 
in mice following sub -passages of the infectious agent (Bruce et al. 1991; Bruce et al. 
1992), although the precise number of strains existing naturally in sheep is unknown. 
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The development of these highly reproducible models of murine scrapie infection 
have resulted in numerous advances in the understanding of the pathology and 
biochemistry of scrapie as well as many of the other human and animal TSE diseases. 
1.2. Host -encoded sialoglycoprotein, PrP` 
1.2.1. The prion protein and the prion protein gene 
Prion diseases are characterised by the conformational conversion of a normal cell - 
surface protein (PrP`) into a protease- resistant, 13-rich form (PIT'S) (Bolton et al. 
1982). Expression of PrP° is essential for the development of TSE disease, as 
highlighted by the lack of disease in PrPc- deficient mice (Pre) during experimental 
scrapie challenges (Bueler et al. 1992; Manson et al. 1992; Bueler et al. 1993). 
Evidence suggests that the primary sequence of PrP is a major determinant of the 
species -specificity, incubation period, and neuropathological characteristics observed 
in the different prion diseases (Westaway et al. 1987). Following translation, PrPc is 
cleaved at the N terminus to leave a protein containing five octapeptide repeats 
(spanning residues 51 -91) with two potential glycosylation sites in mice at residues 
181 and 197 (Figure 1.1.). The molecular weight of the mature PrP` protein in vivo 
ranges from 33 -35 kDa (Oesch et al. 1985), depending on wheither the protein is di -, 
mono -, or un- glycosylated. 
PrP° is encoded by a single copy gene, PRNP in humans and Prnp in mice, the 
structure of which is known to be highly conserved amongst various mammals, 
usually consisting of 2 or 3 exons, a single open reading frame within a single exon 
and a guanine /cytidine -rich promoter sequence. In humans the gene is located on the 
short arm of chromosome 20, whilst in mice is located on chromosome 2 (Liao et al. 







Figure 1.1 Bar diagram of murine PrP 
Murine PrP consisting of 254 amino acids with attached glycosyl -phosphatidylinositol (GPI) 
anchor. The octapeptide repeat region and two potential glycosylation sites are also 
indicated. The synthetic MoPrP105 -125 peptide used in the research described in Chapter 4 
is based upon the hydrophobic region indicated between residues 111 -134 
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1986; Sparkes et al. 1986). A PrP homologue, termed Doppel (Dpl), was discovered 
in 1999 (Moore et al. 1999) and may help us to understand the as yet unknown natural 
function(s) of the PrPc protein (discussed in Section 1.2.3). The Dpl gene (Prnd) lies 
downstream of Prnp, and the Dpl protein exhibits approximately 25% homology to 
two -thirds of the C- terminus of PrP (Moore et al. 1999). Dpl expression is highest in 
the testes, and is over -expressed in some PrP -null mice resulting in late stage ataxia 
due to the loss of cerebellar granules and Purkinje neurons (Moore et al. 1999). 
However, the Dpl protein is not required for prion replication (Tuzi et al. 2002) and 
lacks certain sequences homolgous to the N- terminal domain of PrP containing the 
octapeptide repeat region (Moore et al. 1999), which in PrP is implicated in binding 
copper ions. This copper binding domain of Prnp is thought to be important as 
alterations to the number of octapeptide repeat regions influence the development of 
familial prion diseases. Copper has been shown to induce PrP° into a protease - 
resistant conformation which contains a large proportion of (3- sheet, and which is 
distinct from the conformation of PrPsc (Quaglio et al. 1999). PrP lacking the 
octapeptide repeat region fails to restore scrapie susceptibility to Prnp °'° null mice 
(Supattapone et al. 1999) or produces an atypical disease phenotype, indicating an 
important role for copper -PrP interactions in the disease process. The functions of 
copper -PrP interactions are not completely understood; however, copper induces 
endocytosis of cell surface PrP° which indicates a role for PrP in copper metabolism 
(Pauly et al. 1998), and copper binding has also been reported to confer superoxide 
dismutase properties on PrP (Brown et al. 1999). Further studies on copper -PrP 
interactions will hopefully contribute to understanding the true biochemical functions 
of PrP °, these are further discussed in Section 1.2.3. 
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Dickinson named a gene governing scrapie incubation periods in inbred mice as the 
Sinc gene, derived from the term scrapie incubation period, and the two alleles of the 
gene were termed s7 and p7, which shorten and lengthen incubation periods 
respectively with neither allele showing dominance (Dickinson et al. 1968). Sinc and 
Prn -i, which encodes alleles N and I which also confer short and long incubation 
periods (Carlson et al. 1986; Carlson et al. 1988), were subsequently found to be 
linked to the Prnp mouse gene, and are now believed to be the same gene. The s7 and 
p7 allotypes in mice result from Prnp codon 108L/F and 189T/V dimorphisms, where 
Prnpa (previously termed s7) encodes 108L 189T and Prnpb (previously termed p7) 
encodes 108F 189V (Westaway et al. 1987). In 1998, Moore et al (Moore et al. 1998) 
introduced the polymorphisms for Prnpb (108F189V) into the Prnpa allele of 129 /Ola 
mice, and inoculated these co- isogenic mice with infectivity, confirming the 
congruence of Sinc /Prn -i and Prnp and their control over incubation periods. 
Inoculations of natural scrapie isolates into mice homozygous for Prnpa and Prnpb and 
the F 1 cross populations have formed the basis of scrapie strain typing experiments. 
The majority of such experiments have concentrated on the C57BL (Prnpa) and VM 
(Prnpb) genotypes and the resulting heterozygote Fl cross, CV (Prnpab). Inoculations 
of natural scrapie into these mice have revealed two broad groups of murine scrapie 
strains, the ME7 and 22A groups. The ME7 group has relatively short incubation 
periods in Prnpa mice, but incubation periods are much longer when inoculated into 
Prnpb mice. The 22A group showed the reverse of this observation. ME7 group 
strains inoculated into CVF1 heterozygotes had incubation periods typically between 
those expected for the parental genotypes, but the incubation periods for the 22A 
group are longer. Further complicating genetic influences on incubation periods, a 
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third Prnp allele was reported (Prnpc) with polymorphisms of 108F 189T which in co- 
isogenic mice had incubation period increases greater than 100 days when challenged 
with the Chandler scrapie strain (Lloyd et al. 2004). The two murine scrapie models, 
defined by the combination of host and infecting scrapie strain, examined in this work 
are the 87V strain with the VM mice combination (Prnpb) and the ME7 strain with the 
CVF1 cross (C57xVM) combination (Prnpab) 
1.2.2. Biosynthesis and expression of PrP` from Prnp 
Basler et al (1986) first demonstrated that the Prnp gene in mice encoded for the 
expression of PrP°. Subsequent investigations revealed PrP° expression from Prnpa 
and Prnpb allotypes appear to be similar in brain tissue, (Westaway et al. 1987; 
Manson et al. 1992), therefore differences in incubation periods are less likely to be 
due to differing levels of PrP°, but more likely the ability of different TSE agents to 
interact with the host PrPC. PrP° expression is essential for the development of TSE 
disease, as shown by the lack of disease in PrP° -deficient mice (Prnp °'°) during 
experimental scrapie challenges (Bueler et al. 1992; Manson et al. 1992; Bueler et al. 
1993). Transgenic mice over -expressing PrP' have reduced incubation periods, and 
heterozygosity (Prnp +1 -) appears to confer partial resistance to infection as observed 
by prolonged incubation periods. These observations further establish the central role 
of PrP° in influencing susceptibility to TSE infectivity. Further transgenic and cell 
culture models have hinted at the normal physiological function(s) of PrP°, these are 
discussed further in the next section. 
Transcription of Prnp has been detected from day 12 of embryogenesis in the 
developing central and peripheral nervous systems (Westaway et al. 1987), and is 
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expressed constitutively in adult mice in a number of organs. Highest PrPc expression 
is found in neuronal cells of the brain (particularly in pyramidal neurons of the 
hippocampus, cerebellar Purkinje cells and neurons within the thalamus and 
neocortex) and spinal cord (Manson et al. 1992), but is also expressed by non - 
neuronal cells including oligodendrocytes and astrocytes (Moser et al. 1995). PrPc is 
also found in lower levels in heart, lung, kidney, spleen, liver, and lymphocytes 
(Caughey et al. 1988; Cashman et al. 1990; Mabbott et al. 1997). Nascent PrPc is 
synthesised as a polypeptide chain of 256 amino acids (aa), which undergoes a 
number of post -translational modifications during translocation from the endoplasmic 
reticulum (ER) to the cell surface. The 22 aa N- terminal signal sequence directs the 
polypeptide to the ER, with subsequent cleavage of the signal sequence and removal 
of the 23 aa C- terminal hydrophobic signal sequence. In mice, the formation of a 
disulphide bond between cysteine residues 179 and 214 and glycosylation at 
asparginine residues 181 and 197, permits attachment of the glycosyl 
phosphatidylinositol (GPI) anchor at serine 231 which is essential for correct 
orientation of the protein at the plasma membrane (Stahl et al. 1987; Turk et al. 1988; 
Haraguchi et al. 1989; Zahn et al. 2000). Mature PrPc are 33 -35 kDa proteins (Bolton 
et al. 1982) which have a secondary structure composed primarily of a- helices, and 
are sensitive to digestion by proteinase -K (Pan et al. 1993). The abnormal isoform 
PrPsc has a primary structure identical to PrPc, but with an altered secondary structure 
and differing biochemical properties (Table 1.2) which may contribute to the 
pathogenic process. 
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1)1.1)1 
Located on the surface of cultured neuronal cells, 
via a GPI -anchor I 
PH"' 
Can be located within the extracellular space in the 
neuropil z or surrounding neurons (e.g. 87V scrapie 
infections) 3 in mice, and intraneuronally in different 
species 4 
3-sheet content 3 %, a -helix content 42 % 5' 6 3 -sheet content 43 %, a -helix content 30 % 5, 6 
Size of protein, 33 -35 kDa 7 N- terminal truncation, by proteinase -K digestion, 
results in a molecular weight of 27 -30 kDa 8 
Proteinase -K sensitive 9 Proteinase -K resistant 9 
Soluble in non -denaturing detergents 10 Insoluble in non- denaturing detergents 10 
Table 1.2 Differences between the normal prion protein (PrPc) and the proposed 
infectious isoform (PrPs`) 
'(Stahl et al. 1987); 2(Jeffrey et al. 1994); 3(Jeffrey et al. 1994); 4(Jeffrey & Fraser 
2001);5(Caughey et al. 1991); 6(Safar et al. 1993); 7(Bolton et al. 1982) ; 8(McKinley et al. 
1983; Oesch et al. 1985); 9(Pan et al. 1993); 10(Meyer et al. 1986). 
1.2.3. PrP` function 
The normal physiological function of PrPc has yet to be determined, however, a vast 
literature exists documenting various properties of the protein. The understanding of 
the normal function of this protein is essential in order to grasp its role in TSE 
infections. Transgenic and cell culture models are responsible for furthering our 
understanding, or confusion, of PrP° function. Initial observations that Prnp "0 mice 
were clinically and pathologically normal suggested the function of PrPc may have 
become evolutionary obsolete. However, the protein is highly conserved between 
mammals, has a short half -life and is highly expressed in numerous tissues 
(particularly neurons). Subsequent observations in Prnp °'0 mice revealed altered sleep 
patterns, circadian rhythms and reduced long term potentiation in CA1 hippocampal 
neurons in comparison to wild type animals (Collinge et al. 1994; Tobler et al. 1996; 
Tobler et al. 1997). Other suggested functions include the long -term survival of 
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Purkinje neurons (Sakaguchi et al. 1996), synaptic functions (Collinge et al. 1994), 
and binding of endogenous metal ions to the octapeptide repeat region of the N- 
terminal segment with possible superoxide dismutase activity (SOD) as an anti- 
oxidant (Brown et al. 1997; Brown et al. 1997; Brown & Besinger 1998). Further to 
this, it is believed that PrPc is endocytosed through clathrin- coated pits, cycling 
between the site of endocytosis and the plasma membrane (Shyng et al. 1993; Shyng 
et al. 1994). The function of this rapid recycling is unknown, but may indicate a cell 
signalling function. Some of the suggested PrPc binding partners include metal ions 
such as Cue+ Mn2+ and Zn2+ (Pan et al. 1992; Brown et al. 1997), laminin (Graner et 
al. 2000), and the laminin receptor precursor protein (Rieger et al. 1997). 
Whatever the physiological function of PrPc, its expression and location determine the 
susceptibility of a host to TSE infection. This is most likely by influencing 
interactions with endogenous /exogenous PrPSO molecules. Animals without PrPc 
expression are resistant to infection, and do not form PrPSO following experimental 
challenge with TSE agents. The hypothesised interactions resulting in the 
accumulation of aggregated PrPSO molecules will be discussed. 
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1.3. The nature of the infectious agent 
1.3.1. Viruses, viroids, virinos and SAF 
The identity of the infectious agent of TSE disease remains highly controversial, 
ranging from the suggestion that it is a novel sub- species of a virus or virino, to the 
idea that it is an entirely novel infectious species termed the prion. Early observations 
revealed that the scrapie agent was resistant to extremes of temperature (Stamp et al. 
1959; Hunter & Millson 1964; Pattison 1965) and is inactivated in highly alkaline 
environments which may be attributed to (if present) hydrolysis of RNA, denaturation 
of dsDNA or protein denaturation. Ionisation studies revealed that the agent was 
resistant to levels of radiation known to inactivate known viruses (Alper et al. 1966) 
and infectivity is relatively resistant to formalin fixation and high levels of U.V. 
radiation (Pattison 1965; Alper et al. 1967; Latarjet & Muel 1970; Millson et al. 
1976). However, it is now known that viruses with small genomes have similar 
profiles of resistance to ionising radiation. The observed resistance of the scrapie 
agent to nucleases, psoralens, proteases (eg proteinase -K, trypsin) although not typical 
of conventional viruses, have been observed in other viral species, and the failure to 
identify a nucleic acid component of the scrapie agent is not evidence for its absence. 
The discovery of viroids in 1971 (naked nucleic acids lacking polypeptide 
components) (Diener 1971) revealed the existence of new infectious agents smaller 
than known conventional viruses, further affirming the probability that new infectious 
sub -species have yet to be discovered and classified. Although U.V. radiation 
resistance profiles of viroids are similar to the scrapie agent, the concept that the 
scrapie agent was a viroid was discredited due to requirements for a host protein for 
infectivity (now known to be PrP °), and a number of diverse physiochemical 
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properties including the resistance of the scrapie agent to nucleases and its sensitivity 
to phenol. 
The emergence of new infectious agents justified a hypothesis that the scrapie 
infectious agent was a novel infectious species, with a small nucleic acid (encoding 
strain specific information) permitting interactions with the hosts' replication 
machinery and protected by a host- encoded protein coat. This virino hypothesis 
encompasses a number of the characteristics of these agents, including the lack of 
immune response in infected hosts, the concept of different scrapie strains, species 
barrier effects upon transmission to new hosts, the requirement for interactions with 
host protein(s), difficulties in separation of infectivity from host material, and 
resistance of nucleic acids to ionising radiation. Difficulties in extracting the 
infectious agent have restricted biochemical studies to the investigation of crude 
preparations. It is therefore virtually impossible to clarify if treatments are 
destroying/inactivating possible nucleic acid or protein components of the infectious 
agent. It is also possible that the adhesive nature of the agent to cellular components 
restricts the ability of these treatments to reach, if present, nucleic acid or protein 
components. It is therefore imperative to develop techniques which isolate the 
infectious agent to a high degree of purity, as a means to properly classify the 
infectious agent. 
Electron microscopy had been used successfully to identify viral and viroid structures, 
the proposed similar size of viroids to the scrapie agent led researchers to use this 
technique to search for the scrapie agent. Scrapie associated fibrils (SAF) were 
subsequently identified in negatively stained detergent -treated membrane fractions, 
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which were not isolated in preparations from uninfected control samples (Merz et al. 
1981). SAF were identified as paired or quadrupled fibrillar structures (4 to 6 nm), 
resembling but not identical to amyloid in some TSE strains and amyloidoses. Co- 
isolation of SAF and infectivity from the spleens of scrapie and CJD- infected mice 
led the researchers to propose a close association with infectivity. Prusiner reported 
fibrillar "prion rods" which are morphologically indistinguishable from SAF, varying 
only in length, a difference attributed to preparation procedures (Prusiner et al. 1982; 
Prusiner et al. 1983). Although amyloid plaque deposition is not characteristic of all 
TSE pathology, the extraction of SAF from all tested scrapie isolates has been 
reported (Merz et al. 1983). The relationship linking SAF and infectivity is unclear, 
thus the isolation of infectivity is again essential. 
1.3.2. Prions 
The prion, derived from the term proteinaceous infectious particle (Prusiner 1982; 
Prusiner et al. 1982), is based on a self -replicating kinetic model of protein folding. 
The prion hypothesis postulates the infectious agent to be either a small 
oligonucleotide closely associated with host protein(s), or a novel self -replicating 
protein devoid of a nucleic acid component ( Prusiner 1982; Prusiner 1998). The 
principal support for the prion hypothesis stems from the work of Bolton who co- 
purified infectivity in scrapie -infected hamster brain with an abnormal protease - 
resistant protein, with a molecular mass of 27 -30 kDa not detected in uninfected 
control animals (Bolton et al. 1982). This protein represents the protease -resistant 
core of a larger molecule, termed PrPse, which has an apparent molecular mass of 33- 
35 kDa ( Prusiner et al. 1984). PrPsc is used to describe the pathogenic isoform, whilst 
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digestion of PrPyc by proteinase -K (at approximately aa 90) results in the N- terminally 
truncated fragment termed PrP27'3ß (McKinley et al. 1983: Oesch et al. 1985). 
PrPSO is now known to be an abnormal isoform of a normal host -encoded 
glycoprotein, PrP° (Bolton et al. 1985). PrP" has a secondary structure comprised 
predominantly of J3- sheets, has a tendency to form large insoluble aggregates and is 
partially resistant to proteinase -K digestion (Bolton et al. 1982; McKinley et al. 1983; 
Bolton et al. 1985; Oesch et al. 1985; Pan et al. 1993) (Table 1.2). Biochemical 
analysis has further highlighted differences in size of the isoform, which can plausibly 
be attributed to differences in conformation, and altered glycosylation patterns 
(Kascsak et al. 1986; Somerville & Ritchie 1990; Somerville et al. 1997). It is 
believed that the conformational differences are due to post - translational events, as 
scrapie infection does not alter the quantity or sequence of PrP mRNA (Oesch et al. 
1985; Basler et al. 1986). The prion hypothesis suggests that different strains of TSE 
agent could be attributed to different conformations of PrPc, and that each 
conformation would interact differently with PrP` to determine strain characteristics 
(Bessen et al. 1995). Another theory suggests that modifications to PrP, such as 
altered glycosylation, may be sufficient for transmitting strain -specific information 
(Hecker et al. 1992; Weissmann et aL 1993). Prr in cell cultures and in the brain is 
proteolyticaIly cleaved at the N- terminus in the region akin to proteinase-K cleavage 
(approximately aa 90) leaving a molecular weight of 27 -30 kDa (termed PrP27 3°) 
(McKinley et al. 1983; Oesch et al. 1985), whereas PrP` is cleaved (approximately aa 
110) in a portion of the protein known to be amyloidogenic and neurotoxic (Cauehey 
et al. 1991; Chen et al. 1995). It is hypothesised that as the neurotoxic portion 
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remains intact in PrPSC, but not in PrPc, that this may be important in determining the 
pathogenicity of PrP. 
The postulated conversion sequence of PrPc to PrPSO is poorly understood, but is 
hypothesised to proceed slowly from PrPc molecules interacting with endogenous 
point mutation- containing PrPc or with exogenous PrP'. The site of conversion is 
undetermined, but cell culture studies suggest that conversion may occur on the 
extracellular surface of the cell membrane or within calveolae following endocytosis 
(Caughey & Raymond 1991; Vey et al. 1996), correlating with the cellular location of 
PrPc. The GPI anchor does not appear to be required for the generation of infectivity 
(Legname et al. 2004), however, deletion of the GPI - anchor in vivo reduces 
infectivity replication by up to ten fold, demonstrating the importance of cell surface 
PrPc for the transmission of infectivity (Chesebro et al. 2005). The homology 
between PrPc and PrPs° has been shown to determine the efficiency of the conversion 
process, as a mutational difference of even one amino acid can, but will not always, 
prevent the production of PrPs° and transmission of disease (Priola & Chesebro 1995; 
Manson et al. 1999). The re- folding hypothesis suggests that the spontaneous 
conversion of PrPc to PrPs° would be energetically unfavourable. However, the 
seeding hypothesis suggests that the formation of an aggregated "seed" of PrPs°, 
would be capable of autocatalysing the conversion of further PrPs° molecules from 
endogenous PrPc molecules. Another theory suggests that conversion may be directed 
by binding to as yet unidentified protein(s), termed protein X, which would act as a 
molecular chaperone (Kaneko et al. 1997). 
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Efforts to better understand the spontaneous conversion of PrPc to PrPS, have resulted 
in the development of numerous de novo cell culture and transgenic murine models. 
The requirement of PrP° expression for the development of TSE infection (Bueler et 
al. 1992; Manson et al. 1992; Bueler et al. 1993), and the effects of PrP gene 
mutations on the development of disease suggest that spontaneous conversion of PrPC 
to PrPSO may be facilitated by some PrP gene mutations. Initial attempts to produce de 
novo PrPS° in cell culture systems were unsuccessful (Taraboulos et al. 1992); 
however, murine neuroblastoma N2a cells and the yeast Saccharomyces cerevisiae 
have now been shown to generate PrPS -like molecules in vitro (Ma & Lindquist 
1999). These PrPS -like molecules (Sup35) are biochemically similar to PrPS (Table 
1.2), and de novo yeast PrPS° molecules have recently been demonstrated to 
successfully transmit strain- specific TSE disease (Tanaka et al. 2004). The murine 
transgenic approach has revealed that the over -expression of PrP° can lead to TSE- 
like neurodegeneration (Westaway et al. 1994), and also that a single amino acid 
mutation from proline to leucine (representative of some GS S cases) can result in the 
development of spontaneous TSE disease which is transmissible upon sub -passage to 
uninfected mice (Hsiao et al. 1990; Hsiao et al. 1994; Manson et al. 1999). 
Additional transgenic models further confirm that spontaneous mutations within the 
PrP gene can result in the generation of de novo PrPs° molecules (Telling et al. 1995; 
Telling et al. 1996). However, confirmation that PrPS° constitutes the infectious 
agent, and is not just a pathological by- product of the disease process has yet to be 
proven. Although other proteins have been identified as potential biomarkers for TSE 
infection in humans such as 14 -3 -3 and neuron specific enolase proteins (Hsieh et al. 
1996; Beaudry et al. 1999), PrPS remains the most reliable biomarker in confirming 
TSE infection. However, natural and experimental cases of human and animal 
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disease exist where there are apparently no detectible levels of PrPSC but where 
infectivity levels (as determined by mouse bioassay) are high (Telling et al. 1995; 
Dorandeu et al. 1998; Foster et al. 2001). The ratio of infectious units to PrP is 
known to be in the domain of 1:105 (Bolton et al. 1991), suggesting that only a small 
portion of PrP is infectious or it is possible that the infectious agent has an altered 
conformation to PrPSe, which may be isolated with PrPSC using the methods used for 
its extraction. The infectious agent may be an as yet identified component, such as 
another protein or nucleic acid in association with or separate from PrPSe 
Confirmation that PrP" is infectious would require its generation in vitro, from 
recombinant or highly purified PrPe molecules. PrPs° would then have to be 
infectious on transmission to a susceptible host. In contrast, confirmation that PrPs° is 
not the infectious agent would require the complete separation of PrPs° from 
infectivity. 
The generation of PrP`es in vitro has been achieved by two main techniques; the cell - 
free conversion assay and the protein misfolding cyclic amplification (PMCA) 
reaction. The cell -free conversion assay involves the incubation of excesses of PrPSC 
with 35S- labelled PrPe (Kocisko et al. 1994). This reaction produced a small 
proportion of protease resistant molecules with a mobility profile similar to PrP`eS 
The generation of infectivity using this technique could not be proven, due to pre- 
existing levels of infectivity in the original reaction mixture. Additional studies 
incubating truncated recombinant murine PrPCeS (PrP90 -231) with excesses of PrPe 
have generated molecules biochemically similar to PrPreS In the absence of 
conversion techniques using full length recPrPCeS, truncated recPrP (PrP90 -231) is 
sufficient for the synthesis of PrPCeS. Conversion appears possible as the cleaved N- 
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terminal portion appears to have a role in normal PrPC function but not in the 
conversion process. 
The PMCA reaction involves the incubation of PrPc with scrapie- infected hamster 
brain homogenates, subjected to repeated sonication cycles (Saborio et al. 2001). The 
result is much higher quantities of PrPCeS, in comparison to samples exempt from 
repeated sonication. Sonicating a polymeric aggregate or "seed" would break 
monomeric PrPres molecules which may then autocatalytically convert further PrP° to 
the abnormal conformation. PrPres produced by PMCA also appears to be 
biochemically indistinguishable from PrPee in its mobility and resistance to 
proteinase -K. PMCA of purified proteins and cell lysates yield relatively low 
quantities of PrP', however the reaction is much more efficient using brain 
homogenates suggesting a requirement of cellular factors other than PrP to achieve 
optimal conversion. The addition of host encoded RNA molecules significantly 
enhances PrPres production in a dose -dependent manner (Deleault et al. 2003), 
although amplification was inhibited by RNase molecules specific to single stranded 
RNA, whereas molecules specific to double stranded RNA and DNA had no effect. 
Other molecules such as thiols and glycosaminoglycans have also been reported to 
substantially enhance PrPCeS generation by PMCA (Wong et al. 2001). The use of 
PMCA as a diagnostic tool has recently been reported. PCMA treated homogenates 
of scrapie infected hamsters and experimental BSE- infected cattle detected PrPfeS 
prior to the detection of clinical symptoms. Sensitivity was such that PrPfeS was 
detected by Western blot, in samples from pre -clinical animals which would 
otherwise appear negative (Soto et al. 2005). Future applications of PMCA would 
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have to be optimised for specific disease models, however, PMCA represents an 
attractive pre -clinical test for TSE diseases such as BSE and CWD. 
Very recent reports document the successful development of TSE -like disease in 
transgenic mice over -expressing PrP° which have been inoculated with abnormally - 
folded synthetic murine PrP° molecules (MoPrP89 -230). This disease was 
transmissible to transgenic, and on subsequent passage, wild -type mice (Legname et 
al. 2004; Legname et al. 2005). This research fails to definitively prove the prion 
hypothesis, as it is well documented that the high expression of PrPC can result in the 
development of spontaneous TSE disease (Westaway et al. 1994). However, PrPfes 
molecules synthesised by the described in vitro PMCA technique have been reported 
to successfully transmit TSE disease to wild -type hamsters (Castilla et al. 2005). The 
in vitro conversion of PrPc to PrP' molecules, catalysed by interactions with other 
host cellular factors, is in correlation with the prion hypothesis. Future studies will 
need to determine whether newly generated PrP1es constitutes the sole infectious 
agent, before this hypothesis can be completely substantiated. 
1.4. Murine scrapie strains 
The prion donor is the last host in which the prion was passaged and its PrP sequence 
represents the "species or strain" of the prion. The prion hypothesis (Section 1.3.2) 
suggests that the presence of TSE strains could be attributed to different 
conformations of PrPSC, and that each conformation would interact differently with 
PrPC to determine specific strain characteristics (Bessen et al. 1995). These TSE 
strains are thought to confer the three -dimensional information to nascent PrPS° 
molecules. Murine scrapie strains are distinguished by their distinct neuropathology, 
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lesion profiling (vacuolation scores) (Fraser & Dickinson 1968; Fraser & Dickinson 
1973), incubation periods (Dickinson et al. 1968), but also by differences in clinical 
manifestations, ease of transmission to new species, agent susceptibility to thermal 
inactivation (Dickinson & Taylor 1978) and the immunological and biochemical 
detection of PrPsc 
1.4.1. Lesion Profiles 
Vacuolation of the neuropil is a neuropathological trait of all TSE diseases; however, 
the distribution of neuronal vacuolation targeted to specific brain areas differs 
between TSE strains. The quantitative analysis of the degree of vacuolation of the 
neuropil in nine specific grey and three specific white matter brain areas is termed the 
lesion profile (Fraser & Dickinson 1968). The extent and localisation of vacuolation 
is highly repeatable and dependent on the host - strain combination (Fraser & 
Dickinson 1973), resulting in specifically targeted vacuolation profiles. Vacuolation 
can depend on the route of inoculation, but as a way of classifying strains is 
advantageous over incubation period strain analysis in that lesion profiles are 
unaffected by altering doses of infectivity (Bruce et al. 1991). The mechanisms for 
the strain -targeted vacuolation have yet to be determined, but the targeting of 
vacuolation suggests specific interactions with neuronal subsets. The degree of 
vacuolation can vary from focal areas of small vacuoles to large areas of coalescing 
spongy lesions. CNS vacuolation within cells occurs mainly within dendrites with a 
low frequency in the early stages of infection which increase towards the terminal 
stages of disease. Vacuolation is also observed in axons, axon terminals and the 
neuronal perikaryon. 
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1.4.2. Incubation periods and species barrier effects 
The incubation period is defined as the duration of time from the initial exposure of a 
host to an infectious agent to the development of specific clinical signs of infection. 
Murine scrapie models provide a highly reproducible means of monitoring incubation 
periods when inoculated i.c. into a cohort of highly inbred mice (Dickinson et al. 
1968). Experimental transmission studies confirmed a "species barrier" effect when 
inoculating a scrapie strain into a new host of another species, where incubation 
periods of a characterised strain are initially longer when inoculated into a new host, 
but shorten and stabilise on subsequent passages in the second host. Not all 
inoculated animals succumb to disease in the primary transmission, but subsequent 
passages will result in transmission if the species barrier is overcome (Pattison 1965). 
Incubation periods are now known to be influenced by the host genotype, the 
infecting strain, age and sex of the host, the route of inoculation, and titre of 
infectivity (Dickinson & Meikle 1971; Dickinson 1975). 
1.4.3. Experimental routes of transmission 
1.4.3.1. LRS replication 
The route of experimental transmission determines whether the infectious agent 
replicates directly in the CNS or peripheral nervous system (PNS), or if it replicates in 
the lymphoreticular system (LRS) prior to neuroinvasion and replication. Peripheral 
routes of inoculation usually result in a period of replication in LRS tissues prior to 
neuroinvasion and therefore prolonged incubation periods. Peripheral challenges may 
model certain natural routes of infection such as the oral ingestion of infected material 
and skin scarification. Peripheral challenges permit replication of infectivity in the 
spleen (Eckland et al. 1967), and splenectomised mice can have extended incubation 
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periods (Fraser & Dickinson 1970; Kimberlin & Walker 1989). Following replication 
in the spleen, infectivity spreads first to the thoracic and spinal cords, and brain 
(Kimberlin & Walker 1979; Kimberlin & Walker 1980). Splenectomising mice has 
no further effect on the duration of the incubation period once infectivity has reached 
the spinal cord, i.e. once neuroinvasion has been established. LRS cells involved in 
the replication and neuroinvasion of infectivity are not entirely clear, but ionising 
radiation exposure studies at different times prior and post -scrapie challenge do not 
affect replication in the spleen (Fraser & Farquhar 1987). Follicular dendritic cells 
(FDCs) are non -mitotic long -lived cells with resistance to ionising radiation, and their 
expression of PrPc and location outside the CNS could provide a site for the 
replication of infectivity within the LRS system (Fraser & Farquhar 1987; Fraser et al. 
1992; McBride et al. 1992). The generation of SCID (severe combined 
immunodeficiency) mice (Bosma et al. 1983) has been invaluable in identifying key 
cells involved in peripheral pathogenesis of TSEs. SCID mice (deficient in B -, T- 
cells and FDCs) do not accumulate PrPsc in the spleen and are resistant to i.p. but not 
i.c. ME7 scrapie and CJD inoculations, suggesting a requirement for extraneuronal 
replication prior to neuroinvasion for these strains via peripheral routes of infection. 
Susceptibility of SCID mice to scrapie infection is restored through bone marrow 
grafts or inoculations of normal spleen cells (Brown et al. 1996; Fraser et al. 1996; 
Lasmezas et al. 1996) signifying the primary route of peripheral infection does 
involve LRS replication. However, SCID mice can be infected i.p. with inoculations 
containing high titres of infectivity (Brown et al. 1996; Fraser et al. 1996), suggesting 
peripheral nerve connections to the CNS (Section 1.4.3.2.) in addition to a pre - 
replication phase in the LRS. Immunologically -reconstituted SCID mice have 
functional FDCs, and their developmental inhibition with lymphotoxin -ß receptor 
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fusion protein has been shown to inhibit PrPSC accumulation in the spleen and to 
prolong the incubation period of infected animals (Klein et al. 1997). Further studies 
using skin scarification in mice, which is as efficient as i.p. inoculation (Taylor et al. 
1996), have demonstrated a requirement for FDCs for the accumulation of infectivity 
and neuroinvasion following challenge with ME7 scrapie (Mohan et al. 2004; Mohan 
et al. 2005). The precise cellular interactions have yet to be uncovered but again once 
neuroinvasion has occurred, inhibition of FDC function has no effect on incubation 
period of peripheral challenged animals (Mabbott & Bruce 2002). 
1.4.3.2. Neuronal transport 
As previously stated infectivity has been demonstrated to travel rostrally from the 
spleen to the thoracic cord, spinal cord, and brain (Kimberlin & Walker 1979; 
Kimberlin & Walker 1980). Early evidence for the spread of infectivity within 
neurons was demonstrated by injecting ME7 directly into the mouse retinal vitreous 
body (intraocular) and also 139A scrapie directly into sciatic nerves (Fraser 1982; 
Kimberlin et al. 1983). Infectivity injected directly into PNS or CNS neurons avoids 
a pre -replication phase in the LRS, and the infectious agent travels to the brain. 
Peripheral inoculations into splenectomised or genetically asplenic mice indicate 
additional mechanisms for the spread of infectivity not requiring a pre -replication 
phase in the LRS. More recently, oral inoculation studies of hamsters with 263K 
scrapie have revealed the direct spread of infectivity via the splanchnic nerve to the 
mid -thoracic spinal cord and via the vagus nerve to the dorsal motor nucleus of the 
vagus nerve and solitary tract nucleus of the brainstem (Beekes et al. 1998; McBride 
et al. 2001). These findings correlate well with the primary detection of infectivity 
and PrPSc in the spinal cord and medulla obloganta following peripheral inoculations. 
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It appears that both the parasympathetic and sympathetic nerve circuitry is involved in 
the transport of infectivity and neuroinvasion (Beekes et al. 1998; McBride & Beekes 
1999; Glatzel et al. 2001), and that neuroinvasion is enhanced by overexpression of 
PrPc (Glatzel & Aguzzi 2000). 
The shortest incubation periods, when using comparable doses of infectivity to 
peripheral challenges, follow inoculations directly into the spinal cord or brain (i.c.) 
avoiding the pre -replication phase in the LRS. However, post -inoculation a large 
proportion of inoculum is cleared from the injection site and infectivity is detected in 
organs of the LRS such as the spleen (Millson et al. 1979). Infectivity remaining at 
the site of inoculation will replicate to critical levels in the CNS prior to the 
development of clinical disease. The delivery of infectivity directly to the CNS via 
i.c. inoculations represents an efficient means for establishing agent replication within 
the CNS. 
1.4.4. Neuropathology 
1.4.4.1. Accumulation of PrPs` 
Various immunological and biochemical techniques have been used to detect PrP° and 
PrPs°, although antibodies which apparently discriminate between the two 
conformations have yet to be made widely available. The sensitivity of PrP° to 
proteinase -K (but resistance of PrPSO) allows for the discrimination of the isoforms 
using Western and paraffin- embedded tissue blot techniques. In murine scrapie 
models, PrPs° deposition can be numerous or sparse, and the site of deposition, form, 
and structure is again dependent upon host/agent interactions (Fraser & Bruce 1983; 
Bruce et al. 1993). PrPs° deposition correlates with vacuolation and targeting can be 
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extensive or restricted to distinct neuronal populations depending upon the infecting 
strain and host. Digestion of PrP" by proteinase -K results in a protease- resistant core 
of 27 -30 kDa (PrP27 "30) when analysed by western blot. PrP' glycosylation has been 
used as a further means to differentiate between strains as the glycosylation of PrP in 
mice at asparginine residues 181 and 197 results in three distinct bands representing 
the diglycosylated, monoglycosylated, and unglycosylated forms. Differences in 
Pr-1' s° glycosylation have been described in human TSEs, with a specific pattern found 
for vCJD (Hill et al. 1999; Parchi et al. 2000). PrP' glycosylation can also vary 
between brain regions in scrapie- infected mice and human sCJD (Somerville 1999; 
Head et al. 2001). Futhermore, different PrP isotypes have been detected within a 
single sCJD brain, raising the possibility of more than one sCJD strain within a host 
(Head et al. 2004) or these findings reinforce the need for the analysis of a 
combination of pathological characteristics when discriminating between murine 
scrapie strains. 
1.4.4.2. Amyloid plaques 
Amyloid plaques consist of extracellular aggregated PrPs° molecules in a ß -sheet 
conformation, and are characteristic of some but not all TSE infections. Plaque 
deposition occurs in consistent, predictable and distinct patterns in vivo (Bruce et al. 
1989), and is thought that plaque formation originates at focal points along the length 
of dendrites and possibly along axons at nodes of Ranvier (Jeffrey et al. 1994). 
Primitive plaques initially lack a dense amyloid core and have few or no recognisable 
fibrillar components, but are thought to mature into classical fibrillar plaques upon the 
deposition of extracellular PrPs (Jeffrey et al. 1994). Mature plaques are composed 
of a dense core of amyloid fibrils, containing mainly disease -specific PrP, surrounded 
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by reactive astrocytes with abundant intermediate filament bundles and activated 
microglia (Doerr -Schott et al. 1990; Jeffrey et al. 1994). This aggregated PrP' is 
capable of binding extracellular compounds, including highly sulphated 
glycosaminoglycans (McBride et al. 1998). These observations suggest that 
aggregated and fibrillar forms of PrP are associated with damage to the neuropil. 
However, in defined areas pre -amyloid forms of PrP are also associated with selective 
damage to axon terminals and dendritic spines (Jeffrey et al. 1997). This axonal 
damage appears to be a highly specific process, at least in the initial stages of 
infection, therefore specific mechanisms or receptors confined to particular cells or 
neurites may be responsible for the selective neuronal damage corresponding to PrPS° 
accumulation. Initial characterisations of GSS amyloid proteins identified 7 and 11 
kDa PrP degradation products, indicating that GSS amyloid is formed as a result of 
the proteolytic cleavage of PrP (Tagliavini et al. 1991). The synthesis of peptides 
based on these GSS amyloid peptides identified the PrP106 -126 sequence as the most 
neurotoxic region and also revealed similarities to the biochemical properties of PrPS° 
(Forloni et al. 1993; Tagliavini et al. 1993; Forloni et al. 1994). The characterisation 
of amyloid peptides and the studies involving the human PrP106 -126 peptide 
sequence will be reviewed in Section 4 to introduce the work of this thesis involving 
the homologous murine PrP105 -125 synthetic peptide. 
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1.4.4.3. Neuronal loss, gliosis and tubulovesicular bodies 
Spongiform change is often accompanied by a number of other neuropathological 
features including neuronal loss, astrogliosis and microglial activation. Neuronal loss 
is not due solely to differences in the susceptibility of different subsets of neurons to 
the disease process, but is also influenced by the host /strain combination (Bruce et al. 
1976). Neuronal loss in murine scrapie models is thought to occur concurrently with 
vacuolation, but the mechanisms of neurodegeneration in relation to accumulating 
PrPSO have yet to be determined. Clear detection of neuronal loss in murine scrapie 
models is found in CA1 sector of hippocampal neurons in mice infected with ME7 
scrapie and in the photoreceptor retinal cells following infection with 79A scrapie 
(Scott & Fraser, 1984; Foster 1986). CA1 hippocampal neuronal loss in ME7 scrapie 
infections is extensive by the terminal stages of disease but such loss has been poorly 
described in other strains, presumably due to a rapid clearance of dead or dying cells 
from the neuropil. The rapid clearance of cells with abnormal neuronal functions, 
estimated between 200 -300 cells per day, is indicative of apoptosis. Apoptosis has 
been suggested as a mechanism of cell death in TSE infections, and evidence for 
apoptosis in TSE infected hosts has been documented. These mechanisms are 
described in further detail in Section 3. Astrocytosis and activated microglia are non- 
specific neuropathological characteristics of TSE infection, and again their precise 
functions are unclear. Astrocytosis appears to be closely associated with neuronal 
loss, and astrocytosis and microglial stimulation can be prominent in the hippocampus 
and thalamus (Fraser 1979). Glial cells express PrPc, and astrocytes have been 
demonstrated to support replication of PrPSO and therefore contribute to disease 
susceptibility (Raeber et al. 1997). Co- localisation of glial cells with amyloid plaques 
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and PrPs° deposition has been reported, and it is probable that the stimulation of these 
cells is a consequence of the deposition of PrP'. 
Tubulovesicular bodies (TVBs) are spherical, particulate structures which are 23- 
45mm in diameter (David -Ferreira et al. 1968). TVBs are consistently detected in the 
brains of naturally and experimentally infected animals. TVBs have been recorded in 
many murine scrapie isolates, in natural scrapie, CJD, GSS, FSE and in BSE (Liberski 
et al. 1993). The origins of TVBs are unknown, but are detected prior to the 
described pathological hallmarks and increase in quantity with progression of the 
incubation period (Narang et al. 1987). Increasing quantities of TVBs correlate with 
increasing titres of infectivity, however TVBs appear devoid of and do not associate 
with PrP (Liberski et al. 1997; Jeffrey & Fraser 2000; Jeffrey & Fraser 2001). The 
roles of TVBs and gliosis in TSE pathogenesis remain unclear, but are important not 
only in strain discrimination but in understanding the neuropathology of TSE 
infectious agents. 
1.4.5. The ME7 /CV and 87V/VM models 
The ME7 murine scrapie strain was isolated from a naturally infected Suffolk sheep 
(Zlotnik & Rennie 1963) and isolated in C57BL mice (Section 1.2.1.), whereas the 
87V strain was isolated by from a naturally infected Scottish Blackface Cheviot cross 
following passage in VM mice (Bruce 1985; Bruce & Dickinson 1987). The 
ME7 /CV and 87V/VM combinations are two distinct murine scrapie models; differing 
in incubation periods, sequence of pathological hallmarks and targeting of neuronal 
populations when inoculated by i.c. inoculation. PrPs in both models is located 
within neuronal cell membranes and surrounding neuropil in association with the 
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extracellular space. However, the intensity and targeting of PrP50 to neuronal 
populations differs. These murine scrapie models target many different brain areas 
but due to the well characterised nature of the neuronal connections of the 
hippocampus, a large quantity of research has concentrated on the effects of these 
strains on this area. 
The CVF1 cross (Prnpab) inoculated i.c. with ME7 results in consistently severe 
hippocampal vacuolation and an incubation period of approximately 250 days (Scott 
& Fraser 1984). Vacuolation, gliosis and diffuse granular deposits of PrPSO are 
widespread in all brain areas in animals infected with ME7, although differing in 
severity between regions (Figures 1.2. and 1.4.A.). PrPSO deposition is widespread 
within the hippocampus, whereas vacuolation and neuronal loss are specifically 
targeted to the CA1 hippocampal subfield. PrPSO is first detected at -70 days post 
inoculation (dpi) in the hippocampus by immunocytochemistry (ICC) (Jeffrey et al. 
2001), whereas infectivity is detected -50dpi. This observation suggests a lack of 
correlation between infectivity and PrPsc in this model. At approximately 100dpi; 
astrogliosis, vacuolation and a decrease in long -term potentiation are evident within 
the hippocampus (Johnston et al. 1997). Abnormalities such as the loss of neuronal 
axon terminals and synapses are also found following detection of PrP50 (Jeffrey et al. 
2000). Dendritic abnormalities are detectable from 100dpi but by terminal stages of 
disease there may be complete or partial loss of dendritic spines and spherical 
distensions of the dendrites (Belichenko et al. 2000; Brown et al. 2001). Amyloid 
plaque deposition is rare in this model but aggregated fibrillar PrP can be observed in 
the hippocampus at -154dpi by electron microscopy (Jeffrey et al. 2000). Clinical 
signs of disease appear at -188 dpi, and death is within weeks. 
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VM mice (Prnpb) inoculated with the 87V agent develop a disease with an incubation 
period of approximately 320dpi and a series of neuropathological changes differing in 
sequence to that of the ME7 /CV model. Vacuolation and deposition of PrPSO appear 
to be targeted to specific neuronal populations; including neurons of the CA2 region 
of the hippocampus, the dorsal lateral geniculate nucleus, and the thalamus. In 
contrast to the ME7 /CV model PrPs° is first detected in the hippocampus at 
approximately 200dpi. This deposition is preceded by dendritic dysfunction, 
astrogliosis, vacuolation and neuronal damage (Belichenko et al. 2000; Jeffrey et al. 
2000) (Figures 1.3. and 1.4.B.); therefore pathological features do not appear to be as 
a direct consequence of PrPs deposition in this model. Dendritic dysfunction 
(- 70dpi) is a further pathological feature localised to the CA2 pyramidal neurons. 
Amyloid plaques are common, particularly in the hippocampus and cerebral cortex 
where the plaques appear as mature dense plaques containing amyloid fibrils and 
surrounded by activated microglia (Bruce & Fraser 1975). The primary target for the 
initiation of neurodegeneration in TSE infections remains unknown, however 
evidence for apoptosis in the CA2 hippocampal subfield in vivo has been documented 
by the detection of the up- regulation of Fas and active Caspase 3 100dpi in the 
87V/VM model (Jamieson et al. 200la; Jamieson et al. 2001 b). No such evidence for 
a similar mechanism has yet been detected in the ME7 /CV model, although the 
difficulties in detecting apoptosis in vivo will be discussed in Chapter 3. 
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Figure 1.2 Immunohistochemical staining of coronal brain sections of animals from the 
ME7 /CV murine scrapie model 
ICC (Section 2.2.3) analysis of serial sections of paraffin- embedded terminal ME7 /CV murine 
brain sections. Primary and secondary antibodies used in the analysis are described in Tables 2.1 
& 2.2. Bound antibodies were detected with the ABC kit and diaminobenzidine, resulting in the 
brown precipitate, and neurons were "blued" for contrast using Scott's Tap water (Section 2.2.3). 
Analysis of apoptotic cell death was concentrated in the Hippocampus (Hip) and Thalamus (Tha), 
described in Chapter 3. 
(A) Accumulation of PrPSO (anti -PrP 6H4 antibody), neuronal loss, and vacuolation within the 
CA1 hippocam pal subfield 
(B) Glial fibrillary acidic protein ICC analysis shows numerous reactive astrocytes 
(C) Biotinylated tomato -lectin ICC analysis shows activatation of microglia 
(D) Wide- spread accumulation of PrPs (including the cerebral cortex, hippocampus and thalamus) 
using the anti -PrP 6H4 antibody. 
All magnifications were at x40, except D which was at x2 
34 Chapter 1: Introduction 
Figure 1.3 Immunohistochemical staining of coronal brain sections of animals from 
the 87VNM murine scrapie model 
ICC (Section 2.2.3) analysis of serial sections of paraffin- embedded terminal 87VNM murine 
brain sections. Primary and secondary antibodies used in the analysis are described in 
Tables 2.1 & 2.2. Bound antibodies were detected with the ABC kit and diaminobenzidine, 
resulting in the brown precipitate, and neurons were "blued" for contrast using Scott's Tap 
water (Section 2.2.3). Analysis of apoptotic cell death was concentrated in the Hippocampus 
(Hip) and Thalamus (Tha), described in Chapter 3. 
(A) Accumulation of PrPS6 (anti -PrP 6H4 antibody), disruption to, and vacuolation within the 
CA2 hippocampal subfield 
(B) Glial fibrillary acidic protein ICC analysis shows numerous reactive astrocytes 
(C) Biotinylated tomato -lectin ICC analysis shows activatation of microglia 
(D) Amyloid plaques (typical of the 87VNM model) immunoreactive with the 6H4 anti -PrP 
antibody. 
(E) Wide- spread accumulation of PrPSO (including the hippocampus and thalamus) using the 
anti -PrP 6H4 antibody. 
All magnifications were at x40, except E which was at x2. 
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Figure 1.4 Haematoxylin and eosin (H &E) stained coronal sections (Section 2.2.2) 
demonstrating the vacuolation of coronal brain sections of representative animals from 
the (A) ME7 /CV and the (B) 87VNM murine scrapie models 
Haematoxylin & Eosin staining of paraffin- embedded tissue sections of murine brain samples at 
the terminal stages of the (A) ME7 /CV and (B) 87VNM murine scrapie models (sections were 
parallel to those analysed for the ICC analysis in Figures 1.2 and 1.3). H &E was performed as 
described in Section 2.2.2. and sections show widespread degeneration of the neuropil. 
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1.5. In Vitro TSE models 
Murine scrapie models have been crucial for increasing our knowledge of TSE 
disease, however the development of cell culture models for more detailed 
biochemical analysis of TSE infections is also important. The generation of in vitro 
models of TSE disease have reported various mechanisms for cell death, something 
which is often difficult to detect in vivo if apoptosis is involved. The long incubation 
periods of naturally and experimentally infected animals, economic considerations of 
animal husbandry, and often the relatively large numbers of animals required for 
statistically significant results all favour the development of an in vitro model for 
understanding the neurodegenerative processes of these diseases. 
Difficulties in establishing a successful in vitro TSE model began with the 
observations that many cell lines are resistant to TSE infection. The first successful 
propagation of scrapie within a cell culture system was from a mouse brain 
challenged with the Chandler murine scrapie strain, which maintained infectivity 
upon sub -pass indicating that replication of the agent was occurring and maintained 
within dividing cells (Clarke & Haig 1970; Clarke & Haig 1970). The cell line is of 
mesodermal origin and has been termed the scrapie mouse brain (SMB) culture. 
Infection of a cell line can only be confirmed by taking cells from different sub - 
passages and performing a mouse bioassay to confirm the presence of infectivity, and 
also for analysis of protease- resistant PrPSO. The Chandler strain can be eradicated by 
treatment with pentosan sulphate and SMB cultures remain susceptible to challenge 
with other scrapie strains, successfully maintaining infectivity and strain -specific 
characteristics as confirmed by bioassay (Birkett et al. 2001). Further attempts to 
establish cell culture models for TSEs include the mouse L cell fibroblasts (Clarke & 
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Millson 1976), PC12 cells (Rubenstein et al. 1984), spontaneously immortalised 
hamster brain cells (HaB) (Taraboulos et al. 1990), mouse neuroblastoma N2a cells 
(Butler et al. 1988; Race et al. 1988), and mouse -derived T- antigen -immortalised 
hypothalamic neurons (GT1 cells) (Mellon et al. 1990; Schätzl et al. 1997). In more 
recent years attempts have been made to establish in vitro models for familial TSE 
diseases using a human neuroblastoma cells line (M 17) (Petersen et al. 1996), 
transformed mouse fibroblasts (3T3) (Priola & Chesebro 1998), and the Chinese 
hamster ovary cells (CHO) (Daude et al. 1997). It has now been reported that clones 
of CHO cells expressing mutant PrP have been created as models for GSS, FFI and 
sCJD (Harris 1999). However in attempts to replicate the neuronal effects observed 
in vivo, many researchers have concentrated on the neuronal PC12 and N2a cell 
cultures. 
1.5.1. Hippocampal organotypic slice cultures 
The ideal in vitro model for studying neurodegeneration would be to establish an 
organotypic slice culture system, a novel concept for application to TSE research. 
Organotypic slice cultures (derived from embryonic or neonatal animal tissues) are 
advantageous to dissociated cell cultures in that they retain the original 
cytoarchitecture of the tissue of origin, synaptic connections, differentiation of 
neurons, and almost normal physiological and morphological characteristics of cells 
in vivo (Gahwiler 1984; Gahwiler 1988; Gahwiler et al. 1997). This project was 
initially designed to investigate the feasibility of such a system using murine 
hippocampal slices as a means to maintain in vivo properties in vitro. Organotypic 
cultures would therefore allow the development and execution of more detailed 
research into the effects of various controlled conditions on neuronal tissues. The 
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effects of scrapie infection or treatment with toxic prion peptides (Forloni et al. 1993; 
Tagliavini et al. 1993) would allow more detailed studies on neuronal loss and cell 
death in these diseases. Unfortunately, technical difficulties prevented the successful 
development of such a model for this thesis, and this research has concentrated on the 
well characterised PC12 culture systems as a means to study neuronal cell death when 
exposed to toxic prion peptide sequences. 
1.5.2. N2a Cells 
Murine neuroblastoma cells (N2a) cells (Klebe & Ruddle 1969) were established as a 
model for TSE infection following their successful infection with murine scrapie and 
CJD, resulting in the production of abnormal PrP (Butler et al. 1988). Scrapie 
infected N2a cells (ScN2a) produce abnormal PrPsc with the biochemical and physical 
properties already described in Table 1.2 however, these cells are only capable of 
propagating low levels of infectivity (Race et al 1987; Race et al. 1988). ScN2a cells 
containing PrPse and the highest levels of infectivity have been selected and sub - 
cloned. It is estimated that 80 -90% of ScN2a cells will be infected and contain a titre 
of infectivity of 105 ID50 /107 cells (Butler et al. 1988; Race et al. 1988; Bosque & 
Prusiner 2000). These cloned N2a and ScN2a cells have been used extensively for 
the analysis of PrPsc formation and localisation. However, the highly cloned nature of 
these cells raises the possibility of clonal artefacts between cultures and may alter the 
comparability of data between researchers using these cells. The highly characterised 
neuronal PC12 cell line has been used for the research of neurodegenerative 
mechanisms in this thesis. 
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1.5.3. PC12 cells 
The PC12 cells are derived from a transplantable rat adrenal pheochromocytoma, and 
are of neural cleft origin (Greene & Tischler 1976). PC12 cells differentiate into a 
neuronal phenotype when cultured with nerve -growth factor (NGF), when mitosis is 
reduced and the cells acquire the morphological, biochemical and physiological 
properties of differentiated sympathetic neurons. Differentiation with NGF results in 
neurite extension (500- 1000µm), electrophysiological responsiveness and the 
synthesis of neurotransmitters. This differentiation is reversible, and within 72 hours 
of NGF withdrawal, cells de- differentiate and mitosis resumes (Greene & Tischler 
1976). It is thought that NGF causes the neuronal differentiation in vivo of stem cells 
migrating from the neural cleft (Bjene & Bjorklund 1973). It is therefore believed 
that PC12 cells are equivalent to such early progenitor cells, differentiating to the 
neuronal phenotype in vitro in the presence of NGF. It is also now known that NGF - 
differentiation increases PrPc expression (Wion et al. 1988; Lazarini et al. 1994), 
which may contribute to the susceptibility of cells to infection with TSE agents. 
Undifferentiated (naive) cell cultures are unable to maintain infectivity when treated 
with the 139A (Chandler) scrapie strain, whereas differentiated cultures are 
susceptible to infection and successfully propagate infectivity for several sub - 
passages (Rubenstein et al. 1984; Rubenstein et al. 1990). Differentiated PC12 cell 
cultures are also susceptible to infection with the MET scrapie strain, but infectivity 
titres are at much lower levels than with 139A. Differentiated PC12 cells are resistant 
to infection with the hamster scrapie strain 263K and surprisingly do not permit 
replication of the rat -passaged 139R scrapie strain (Rubenstein et al. 1992). Scrapie 
infections do not result in obvious altered morphology of PC12 cells. The relative 
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lack of cytopathological features is a common feature of scrapie- infected cell cultures 
and has been commonly reported for the other cell lines already mentioned. 
However, scrapie infection can alter a number of biochemical properties of infected 
PC12 cells. Infection of differentiated PC12 cells with either 139A and ME7 scrapie 
interferes in a dose -dependent manner with excitatory neurotransmittors of the 
cholinergic signalling pathway (acetylcholinesterase and choline acetyltransferase) 
and the inhibitory neurotransmitter y- aminobutyric acid, but not with adrenergic 
signalling mechanisms (tyrosine hydroxylase) (Rubenstein et al. 1994). These 
disruptions to cholinergic pathway enzymes have also been confirmed in N2a cells 
infected with 139A (Race et al. 1987). 
PC12 cell culture systems have been used extensively for modelling the neurotoxic 
effects of PrPse in vivo using the synthetic human peptide PrP 106 -126 (HuPrP 106- 
126). In addition to HuPrP 106 -126, PC12 cells have been used for modelling other 
amyloidogenic diseases such as Alzheimer's disease using the 13- amyloid peptide 
(Shearman et al. 1994). The studies of the HuPrP106 -126 peptide will be detailed in 
Section 4 in relation to the work of this thesis in the analysis of the mouse synthetic 
peptide PrP105 -125 (MoPrP105 -125). The PC12 cell culture system therefore 
represents a good model for the in vitro modelling of the neurotoxic and 
neurodegenerative processes of TSE diseases. The investigation of such processes 
has led to the development of two main types of in vitro PrP conversion reaction (as 
discussed in Section 1.3.2), which may prove to be even more effective in 
understanding the progression of these diseases. The cell free conversion (Kocisko et 
al. 1994) has shown us that direct interactions between PrP° and PrPsc can account for 
the observed species barrier effects when new strains are introduced into a new host 
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(Kocisko et al. 1995). The PMCA reaction (Saborio et al. 2001) has proved to be 
more efficient for converting PrP° to PrPfeS molecules. Future research using this 
technique may prove to be an invaluable tool for; (1) the pre -clinical identification of 
TSE diseases, (2) the identification of PrP interacting proteins, and (3) the testing of 
therapeutic agents to break disease -specific PrP aggregates or even better prevent 
their formation. Increased understandings of the neurodegenerative mechanisms of 
these diseases could allow intervention strategies to be developed in an effort to 
inhibit the neurodegenerative processes. 
As mentioned above, the research of this thesis concentrated on the in vitro use of a 
synthetic PrP peptide corresponding to the most conserved region of the PrP protein. 
These shorter synthetic peptides are based on the 7 and 11 kDa peptides found in 
amyloid from individuals diagnosed with GSS (Forloni et al. 1993; Tagliavini et al. 
1993). These synthetic peptides harbouring fibrillogenic and neurotoxic properties, 
are fully discussed in Chapter 4, and have been used in this thesis to better understand 
the peptide conformations which might in vivo represent neurotoxic PrP 
conformations. Understanding the mechanisms resulting in the formation of 
neurotoxic PrP conformations may therefore allow strategies to be developed which 
prevent the initiation of neuronal cell death in these diseases. However, the 
mechansisms resulting in this neuronal loss are also poorly understood. Apoptosis, or 
programmed cell death (discussed in Chapter 3), has been identified as a mechanism 
of neuronal cell death following treatment with neurotoxic PrP peptides in vitro and in 
vivo (Forloni et al. 1993; Tagliavini et al. 1993; Ettaiche et al. 2000); and also in 
human TSE diseases and in murine scrapie disease models (Giese et al. 1995; 
Lucassen et al. 1995; Fraser et al. 1996; Jesionek -Kupnicka et al. 1997; Dorandeu et 
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al. 1998; Gray et al. 1999; Jamieson et al. 2001a; Puig & Ferrer 2001). Evidence for 
apoptosis in the TSEs will be described in depth in Chapter 3. The precise apoptotic 
pathways involved in executing the neuronal cell death process in the TSEs are not 
clear, but understanding these pathways represents an opportunity to interrupt the 
cellular mechanisms of neurodegeneration. This research has included the analysis of 
caspase -independent mechanisms of apoptotic cell death in two well described murine 
scrapie models, the ME7 /CV and 87VNM models described in Section 1.4.5. The 
involvement of caspase- independent proteins in models of other neurodegenerative 
diseases (Chapter 3) had been reported at the time of the conception of the work 
described in this thesis, therefore representing a novel and highly relevant potential 
pathway of neuronal cell death in the TSEs. The inclusion of this research was felt to 
be important as the identification of the precise mechanisms of cell death in these 
diseases may lead to future techniques which prevent the cell death processes in these 
and other neurodegenerative diseases. 
1.6. Thesis aims 
The aims of this thesis were therefore to: 
Establish a reproducible in vitro model suitable for analysing the mechanisms 
of neurodegeneration associated with the TSE diseases 
Use the established in vitro model to analyse the relationship of fibril structure 
to neurotoxicity 
Assess the role of caspase- independent mechanisms of neuronal cell death in 
vivo using the ME7 /CV and 87VNM murine scrapie models and in vitro using 
the above model of neurodegeneration 
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Chapter 2: Materials and Methods 
2.1 Experimental animal procedures 
2.1.1 Experimental animal groups and murine scrapie strain combinations 
Animals were taken from the specified pathogen free colony maintained at the 
Institute for Animal Health, Neuropathogenesis Unit in Edinburgh. Animal -related 
procedures comply with the Animals (Scientific) Act of 1986 in accordance with 
Home Office regulations. The two inbred mouse strains inoculated in these 
experiments were the VM/Dk (VM, Prnpb genotype) inoculated with the 87V murine 
scrapie strain, and the F1 cross between C57B1/Dk and VM/Dk (CV, Prnpab 
genotype) inoculated with the ME7 murine scrapie strain. The incubation period and 
neuropathological details of these mouse and scrapie strain combinations have been 
detailed in Section 1.4.5. 
2.1.2 Animal husbandry 
Experimental animals were maintained in a tightly controlled environment and 
checked twice weekly at cleaning. Animals were kept in cages of up to six animals at 
a constant temperature between 19 -23 °C, with a 12 hour light /dark cycle to minimise 
animal stresses. Infected and uninfected controls were maintained in separate cages 
to prevent possible transmission through cannibalism. The specified pathogen -free 
status of the colony was sustained by a number of measures including autoclaving the 
animal bedding, irradiating solid food pellets and maintaining the water at an acidified 
pH of 2.3 -3.0. Scoring for clinical signs of disease (by the staff of the animal unit) 
begins in the weeks prior to their expected development, and was continued on a 
weekly basis until the terminal stages of disease. Clinical signs are dependent upon 
the murine scrapie /host combination but include lethargy, hyperactivity, altered gait, 
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weight loss /gain, "startle" reflex and scratching behaviour. Animals were culled at 
the clinical end -point as it would be inhumane to prolong the suffering of infected 
animals. The clinical end points for the 87VNM (and NBNM control) and the 
ME7 /CV (and NB /CV control) animals were approximately 320 dpi and 250 dpi 
respectively. 
2.1.3 Scrapie inoculation and tissue collection procedures 
2.1.3.1 Inoculum preparation 
Inoculum for injection was prepared from the brains of animals which had reached the 
terminal stages of disease. Brains were removed using aseptic techniques and stored 
at -20 °C, or below, until required. Brains were thawed, weighed, and homogenised in 
0.9% sterile saline. Microbial contamination was minimised through the use of sterile 
single -use instruments and by screening inoculum for microbial content. 
2.1.3.2 Intracerebral inoculation 
Mice under halothane anaesthesia were injected by intracerebral inoculation into the 
right frontal cortex with a 25 gauge needle fitted with a 2mm needle guard to prevent 
penetration of the needle beyond the outer cortical layers. Mice were inoculated with 
2011l of 1% brain homogenates prepared from scrapie- infected animals at the terminal 
stages of disease. Cohorts of control animals were inoculated with equivalent 
volumes of normal brain homogenates. Mice in these experiments were inoculated by 
the trained staff of the animal facility. 
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2.1.3.3 Mouse brain collection 
All experimental animals were culled by cervical dislocation at the terminal stages of 
disease by the experienced staff of the animal handling facility. The skin was 
carefully cut from the hind- to fore -brain, the skull was cut open and the whole brain 
carefully removed. Brains for histopathological analysis were fixed and processed 
(Section 2.2.), whereas brains for biochemical analysis were snap- frozen in liquid 
nitrogen and samples homogenised or micro -dissected (Section 2.3.) immediately and 
proteins extracted (Section 2.3.1. or 2.3.2.2.). The ages of the animals for the 
87V/VM experiment were sacrificed at 322, 322 and 319 dpi, an aged- matched 
NB/VM control was also taken for each time point. The three animals for the 
ME7 /CV experiment were sacrificed at 248 dpi, aged- matched NB /CV controls were 
also taken at the same time point. 
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2.1.4 Antibodies 
2.1.4.1 Primary antibodies 









Anti -PrP 8H4 Mouse 
Monoclonal 
1/30,000 1 /1000 1 /200 
Anti -PrP 6H4 2 Mouse 
Monoclonal 
1/30,000 1 /1000 1/400 
Glial Fibrillar acidic 
protein (GFAP) 3 
Rabbit 
Polyclonal 
n/a 1/400 n/a 
Tomato lectin 
(biotinylated) 4 





n/a n/a 1/600 




0.4 µg /ml n/a n/a 
Endonuclease G 
(Endo G) 7 
Rabbit 
Polyclonal 
0.5 µg /ml n/a n/a 




1 /15,000 n/a n/a 
VDAC /Porin -19 Rabbit 
Polyclonal 
1/2000 n/a n/a 
Cytochrome c 1° Mouse 
Monoclonal 
0.2 µg /ml n/a n/a 
Active caspase -3 
(alexa 488 conjugated) 11 
n/a n/a n/a 1 /10 
Anti -PrP 1B3 12 Rabbit 
Polyclonal 
n/a 1 /1000 1/400 
Table 2.1 Primary antibodies used in TSE research for Western blot, 
immunocytochemistry (ICC) and fluorescence activated cell sorting (FACS) analysis 
1(Li et al. 2000); 2(Korth et al. 1997); 3 Supplied by DAKO; 4 Supplied by Sigma, 1 mg /ml stock 
solution; 3 -3 Supplied by Abcam Ltd; 10 Supplied by Chemicon Incorporated, 0.2 mg /ml stock 
solution. This antibody recognises residue 64 which is exposed only by the conformation 
adopted by holocytochrome c; 11 Supplied by Cell Signalling Technologies. This antibody 
recognizes only active caspase -3 which is cleaved at Asp175 (17/19 kDa); 12 Farquhar et al. 
1989 
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2.1.4.2 Secondary antibodies 
Antibody 
Goat anti -mouse 
Alexa -488 1 
l- IRP /lluorochrome/ 
Biotinylated 
Fluorochrome 











Goat anti -mouse HRP con'u ' ated 1/30000 n/a n/a 
Goat anti -rabbit HRP con'u ' ated 1/30000 n/a n/a 
Rabbit anti -mouse Biotin lated n/a 1/400 n/a 




con'u ' ated 
n/a 0.2µg /m1 n/a 




n/a n/a 1/200 
Table 2.2 Secondary antibodies used in TSE research for Western blot, 
immunocytochemistry (ICC) and fluorescence activated cell sorting (FACS) analysis 
1,6 Supplied by Molecular Probes Ltd, 1mg /m1 and 0.5mg /m1 stock solutions respectively; 
2 -3 
Supplied by Upstate Ltd, 1 mg /ml stock solutions; 4 -5 Supplied by Jackson Laboratories (USA), 
1mg /m1 and 0.9mg /m1 stock solutions respectively; 7 Supplied by Sigma Immunochemicals 
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2.2 Processing of tissues for pathological analysis 
2.2.1. Brain fixation, processing and cutting procedures for paraffin -embedded 
tissues 
Brains removed for histopathological analysis were fixed overnight in 10% formol 
saline, decontaminated in 98% formic acid for 60 minutes, and returned to 10% 
formol saline prior to embedding in paraffin wax. Brains were transferred to an 
automated tissue -embedding processor (Jung TP, Leica) and processed for embedding 
in wax following a routine dehydration protocol (Table 2.3). 
Solution 
70% alcohol 
Duration in solution 
40 minutes 
80% alcohol 40 minutes 
95% alcohol 40 minutes 
99% alcohol 40 minutes 
99% alcohol 40 minutes 
99% alcohol/Xylene (equal parts) 30 minutes 
99% alcohol/Xylene (equal parts) 30 minutes 
Xylene 30 minutes 
Xylene 30 minutes 
Paraffin wax 25 minutes 
Paraffin wax 25 minutes 
Paraffin wax 25 minutes 
Table 2.3 Automated tissue processing procedure for 10% formol saline fixed 
formic acid treated mouse brains for embeddin in araffin wax 
Tissues were removed from the automated processor, trimmed coronally at four 
standard cutting levels (Figure 2.1) and orientated within a cassette for embedding in 
hot paraffin wax (Figure 2.2). Prior to cutting sections for routine histopathological 
and immunocytochemical analysis, blocks were trimmed of excess wax and cooled on 
ice for 2 hours. Cooled blocks were then cut at 6µm using a microtome, serial 
sections floated in a water bath at 37 °C, and sections transferred to Superfrost -Plus 
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slides. Sections were air dried overnight at room temperature, oven dried for 2 days 




Figure 2.1 Mouse brain sectioning levels for immunocytochemical and Haematoxylin 
& Eosin staining 
Blue lines indicate the brain sectioning levels used routinely for histopathological analysis. 
Brains are cut coronally (from fore to hind brain) at the septum, hippocampus, superior 
colliculus, and cerebellum & medulla (Fraser & Dickinson 1968) 
Figure 2.2 Alignment of coronal mouse brain sections in paraffin wax embedded 
blocks 
Mouse brains are cut at the coronal levels described in Figure 2.1. 
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2.2.2 Haematoxylin and Eosin staining 
Paraffin- embedded 6µm tissue sections (Section 2.2.1.) were stained with 
haematoxylin and eosin for histopathological analysis, including vacuolation scoring. 
Sections were stained using an automated staining process (Table 2.4). 
Solution 
Xylene 
Duration in solution 
5 minutes 
Xylene 5 minutes 
90% alcohol 2 minutes 
90% alcohol 2 minutes 
95% alcohol 1 minute 
99% alcohol 3 minutes 
Haematoxylin 3 minutes 
Haematoxylin 3 minutes 
Scott's Tap Water 2 minutes 
Scott's Tap Water 3 minutes 
Putts Eosin 0.5 minutes 
Putts Eosin 2.5 minutes 
1.5 minutes 
95% alcohol 0.5 minutes 
95% alcohol 0.5 minutes 
99% alcohol 0.5 minutes 
99% alcohol 0.5 minutes 
99% alcohol /Xylene (equal parts) 1 minute 
Xylene 1 minute 
Xylene 1 minute 
Xylene 1 minute 
Table 2.4 Automated rocess for Haematox lin & Eosin stainin 
Standard protocol for the analysis of tissue sections by Haematoxylin & Eosin in the 
analysis of the pathology related to infection with TSE disease (as described in Figure 1.4) 
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2.2.3 Immunocytochemical analysis of paraffin- embedded samples 
Paraffin -embedded 6µm tissue sections (Section 2.2.1.) were hydrated by passage 
through alcohols (Table 2.5) to water prior to immunocytochemical (ICC) analysis. 
Solution 
Xylene 
Duration in solution 
5 minutes 
Xylene 5 minutes 
99% alcohol 3 minutes 
94% alcohol 3 minutes 
70% alcohol 3 minutes 
Table 2.5 Hydration procedure of paraffin- embedded tissue sections for ICC analysis 
Standard protocol for the hydration of paraffin- embedded tissue sections prior to analysis by 
ICC 
If samples were to be labelled for PrP using 6H4 (Table 2.1), antigen unmasking was 
achieved by autoclaving hydrated sections at 121°C for 15 minutes in dH2O followed 
by immersion in 98% formic acid for 5 minutes. If labelling sections for astrocytes 
(glial fibrillary acidic protein (GFAP)) or microglia (tomato lectin) (Table 2.1), these 
pre- treatments were not required. Endogenous peroxidases were blocked by 
incubation for 10 minutes in 1% hydrogen peroxide in methanol, followed by 
thorough washes in dH2O. If labelling for GFAP or PrP, non -specific antibody 
labelling was prevented by incubation of samples with 1O0111 of 1/20 normal serum 
for 20 minutes at room temperature (The normal serum chosen to block was from the 
same species used to raise the secondary antibody). Normal serum was gently 
removed, without washing sections, and 1O010 of the primary antibody incubated 
overnight (if 6H4 or tomato lectin) or for 1 hour (if GFAP) at room temperature. 
Primary antibodies were removed by 3 washes each for 5 minutes in 250m1 wash 
buffer; PBS /BSA (for GFAP and PrP) or TBS pH 7.6/1% Triton x -100 (for tomato 
lectin). If labelling for PrP or GFAP, 100111 of biotinylated secondary antibody (Table 
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2.2) was added to each slide and incubated for 60 minutes at room temperature. 
Secondary antibodies were removed by 3 washes each for 5 minutes in 250m1 
appropriate wash buffer. Avidin- Biotin complex (ABC) -solutions were prepared by 
adding 101..l reagent A and 10µl reagent B to 1000µ1 antibody diluent (for GFAP or 
PrP) or to l000111 TBS (for tomato lectin). 100µ1 of ABC Elite was added to each 
slide and incubated at room temperature for 30 minutes; followed by 3 washes each 
for 5 minutes in 250m1 appropriate wash buffer. ABC bound to specific epitopes was 
visualised by immersing slides into 0.05% diaminobenzidine (DAB) in lx PBS 
activated with 0.025% hydrogen peroxide. DAB staining was performed for 3 -5 
minutes and slides washed thoroughly in dH2O then counterstained and dehydrated 
(Table 2.6) prior to cover -slipping sections with DPX mountant (BDH). To determine 
the specificity of labelling, duplicate sections were incubated with 1 /1000 normal 
serum and processed as detailed above (The normal serum chosen was from the same 
species used to raise the primary antibody). Staining was analysed by light 
microscopy (E800, Nikon) and images were captured with the digital camera 
(Micropublisher 5.0 RTV) and images captured using the Image Pro Plus software. 
Solution Duration in solution 
Haematoxylin 1 minute 
Scott's Tap Water 0.5 minutes 
Distilled Water 5 minutes 
70% alcohol 3 minutes 
94% alcohol 3 minutes 
99% alcohol 3 minutes 
99% alcohol 0.5 minutes 
99% alcohol / Xylene (equal parts) 0.5 minutes 
Xylene 1 minute 
Xylene 1 minute 
Xylene 1 minute 
Table 2.6 Counterstainin and deh dration .rocedure for araffin- embedded tissue 
sections following the ICC protocol 
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2.3 Western blot analysis of murine brain samples 
2.3.1 Sub -cellular fractionation of whole brain samples by sucrose gradients 
Snap- frozen brain samples were partially thawed on ice and weighed in pre- cooled 
Dounce homogenisers. 10% brain homogenates were prepared by adding 9x 
volumes /weight of 0.32M sucrose solution to each sample, in a method adapted from 
a published protocol (Merz et al. 1981) in consultation with Robert Somerville (IAH, 
Edinburgh). Protease degradation was inhibited by adding phenylmethanesulfonyl 
fluoride (PMSF) and N- ethylmaleimide (NEM) at final concentrations of 1 mM to 
each sample. All techniques were performed on ice, or where possible at 4 °C. Brains 
were gently homogenised with 20 -30 strokes of the pestle, transferred to 15ml 
centrifuge tubes (Corning) and centrifuged at 1000g (2250rpm) for 10 minutes (GS- 
GR centrifuge) (Figure 2.3). Supernatants were carefully removed and the nuclear 
pellet discarded. Centrifugation was repeated to enhance the purity of the fractions. 
Supernatants were aliquoted into 2m1 centrifuge tubes (Corning) and centrifuged at 
10,000g (9,500rpm) for 10 minutes (JA20 rotor, J2 -21 centrifuge). The pellet 
represents the crude mitochondrial extract and the supernatant the crude cytosolic 
fraction. Crude mitochondrial extracts were re- suspended in 1ml 0.32M sucrose and 
layered on top of 3m12M sucrose solution in 4ml centrifuge tubes. Samples were 
centrifuged at 100,000g for 60 minutes and supernatants gently removed and 
discarded. Residue was carefully cleaned from the inside of each centrifuge tube and 
crude mitochondrial pellets re- suspended in lml 0.8M sucrose solution. Extracts 
were carefully layered onto 1.5ml of 1.0M sucrose solution layered onto 1.5ml of 
1.2M sucrose solution in new 4m1 centrifuge tubes. Samples were centrifuged at 
100,000g for 60 minutes and supernatants gently removed and discarded. Residue 
was carefully cleaned from the inside of each centrifuge tube and pellets re- suspended 
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(10,000g 10 mins) 
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Cytosol extract purified 
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Figure 2.3 Centrifugation protocol for the subcellular fractionation of crude brain 
extracts into mitochondria) and cvtosolic fractions 
Frozen ( -70 °C) mouse brains were thawed and 10% homogenates prepared in 0.32M sucrose 
(Section 2.3.1.). Samples were centrifuged at 1000g for 10 mins at 4 °C and nuclear deposits 
discarded. The supernatant was centrifuged at 10,000g for 10 mins at 4 °C, and the supernatant 
(crude cytosol) carefully separated from the pellet (crude mitochondria). The cytosol was 
purified by ultracentrifugation at 100,000g 60 mins at 4 °C. The pellet was resuspended in 1m1 
0.32M sucrose and layered onto 3m1 2M sucrose and centrifuged at 100,000g for 60 mins. The 
pellet was then resuspended in 1ml 0.8M sucrose and layered onto 1.5ml 1M sucrose which 
was layered on 1.5ml 1.2M sucrose and centrifuged for 60 mins at 100,000g. The pellet 
represents the purified mitochondrial extract, which was resuspended in 1m1 0.32M sucrose. 
PMSF and NEM protease inhibitors were added at all stages at a final concentration of 1mM. 
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in 1ml 0.32M sucrose solution. PMSF and NEM protease -inhibitors were added at 
final concentrations of 1mM and these mitochondrial fractions were aliquoted and 
snap- frozen in liquid nitrogen prior to storage at -70 °C. 
As this research involves analysing the translocation of apoptosis- related proteins 
from the inner mitochondrial membrane space (IMM) to the cytosol, the creation of 
mitochondria -free cytosolic samples was a crucial requirement for meaningful 
analysis. The mitochondrial porin/voltage- dependent anion channel (VDAC) protein 
was used as a reliable marker for the detection of mitochondria. Cytosolic samples 
were analysed by Western blot (Section 2.3.6.) using the anti -VDAC antibody. The 
following procedure produced cytosolic fractions consistently free of mitochondrial 
contaminants. Crude cytosolic fractions were transferred to 4m1 centrifuge tubes 
(thin -walled polyallomar tubes, Beckman) and ultracentrifuged at 100,000g 
(50,000rpm) for 60 minutes to remove contaminants (TL -100, TLA100.3 rotor, 
Beckman Ltd). PMSF and NEM protease -inhibitors were added at a final 
concentration of 1mM, and purified cytosolic fractions were aliquoted and snap - 
frozen in liquid nitrogen prior to storage at -70 °C. 
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2.3.2 Sub -cellular fractionation from microdissected mouse hippocampus and 
thalamus 
2.3.2.1 Micro -dissection of mouse hippocampus and thalamus 
The micro -dissection procedures for obtaining the hippocampal and thalamus samples 
were performed following a published protocol (Barr et al. 2004), the details of which 
will be described. Brains were removed from -70 °C storage and allowed to partially 
thaw on a -20 °C cold plate. Each brain was cut using disposable scalpel blades 
(Swann Norton No. 11) at the level of the hippocampus (Figure 2.1). The thalamus 
was carefully dissected using the scalpel and curved forceps, and the hippocampus 
was excised using a punch technique involving the hollow cannula of a biopsy needle 
(Scottish Medical) (Figure 2.4). Several punches were required to remove each 
hippocampus, and tissue was expelled from the cannula using an empty 5m1 syringe 
attached to one end. The pooled hippocampus and thalamus samples from each brain 
were then snap- frozen in liquid nitrogen and immediately processed to separate 
proteins according to their subcellular location (Section 2.3.2.2.). 
Figure 2.4 Micro -dissection of hippocampus and thalamus for the sub -cellular 
fractionation procedure 
Frozen ( -70 °C) mouse brains are thawed on a -20 °C cold plate and cut at the level of 
the hippocampus (Figure 2.4). A hollow bore of a biopsy needle was used to gently 
collect both hippocampi (blue hexagons). A disposable scalpel blade is then used to 
gently excise the thalamus (location indicated by a solid red box). 
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2.3.2.2 Sub -cellular fractionation technique for micro -dissected samples 
In addition to analysing samples created from whole mouse brains, it was thought that 
micro -dissecting areas with TSE pathology, such as the hippocampus and thalamus, 
would enhance the likelihood of detecting apoptosis -related proteins. A scaled down 
version of the sucrose -gradient centrifugation procedure (Section 2.3.1.) was 
attempted several times however, the repeated centrifugation procedures resulted in 
unacceptable losses from these small samples. A commercial kit (Calbiochem) was 
purchased and proteins from micro -dissected brain areas were separated according to 
their solubility in different sub -cellular locations. The precise chemical compositions 
of the extraction buffers in this kit where not publicised by the manufacturer. The 
protocol used in these extractions was based on that for frozen -tissue samples. As 
before (Section 2.3.1.), cytosolic samples were analysed by Western blot (Section 
2.3.6.) using the anti -VDAC antibody to ensure that samples were free of 
contaminating mitochondria. Optimisation of the kit to achieve the required purity 
required increasing the centrifugation steps and altering the homogenisation 
procedures. All techniques were performed on ice, or where possible at 4 °C. Snap - 
frozen brain samples were partially thawed on ice, and lml of extraction buffer 1 and 
5111 of protease -inhibitor cocktail were added to each sample. Homogenisation was 
performed by serially passaging samples 20 -30 times within a 19 gauge needle using 
1m1 syringes. Tissue clumping was prevented by gently shaking the samples for 10 
minutes. Samples were centrifuged at 1000g for 10 minutes and supernatants 
(cytosol) gently removed and purity enhanced by centrifuging two further times at 
10,000g for 10 minutes to remove contaminating mitochondria -containing pellets. 
Cytosolic fractions were aliquoted and snap- frozen in liquid nitrogen prior to storage 
at -70 °C. The original pellet was re- suspended in lml extraction buffer 2 and 51,il 
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protease -inhibitor cocktail and shaken for 30 minutes. Samples were centrifuged at 
6000g for 10 minutes and the mitochondrial supernatants were aliquoted and snap - 
frozen in liquid nitrogen prior to storage at -70 °C. 
2.3.3 BCA total protein determination assay 
Total protein estimation was determined using the microplate protocol of the 
bicinchoninic acid (BCA) assay (Pierce). This assay uses BCA to detect cuprous ions 
generated from cupric ions by reaction with protein in the samples under alkaline 
conditions. Bovine serum albumin (BSA) standards (Pierce) and samples to be 
analysed were diluted in (a) 0.32M sucrose if samples were prepared using those 
described in Section 2.3.1. or (b) in extraction buffers 1 or 2 if samples were prepared 
using techniques described in Section 2.3.2.2. BSA standards were prepared 
(1500µg /ml, 1000µg /ml, 750µg /ml, 500µg/ml, 250µg/ml, 100µg /ml and 50µg /m1) and 
samples to be analysed were diluted in the ratio of 1:5 and 1:10 to calculate the total 
protein content in each sample as derived from the standard curve. 251.t1 of each 
standard and diluted sample were added in duplicate to wells of a 96 well microplate. 
The BCA working reagent was prepared fresh for each assay by combining BCA 
reagents A and B in the ratio of 50:1. 200µ1 of this working reagent was added to 
standard and test samples, and was also used as a blank for the assay. The microplate 
was sealed and incubated at 37 °C for 30 minutes, then allowed to cool to room 
temperature for 5 minutes. The absorbance values at 570nm were then read and 
analysed on a V -Max microplate reader (Molecular devices). Protein concentrations 
for each sample were derived from the BSA standard curve. 
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2.3.4 Preparation of samples for Western blot analysis 
2.3.4.1 Brain sample preparation 
Total protein from the samples to be analysed was assessed (Section 2.3.3.) and 
mitochondrial and cytosolic samples were taken so as to contain 30µg total protein 
per sample. The aim of this analysis was to detect the translocation of proteins from 
the mitochondria to the cytosol, therefore cytosolic samples containing 60 and 901,tg 
of total protein were also prepared to maximise detection of translocated proteins. If 
required, samples were concentrated using a methanol precipitation technique. To 
methanol precipitate samples, a 4x volume of ice -cold methanol /2% acetic acid was 
added to each sample, the tube gently inverted twice and precipitated overnight at 
-20 °C. Samples were centrifuged at 16,000g for 10 minutes, methanol /2% acetic acid 
supernatants were carefully removed and the protein pellet dried for up to 2 hours in a 
centrifugal vacuum concentrator (Thermo Savant Speed -Vac). Dried samples were 
each re- suspended in 200 lx Sample buffer, sample- reducing agent added at Ix, and 
samples gently vortexed. Samples were heated at 98 °C for 5 minutes prior to SDS- 
PAGE (Section 2.3.5.). 
2.3.4.2 Positive control preparation 
Positive controls of 3T3 cell lysate for Endonuclease G (Endo G) and K -562 cell 
lysate for apoptosis- inducing factor (AIF) were purchased from Abcam. Both cell 
lysates reacted strongly with the anti -Hsp70 antibody but weakly with the anti - 
VDAC1 antibody. Depending upon the batch of positive control, the anti -cyt c 
antibody would recognize either of the cell lysates or both. Positive control samples 
were loaded at a concentration of 31.tg /ml in lx sample buffer. Sample reducing agent 
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was added (lx) and samples were heated at 98 °C for 5 minutes prior to SDS -PAGE 
(Section 2.3.5.). 
2.3.5 SDS -PAGE procedure 
All biological reagents and experimental equipment were purchased from Invitrogen, 
unless otherwise stated, and analysed using procedures derived from published 
protocols (Laemmli 1970). Protein separation was performed using pre -cast 12 well 
Novex Bis-Tris-HC1 (pH 6.4) 4 -12% acrylamide gradient gels under reducing 
conditions. Running buffer (lx) (50mM MES, 50mM Tris Base, 3.47mM SDS, 
0.125mM EDTA) was prepared fresh from a stock solution (x20) (Invitrogen) in 
ultrapure water for each procedure. Gel combs were carefully removed from the 
wells of the pre -cast gels and wells gently rinsed with lxRunning buffer. Gels were 
assembled in the Novex gel tanks and 5000 NuPAGE antioxidant was added to 
200m1 lx Running buffer and added to the upper chamber of the tank. The outer 
chamber of the gel tank consisted of lxRunning buffer. 6111 of the SeeBlue Plus2 pre - 
stained standard and 20111 of each sample (Section 2.3.4.1), positive control (Section 
2.3.4.2.) and blank (lx sample buffer) were electrophoresed using a BIORAD 
PowerPac at 200V for 55 -60 minutes until the dye front reached the foot of the gel. 
Gels were carefully removed from the gel cassette and trimmed of excess acrylamide 
prior to the Western blot procedure (Section 2.3.6.) 
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2.3.6 Western blot procedure 
All biological reagents and experimental equipment were purchased from Invitrogen, 
unless otherwise stated. Proteins were transferred from the 4 -12% Bis -Tris gels to 
polyvinylidene difluoride (PVDF) membranes using the Novex Transblot module: 
3MM filter paper and PVDF membranes were purchased pre -cut. Transfer buffer 
(lx) (25mM Bicine, 25mM Bis -Tris, 1.025mM EDTA, O.O5mM chlorobutanol, 10% 
methanol [v /v], lml NuPAGE antioxidant) was prepared fresh from a stock solution 
(x20) (Invitrogen) in ultrapure water for each procedure. For the transfer of proteins 
from each gel, a "transfer sandwich" (Figure 2.5) was constructed consisting of a 
single PVDF membrane, two pieces of 3MM filter paper and five blotting pads. 
PVDF membranes were pre -wet by immersion in 100% methanol (BDH) for 10 
seconds followed by thorough washes in dH20. PVDF membranes, 3MM filter paper 
and blotting pads were then pre -soaked in lx Transfer Buffer for at least 10 minutes 
prior to transfer. The "transfer sandwich" was constructed within the Novex Blot 
module, and inserted into the Novex gel tank. The "transfer sandwich" was 
constantly kept wet with lx Transfer buffer and the chamber of the Novex blot 
module was topped up with lx Transfer buffer when assembled into the Novex gel 
tank. The outer chamber of the gel tank was filled with dH2O, and transfer was 
performed at 120mA per gel for 60 minutes at 30 volts using a BIORAD PowerPac 
200. Following transfer, the proteins on the PVDF membrane were fixed by 
immersion in 100% methanol for 10 seconds followed by thorough dH20 washes prior 
to Ponceau Red staining (Section 2.3.7.) or the immunoblotting procedure (Section 
2.3.8.) 
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Figure 2.5 Transfer "sandwich" for the transfer of SDS -PAGE separated proteins 
to the PVDF membrane 
Electrical current from the cathode to the anode transfers SDS -PAGE separated 
proteins to the PVDF membrane 
2.3.7 Ponceau Red staining 
The transfer of proteins to the PVDF membrane was confirmed by incubating the 
PVDF membrane with Ponceau Red (Sigma) on the shaker at room temperature for 
up to 5 minutes. Excess stain was removed and the membrane washed three times in 
dH2O to visualize the protein bands. PVDF membranes were de- stained through 
several 20m1 TBS /0.5% Tween 20 washes on the shaker at room temperature prior to 
the immunoblotting procedure (Section 2.3.8.). 
2.3.8 Immunoblotting procedure and protein detection 
All incubations were performed at room temperature on the shaker and using reagents 
purchased from Invitrogen, unless otherwise stated. PVDF membranes were blocked 
with 20m1 3% non -fat dried milk (Upstate) in TBS for 2 hours prior to incubation 
with the primary antibody of choice (Table 2.1.). PVDF membranes were then 
incubated overnight at 4 °C in 20m1 of antibody solution in freshly prepared 3% non- 
fat dried milk in TBS. Membranes were washed three times in 20m1 TBS /0.5% 
Tween 20 for 5 minutes per wash, followed by a 15 minute block in 20m13% non -fat 
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dried milk in TBS. PVDF membranes were then incubated in 20m1 of secondary 
antibody solution (Table 2.1.) in freshly prepared 3% non -fat dried milk in TBS for 40 
minutes. Membranes were washed six times in 20m1 TBS /0.5% Tween -20 for 10 
minutes per wash, followed by two washes in 20m1 dH2O for 10 minutes per wash. 
Proteins were visualised by chemiluminescence by incubation with the VisualizerTM 
detection reagent (Upstate) for 3 minutes at room temperature. Membranes were 
sandwiched between acetate film pieces and placed within a light -proof cassette. 
Proteins were then detected by exposing the membranes to photographic Lumi -film 
(Roche) for up to 10 minutes. Exposed film pieces were developed as follows: 2x 30 
seconds developer (AGFA; 100m1 developer + 400m1 dH2O), 2x 30 seconds stop 
solution (400m1 dH2O + lml 2% acetic acid), 2x 30 seconds fix solution (AGFA; 
100m1 fixer + 300m1 dH2O), followed by thorough washes in water. Film pieces were 
allowed to dry and aligned with the membranes within the cassettes. Protein sizes 
were determined according to the pre- stained SeeBlue Plus2 standard, and membranes 
were discarded or re- probed for the detection of other proteins (Section 2.3.9.). 
2.3.9 Antibody stripping and re- probing procedure 
To re -probe a membrane for other proteins, membranes were removed from the light- 
proof cassette and washed twice in 20m1 TBS /0.5% Tween -20 for 10 minutes per 
wash. Membranes were then incubated with the membrane strip and re -probe buffer 
(Pierce) for 40 minutes and washed twice in 20m1 TBS /0.5% Tween -20 for 10 
minutes per wash. Membranes were blocked with 20m13% non -fat dried milk in 
TBS for 2 hours and immunoblotting continued as described in Section 2.3.8. 
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2.4 Analysis of MoPrP105 -125 peptide and MoScrambled105 -125 peptide 
samples 
2.4.1 Synthesis of MoPrP105 -125 and MoScrambled105 -125 peptides 
Peptides of MoPrP105 -125 (normal) and MoScrambledPrP105 -125 (scrambled) 
(Figure 2.6.) were synthesised by Dr. Lawrence Hunt (IAH Compton) using 
conventional Fmoc chemistry on a Pioneer Peptide synthesis system (PerSeptive 
Biosystems). Fmoc amino acids and resins were purchased from Novabiochem, 
solvents were prepared in MilliQ water unless stated otherwise, and 10m1 cleavage 
cocktails (1% v/v tri- isopropyl silane; 2.5% v/v ethanedithiol in Trifluoroacetic acid 
(TFA) were required per 0.1mM batch of peptide. Peptides containing the normal and 
scrambled sequences were separately dissolved in 10% acetonitrile containing 0.1% 
TFA. The hydrophobic nature of the normal peptide required a specialised synthesis 
involving the agitation of 10mg or less of this solution for 10 minutes at room 
temperature in 5ml acetonitrile. Following addition of l0111 TFA, samples were again 
agitated for 10 minutes. 2m1 MilliQ water was added and samples agitated until 
peptides completely dissolved. Normal and scrambled peptide containing solutions 
were centrifuged to remove excess suspension and supernatants pumped onto a high 
pressure liquid chromatography (HPLC) column as 14% peptide (86% Solvent A). 
HPLC was performed using Xterra prep MS C18 columns (Waters) on a Biocad 
Sprint (PerSeptive Biosystems). HPLC solvents were solvent A (0.1% v/v TFA in 
MilliQ water) versus solvent B (0.1% TFA in acetonitrile) at a flow rate of 
7m1/minute. Gradients were 10% solvent B for 1 minute, elution with 10 -40% 
solvent B for 7.5 minutes, and 10% solvent B for 30 seconds. Mass spectrometry was 
performed on a Quattro II (Micromass) to identify correct peptide sequences, samples 
were pooled and freeze -dried for storage. 
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1°5KTN LKHVAGAAAAGAVVGGLG125 mouse 
1 °6KTNMKHMAGAAAAGAVVGGLG126 human 
1°5LATVKVGAGHGANVAAGKGAL125 mouse scrambled 
Figure 2.6 Primary amino acid sequence of synthetic PrP peptides used in this research 
Comparison of the primary amino acid sequence of the MoPrP105 -125 sequence used for the 
research described in this thesis, in comparison to the well studied HuPrP106 -126 peptide, 
discussed in Chapter 4. The mouse scrambled peptide was synthesised based on the human 
scrambled peptide used in all other peptide research, which was created from the same amino 
acids but in a random sequence. 
2.4.2 Peptide sample preparations 
MoPrP105 -125 (normal) and MoScrambledPrP105 -125 (scrambled) (Figure 2.6.) 
peptides were dissolved at final concentrations of 2mg /ml in a series of vehicle 
buffers including 10mM 2- (N- morpholino) ethane sulfonic acid (MES) (Melford), 
200mM citrate (Sigma) and tissue culture tested distilled water (GibcoBRL). The 
findings of initial studies (Section 4.3) involving these buffers revealed that MES 
buffers would be more appropriate for the requirements of this research, and were 
therefore studied in more detail in the continuing studies. These buffers comprised; 
10mM MES buffers containing either OmM, 50mM or 200mM concentrations of 
NaC1 (BDH) which were prepared at pH 5 and pH 7 in sterile tissue- culture tested 
water (GibcoBRL) and sterile -filtrated through a 0.41M filter pore. Peptide solutions 
were incubated at 37 °C in a water bath for periods up to 14 days. Aliquots were 
removed at various time -points, snap- frozen in liquid nitrogen and maintained at - 
20 °C prior to analysis by Thioflavin -T assay (Section 2.4.3.) or fourier transform 
infra -red spectroscopy (Section 2.4.4.) 
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2.4.3 Thioflavin-T binding assay 
Thioflavin -T (Sigma) binds rapidly to amyloid fibrils with altered excitation maxima 
and enhanced emission than unbound Thioflavin -T. Analysis of peptide amyloid 
fibril formation in peptide samples (Section 2.4.2.) involved incubating samples with 
a molar excess of Thioflavin -T (Sigma), using a procedure modified slightly from a 
published protocol (Heegaard et al. 2004). A 2mM stock solution of Thioflavin -T 
was prepared in sterile MilliQ water, diluted in the test peptide vehicle buffer to 
achieve 20µM Thioflavin -T. 250µ1 of the 20µM Thioflavin -T solutions were added to 
a thoroughly cleaned Quartz crystal cuvette (Starna) and fluorescent excitation 
performed at 437nm with a step size of lnm /second between 450 -550nm on a 
PerkinElmer LS -50 fluorimeter. The average of three readings was used to baseline 
correct samples. 5µl of an aliquot of each peptide sample (2mg /ml) was removed 
from storage at -20 °C and mixed with 2501201AM Thioflavin -T sample in 
appropriate peptide vehicle buffer and analysed for altered excitation and therefore 
the presence of amyloid fibrils. 
2.4.4 Secondary structure analysis of normal and scrambled MoPrP105 -125 
peptides by Fourier Transform Infra -red spectroscopy 
Secondary structure analysis was performed using Fourier transform infra -red 
spectroscopy (FTIR) to analyse the peptide samples in the tested peptide vehicle 
buffers (Section 2.4.2). Analysis concentrated primarily on the amide I region (1600 - 
1700cm -1) which is most widely used for secondary structure analysis. The FTIR 
spectrometer (Vector 22, Bruker) was constantly purged with nitrogen to minimise 
interference from background water vapour and the mercury cadmium telluride 
detector was cooled with liquid nitrogen. Each spectrum represented the average of 
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256 scans, recorded with a 4cm -1 resolution in the range 1000 -4000 cm-1. The 
internal reflection element was a cleaned germanium crystal (50 x 20 x 2 mm), with 
an aperture angle of 45° yielding 25 internal reflections. The FTIR signal from a 
cleaned germanium crystal in the purged spectrometer was taken for background 
corrections. In addition, a background atmospheric water vapour signal was taken 
from the open spectrometer for additional background corrections. 10111 of an aliquot 
of each peptide sample (2mg /ml) was removed from storage at -20 °C and gently 
spread onto a cleaned germanium crystal using a 2O111 pipette tip and the sample dried 
under a gentle flow of nitrogen gas. The spectrometer was allowed to purge of water 
vapour for 10 minutes prior to reading each FTIR signal. To assess the quantities of 
a -helix and random structure from the amide I region, a Hydrogen- Deuterium (2H20) 
exchange was performed to separate their overlying FTIR spectra. Nitrogen gas 
coupled to a source of Deuterium was connected to the germanium crystal and 
complete Deuterium exchange was established after 20 minutes. FTIR spectra for 
deuterated samples were base -line corrected by subtracting the crystal and water 
vapour backgrounds. For comparisons between peaks of different samples, samples 
were baseline corrected at points prior to the amide I peak (1900nm), at the foot of the 
amide I peak and also after the amide III peak (1400nm). Specific secondary 
structure curve fittings were performed by Dr. Matthew Hicks (University of 
Warwick, U.K) using the Grams software analysis package (Thermo Corporation, 
California). 
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2.4.5 Electron microscopy sample preparation and analysis 
Electron microscopy was used to analyse the morphology of fibrils formed in the 
peptide samples (Section 2.4.2). 5µl of an aliquot of each peptide sample (2mg /ml) 
was removed from storage at -20 °C onto a sterile plastic sheet. A 3.05mm 
carbon/formvar 200 mesh grid (TAAB Laboratories Ltd) was gently floated on top of 
the peptide sample and incubated at room temperature for 5 minutes. Grids were 
carefully blotted onto filter paper, allowed to air dry for 5 minutes, and negatively 
stained by floating on top of 5p1 2% sodium phosphotungstate (pH 7.2) for 30 
seconds. Grids were carefully blotted onto filter paper and allowed to air dry. 
Samples were analysed by electron microscopy by Gilian McGovern (Veterinary 
Laboratory Agency, Lasswade). 
2.5 Culture of naive and NGF- differentiated PC12 cells 
2.5.1 Source of PC12 cells 
PC12 cells were derived from a male transplantable rat (Rattus norvegicus) adrenal 
pheochromocytoma, which respond reversibly to NGF- differentiation. PC12 cells 
adhere poorly to plastic and attachment is increased by growing the cells on Collagen 
IV- coated surfaces. Naive (undifferentiated) PC12 cells are round in shape and have 
a tendency to grow in small clumps; NGF- differentiated PC12 cells have enlarged cell 
bodies and extended neuritic processes. NGF- differentiation is dependent upon the 
presence of Collagen IV coated surfaces, the concentration of NGF and the density of 
cells exposed to NGF. The cells were obtained from LGC Promochem and cultured 
as described (Greene & Tischler 1976). All biological reagents used were obtained 
from GibcoBRL Life Technologies (Invitrogen) and all disposable plastic -ware from 
Corning Costar, unless stated otherwise. 
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2.5.2 Collagen IV coating procedure for glass coverslips 
PC12 cells adhere poorly to plastic and glassware, however treatment with murine 
Collagen IV substantially increases their attachment and replication of these cells. 
Murine collagen IV was maintained at -70 °C and dissolved at a concentration of 51,ig 
in 0.05N HC1 (BDH Ltd). Circular glass coverslips to be coated were cleansed and 
sterilised in 70% alcohol and dried by blotting onto sterile filter paper. Coverslips 
were transferred to 24 -well plates and 300111 of dissolved collagen -IV was added and 
plates were placed on the cell shaker for 60 minutes at room temperature. The 
collagen suspension was then removed and used to treat further surfaces. Coated 
surfaces were washed a minimum of three times for 20 minutes each with 1 ml sterile 
endotoxin -free tissue culture water (GibcoBRL). Surfaces were then dried in a sterile 
laminar fume hood, followed by overnight sterilisation using the U.V. light source. 
Coated surfaces were stored at 4 °C for up to 4 weeks. 
2.5.3 Media preparation 
2.5.3.1 Media for naive PC12 cells 
Cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented 
with 10% heat -inactivated horse serum, 5% heat -inactivated newborn calf serum, 1% 
200mM L- glutamine (Sigma) and 1% Penicillin/Streptomycin. Cells were 
maintained at 37 °C, 5% CO2 and cells had a two- thirds media change every two days. 
Cells were spilt in the ratio of 1:2 when cells reached 80 -90% confluence. Freshly 
prepared and microbial free -media was maintained for no more than 4 weeks at 4 °C. 
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2.5.3.2 Media for NGF- differentiated PC12 cells 
Cells were grown in DMEM supplemented with 5% heat -inactivated horse serum, 1% 
200mM L- glutamine, 1% Penicillin/Streptomycin and 100ng /m12.5S NGF. NGF was 
maintained in frozen aliquots and added to media aliquots immediately prior to adding 
to the cells. Cells were maintained at 37 °C, 5% CO2 and cells had a two -third media 
change every two days. Cells were cultured for 14 days prior to exposure to 
MoPrP105 -125 and MoScrambledPrP105 -125 (Section 2.5.12.). 
2.5.4 Protocol for culture of PC12 cells from liquid nitrogen stock 
25m1 of media (as described in Section 2.5.3.1.) was heated to 37 °C for a minimum of 
20 minutes in a water bath to reduce media alkalinity. Frozen PC12 cell aliquots were 
removed from the liquid nitrogen stock (Section 2.5.7.) and thawed rapidly in the 
water bath for 2 minutes. Thawed cells were transferred to a 15ml centrifuge tube 
(Corning) containing 9ml of the heated media. Cells were washed of dimethyl 
sulphoxide (DMSO) (Sigma) by centrifugation at 250g for 5 minutes at 4 °C. Without 
disturbing the cell pellet, the supernatant was discarded and the pellet washed again 
by re- suspension in 10m1 heated media, followed by a further centrifugation step. 
The supernatant was again carefully discarded and the pellet re- suspended in 5m1 
media and transferred to a 25cm2 Collagen IV- coated vented flask (BD Biosciences). 
Cells were incubated at 37 °C, 5% CO2 and a two -thirds media change was performed 
after 24 hours. Maintenance of the cell cultures was performed as described in 
Section 2.5.5. 
71 Chapter 2: Materials & Methods 
2.5.5 Sub -culturing procedure 
Cells were monitored daily to check cell growth and to check for evidence of 
microbial contamination. When cells reached 80 -90% confluence, they were split in a 
ratio of 1:2 using the following technique. Media was removed from all flasks and 
cells in each flask were washed with 3ml Mgt + - and Cat + - free Hanks balanced salt 
solution (HBSS) for 2 minutes on the cell shaker. HBSS was then discarded and 3ml 
enzyme -free cell dissociation buffer (Invitrogen) was added to each flask and 
incubated at 37 °C, 5% CO2 for 15 minutes. Cells were dislodged by gentle tapping of 
the flask and by washing the dissociation buffer over the surface of the flask several 
times using a 5m1 strippete. Cell solutions were pooled and centrifuged at 250g for 5 
minutes at 4 °C. Supernatants were discarded and cells were re- suspended by adding 
2m1 heated media (Section 2.5.3.1.) for every flask to be split (1:2 split ratio). Cell 
clumps were dissociated by passaging cells several times through 1000111 and then 
2000 pipette tips. lml volumes of this cell suspension were added to each of two 
25cm2 flasks each containing 4m1 of heated media and returned to the incubator, and 
cells again split when necessary. 
For cells to be differentiated with NGF, a flask of confluent cells was harvested as 
described above. Complete differentiation media (Section 2.5.3.2.) was prepared and 
heated in the water bath for a minimum of 20 minutes at 37 °C. Centrifuged cells 
were spit in the ratio 1:4 and therefore for every flask to be differentiated, pellets were 
re- suspended in 4m1 differentiation media. lml of this suspension was added to each 
of four 25cm2 flasks, each containing 4m1 of differentiation media, and returned to the 
incubator. A two -thirds media change was performed every two days with freshly - 
prepared differentiation media. 
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2.5.6 Protocol for counting adherent PC12 cells 
Media was removed from the cells to be harvested and cells were washed with 3ml 
Mgt + - and Cat + - free HBSS for 2 minutes on the cell shaker. HBSS was then 
discarded and 3ml cell dissociation buffer (Invitrogen) was added to each flask and 
incubated at 37 °C, 5% CO2 for 15 minutes. Cells were dislodged by gentle tapping of 
the surface and by washing the dissociation buffer over the adhered surface several 
times using a 5m1 strippete. Pooled cell suspensions were centrifuged at 250g for 5 
minutes at 4 °C and re- suspended in lml heated media (Section 2.5.3.1.). Cell clumps 
were dissociated by passaging cells several times through 100011l and then 2001_1,1 
pipette tips. A 1011l aliquot of the cell suspension was removed and added to 90µl 
toluidin blue (Sigma). 1011l of this cell suspension was then added to a 
haemocytometer and cell counts were performed within a total of 25 squares, where 
viable cells (white) exclude the uptake of the toluidin blue dye. The number of viable 
cells per ml of media was approximately calculated and used to dilute cells to the 
desired concentration. 
2.5.7 Protocol for the creation of frozen stocks of PC12 cells 
Upon receiving the cell stock from LGC Promochem, cells were subcultured to obtain 
large quantities in order to obtain sufficient cells for the duration of the experiment 
and also to create stocks so that all cells to be used were from low sub -passage 
numbers. Cells to be frozen had a two -thirds media change 24 hours prior to the 
freezing down process. Freeze -media was prepared on the day of the process and 
consisted of 9m1 media (as described in Section 2.5.3.1.) and lml DMSO which was 
maintained on ice for 30 minutes prior to freezing down the cells. Cells were 
maintained, harvested and counted (Sectionss 2.5.5.- 2.5.6.) to estimate the number of 
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viable cells. Cells were centrifuged at 250g for 5 minutes at 4 °C, and re- suspended in 
the appropriate volume of freeze media to obtain approximately 3 x 106cells /ml. Cell 
suspensions were aliquoted in lml volumes into 1.2ml cryovials and placed into the 
Cryo -1 °C Freezing container (Nalgene) to gently freeze the cells for optimum 
viability. Cells were frozen at -70 °C for 24 hours prior to transferring the cells to 
liquid nitrogen for storage. 
2.5.8 Immunofluorescence procedure 
Cells to be analysed by immunofluorescence were harvested using the technique 
described (Section 2.5.5.) and the cell pellet re- suspended in 1ml of either media for 
naive (Section 2.5.3.1.) or differentiated (Section 2.5.3.2.) cell cultures. Viable cells 
were counted (Section 2.5.6.) and re- suspended at a concentration of 50,000cells /m1 
in the appropriate media. Collagen IV- coated glass coverslips (Section 2.5.2.) were 
transferred to the base of 24 -well plastic culture plates and lml of the cell suspension 
added to the number of wells required. Naive and NGF- differentiated cells were 
grown for periods of 7 and 14 days prior to immunofluorescence analysis. 
Media was completely removed from the wells containing the cells to be analysed and 
cells fixed by gently adding lml of ice -cold methanol down the side of each cell - 
containing well. Cells were fixed for 20 minutes at -20 °C, and methanol completely 
removed. Cells were then permeabilized for 10 minutes at room temperature with 
1ml of TBS /0.2% Triton x -100. Permeabilization reagent was removed by three 5 
minute washes with 1ml TBS/BSA, and cells were blocked for 60 minutes at room 
temperature with 4001.11 TBS /2 %BSA. The blocking reagent was removed and 4000 
1 /1000 anti -PrP 8H4 primary antibody (Table 2.1) was added and incubated overnight 
at room temperature. Primary antibody was removed and cells washed by three 5 
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minute washes with lml TBS/BSA. 400111 of 1 /1000 goat anti -mouse biotinylated 
secondary antibody (Table 2.2) was incubated for 60 minutes at room temperature 
followed by three 5 minute washes with lml TBS /BSA. Cells were then incubated 
with streptavidin- conjugated Alexa 594 (Table 2.2) for 60 minutes at room 
temperature in the dark. Excess antibody was removed by three 5 minute washes with 
TBS /BSA. Immunofluorescence -labelled cells on coverslips were transferred to 
Superfrost -Plus slides and cover -slipped with fluorescent -mounting medium (DAKO). 
To determine the specificity of antibody labelling, duplicate cell samples were 
incubated with 1 /1000 normal mouse serum (Jackson's, USA) and processed as 
detailed above. Staining was analysed by fluorescent confocal microscopy (Zeiss) 
and images captured using the Axioskop 2 camera. 
2.5.9 Western blot analysis of PC12 cells for PrP` expression 
SDS -PAGE and Western blot protocols (previously described in Sections 2.3.5. and 
2.3.6.) were used to analyse the PrP` expression of naive and NGF- differentiated 
PC12 cells. Cells were dislodged from collagen IV- coated 25cm2 flasks using 
techniques already described for harvesting cells (Section 2.5.5.). To maximise 
detection, all cells from a confluent 25cm2 flask were dislodged and re- suspended in 
either 2 ml lysis buffer; (1) 40mM NaCl, 3mM KC1, 50mM NaHCO3, 2g /litre 
glucose, 1% NP40, pH 7.5 (Brown et al. 1997), or (2) 150mM NaC1, 0.5% Triton x- 
100, 0.5% deoxycholic acid, 50mM EDTA, 2mM EDTA as described in (Wooten et 
al. 2000). Protease degradation was inhibited by adding PMSF and NEM at final 
concentrations of 1mM to each sample. Cell suspensions were maintained at 4 °C and 
vortexed every 15 minutes for 1 hour. Cell lysates were prepared in 1X sample buffer 
using dilutions of 1:5, 1:10 and 1:20 and lysates analysed according to the described 
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protocols (Sections 2.3.5. and 2.3.6.) using the anti -PrP antibodies in Table 2.1. 
Unfortunately, attempts to detect PrP° by Western blot were unsuccessful and are not 
discussed further in this thesis. 
2.5.10 Flourescence- activated cell sorting (FACS) procedure 
2.5.10.1 External Staining for PrP` 
Naive and NGF- differentiated PC 12 cells to be analysed for FACS analysis were 
dislodged from collagen IV- coated T25cm2 flasks using techniques already described 
for harvesting cells (Section 2.5.5.). Cells were counted (Section 2.5.6.) and re- 
suspended in 1xFACS buffer (100m1 10xFACS buffer + lg sodium azide, lg BSA, lg 
EDTA + 900m1 dH2O) (1 litre 10x FACS buffer: 25.6g Na2PO4, 74.8g NaC1, 3.88g 
KH2PO4, 2.01g KC1) at a concentration of 50,000cells /l000, and l00111 volumes 
added to the wells of U -form 96 well plate in quadruplicate. All stages were 
performed on ice, or where possible at 4 °C. In the absence of isotype controls for the 
primary antibodies, non -specific binding was determined by including cells incubated 
with secondary but no primary antibodies. Cells were incubated with 50µ1 of the 
anti -PrP 8H4 primary antibody (Table 2.1), or 50µl 1xFACS buffer for controls, for 
40 minutes and centrifuged at 16,000g for 5 minutes. Pellets were washed three times 
by re- suspension in 200µl 1xFACS buffer and centrifugation at 16,000g for 5 
minutes. Pellets were re- suspended in l00µ1 1xFACS buffer and incubated with 50µl 
of the Goat anti -mouse Alexa 488 secondary antibody (Table 2.2) for 40 minutes. 
Pellets were again washed three times by re- suspension in 200µl 1xFACS buffer and 
centrifugation at 16,000g for 5 minutes. Cells were re- suspended in 400µ1 1xFACS 
buffer in FACS tubes (Falcon), fixed with 1% paraformaldehyde for 15 minutes at 
37 °C, and analysed using a FACS Calibur (BD Biosciences). The 488nm line of the 
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argon laser was used to excite the fluorochrome- conjugated secondary antibodies, and 
Go /Gl doublet naive PC12 cells were gated out for comparison with mitotically- 
arrested NGF- differentiated cultures. Statistical analysis for FACS was derived from 
the analysis of 10,000 cells per sample. 
2.5.10.2 Internal staining for neurofilament protein and active caspase -3 
Naive and NGF- differentiated PC 12 cells to be analysed for FACS analysis were 
harvested and prepared for FACS analysis as described in Section 2.5.10.1. Prior to 
incubating the cells with a primary antibody, cells were fixed with 1% 
paraformaldehyde for 15 minutes at 37 °C, washed three times by re- suspension in 
200111 1xFACS buffer and centrifugation at 16,000g for 5 minutes. Cells were 
permeabilised with 0.2% Triton -x100 (in 1xFACS buffer) for 10 minutes and washed 
three times by re- suspension in 2O0µ1 1xFACS buffer and centrifugation at 16,000g 
for 5 minutes. Cells were incubated with 50111 of the primary antibody of choice 
(Table 2.1), or 50111 1xFACS buffer for controls, for 40 minutes and centrifuged at 
16,000g for 5 minutes. Pellets were washed three times by re- suspension in 200111 
1xFACS buffer and centrifugation at 16,000g for 5 minutes. Pellets were re- 
suspended in 100µl 1xFACS buffer and incubated with 5011,1 of secondary antibody 
(Table 2.2) for 40 minutes. Pellets were again washed three times by re- suspension in 
2001_11 1xFACS buffer and centrifugation at 16,000g for 5 minutes. Cells were re- 
suspended in 4O0µ1 1xFACS buffer in FACS tubes (Falcon) and analysed as before 
using a FACS Calibur (BD Biosciences). 
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2.5.10.3 Annexin V labelling 
Naive and NGF- differentiated PC 12 cells to be analysed for FACS analysis were 
harvested and prepared for FACS analysis as described in Section 2.5.10.1. Cells 
were counted (Section 2.5.6.) and re- suspended in 1xFACS buffer at a concentration 
of 50,000cells /l00µ1, and l000 volumes added to the wells of U -form 96 well plate 
in quadruplicate. All stages were performed on ice, or where possible at 4 °C. 
Annexin V binding was investigated using a commercially available kit (Vybrant 
Apoptosis detection kit, Molecular Probes). l00µ1 of the lx Annexin- binding buffer 
was added to each well to block potential unspecific binding to Annexin V. Viability 
and Annexin V staining was then attempted by the addition of 511l Alexa Fluor 488 
Annexin V (Component A) and 1111 of propidium iodide (Component B). 
Unfortunately Annexin V was found to bind non -specifically in this assay, despite 
several attempts to improve the specificity of the binding. Potential reasons for this 
non -specificity are discussed in Section 4.3.9. 
2.5.11 Cell proliferation and cytotoxicity assays 
2.5.11.1 MTT assay 
The MTT [3 -(4,5- Dimethylthiazol- 2- yl) -2,5- Diphenyltetrazolium Bromide] assay was 
investigated in order to measure PC12 cell proliferation, and cytotoxicity following 
exposure to neurotoxic PrP peptides (Section 4). The percentage reduction of the 
tetrazolium salt is therefore related to the viability of cell cultures in the test assay. 
PC12 cells were harvested and counted as described (Sections 2.5.5. -2.5.6.) and re- 
suspended at a concentration of 800cells /200µ1 in the appropriate media. 2O0111 of the 
cell suspension was added to each well of a Collagen N- coated 96 -well plate (BD 
Biosciences) until sufficient wells for the assay were obtained. Cells were incubated 
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for 24 hours at 37 °C, 5% CO2 and a 50% media change was performed prior to 
addition of the desired amount of test reagent to triplicate wells as described (Section 
2.5.12.). Plates were incubated at 37 °C, 5% CO2 for the desired period of exposure to 
the peptide sequences. 2511l of 0.5mg/ml MTT (Sigma) solution in PBS was then 
added to each well and incubated at 37 °C, 5% CO2 for 4 hours. Converted formazans 
were released from PC12 cells by addition of l00µ1 of cell lysis buffer ( 20% (w /v) 
SDS in 50% N,N- dimethyl formamide, pH 4.7). Plates were agitated for 10 mins on 
the cell shaker, and colorimetric determination of MTT reduction was carried out by 
taking absorbance readings at 570nm on a V -Max microplate reader (Molecular 
Devices). Unfortunately, the MTT assay could not be successfully reproduced and 
eventually the alamarblue assay (Section 2.5.11.2.) was developed as a suitable assay 
for the purposes of the work described in this thesis. 
2.5.11.2 Alamarblue assay 
The alamarblue assay is a sensitive reduction -oxidation (REDOX) assay which has 
been developed to quantitatively measure the proliferation of cell lines and as 
cytotoxicity assay for the screening of various chemical compounds. The chemical 
reduction of the alamarblue compound by viable cells results in a specific 
fluorometric and colorimetric change, which can be used to measure the proliferation 
and viability of cell cultures. Inhibition of cell growth through the exposure to toxic 
compounds maintains the alamarblue reagent in the oxidised form. The percentage 
reduction of alamarblue in cell cultures exposed to a test agent can quantitatively 
measure the cytotoxicity of that test compound on exposed cells. The reduction of the 
alamarblue compound is thought to involve mitochondrial, cytosolic and microsomal 
enzymes. 
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PC12 cells were harvested and counted as described (Sections 2.5.5.- 2.5.6.) and re- 
suspended at a concentration of 800cells /2001.1.1 in the appropriate media. 200µ1 of the 
cell suspension was added to each well of a Collagen IV- coated 96 -well plate (BD 
Biosciences) until sufficient wells for the assay were obtained. Cells were incubated 
for 24 hours at 37 °C, 5% CO2 and a 50% media change was performed. 20111 of the 
alamarblue reagent (Serotec) was added to each well and the desired amount of test 
reagent added to wells in triplicate as described (Section 2.5.12.). Plates were 
incubated at 37 °C, 5% CO2 for the desired period of exposure to the peptide 
sequences. Plates were blanked by transferring 1001110f media alone to each of three 
wells in uncoated 96 well plates (Sigma). Readings for negative control (medía + 
alamarblue) and test samples are obtained by again transferring 10O111 of each sample 
to wells of the uncoated 96 well plate. The absorbances of the wells were read at both 
570nm and 600nm on a V -Max microplate reader (Molecular Devices), and the 
percentage reduction calculated as per the protocol provided by the manufacturer. 
2.5.12 Protocol for the exposure of cells to MoPrPlOS -125 and 
Trimethyltin (TMT) 
Test wells were prepared as described in Section 2.5.11.2_, con áning ;Ian e o 
NGF- differentiated PC12 cells (800ceIls l200111). Test wells were prepared in 
triplicate, incubated for 24 hours at 37 °C, 5% COT prior to a 5O medi ,. change and 
20µ1 of the alamarblue reagent (Serotec) added to each well_ Test wells were expC,sed 
4 dan., 
to either the normal (MoPrP105 -125) or scrambled peptics'ir sequences at 
concentrations of OµM, 501.LM, 8011M, 100µM, or l 50guM for perñcrnds (4.24 houurs, 48 
hours, 72 hours, 5 days and 7 days. Peptide conftrmat.ions Pre ed as detaiDed 
in Section 2.4.2. Negative control samples, consisting only of equivalent volumes of 
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the buffers minus any peptide, were added in triplicate and analysed over the same 
duration for each experiment. A positive control for the alamarblue assay was 
obtained by incubating PC12 cells in triplicate with 400µM Trimethyltin (TMT) 
(Sigma -Aldrich), a neurotoxic compound which has been demonstrated to induce 
apoptosis and necrosis in PC12 and other cell culture systems. The cytotoxicity of the 
peptide conformations, scrambled peptide conformations, vehicle buffers minus 
peptides, and cells exposed to TMT were measured by alamarblue assay (Section 
2.5.11.2.). The most toxic peptide conformation determined by this assay was then 
added to further cells and these cells were analysed for activated caspase -3 using the 
FACS protocols detailed in Section 2.5.10.3. 
2.5.12. Statistical Analysis 
Statistical analysis for the cytotoxicity and FACS data obtained in Section 4 was 
performed following consultations with Jill Sales from the Biological Statistic 
Service, Scotland (BioSS). This data was analysed in all cases using balanced two - 
way ANOVA (analysis of variance) on the minitab statistical package (Minitab, 
Version 14). Two -way ANOVA analysis was chosen to analyse the effects of 
independent variables and to analyse if there were interaction effects of these 
independent variables. Data from the alamarblue cytotoxicity analysis was 
transformed using the angular transformation to convert percentages prior to the 
balanced ANOVA analysis. 
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Chapter 3: Mechanisms of neuronal cell death in TSEs 
3.1 Neuronal degeneration 
Neuronal loss is not due solely to differences in the susceptibility of different subsets 
of neurons to the disease process, but is influenced by the infecting agent and the host 
genotype (Bruce et al. 1976). The mechanisms by which neuronal damage are related 
to accumulating PrPSO are not fully understood; this research will investigate further 
the mechanisms of neurodegeneration in these diseases. Understanding the 
mechanisms of cell death in murine scrapie models may identify intervention 
strategies to inhibit, repair or delay the neurodegenerative brain damage caused by 
these fatal diseases. 
3.1.1 Necrosis 
Necrosis represents the localised death of a cell, tissue or organ in response to stresses 
beyond their homeostatic capabilities. Extreme stresses resulting in necrosis include 
the withdrawal of oxygen or essential nutrients, and also the exposure to toxic 
compounds or the presence of mutated genes. Necrotising cells have a number of 
distorted morphological hallmarks, including; extensively vacuolated cytoplasms, 
swollen mitochondria and dilated endoplasmic reticula (ER). Cells also swell and 
lyse, inducing inflammatory responses within the host. DNA damage specifically 
activates the DNA repair enzyme poly (ADP- ribose) polymerase (PARP), which has 
generally been considered to be a necrosis -specific event. PARP polymerises poly 
(ADP- ribose) from NAD monomers, resulting in the depletion of cellular ATP levels 
which would be required for the active process of programmed cell death (Apoptosis). 
Increasing knowledge of the mechanisms of cell death suggest that there may be 
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many crossovers than the presently accepted strict definitions of necrosis, apoptosis 
and autophagy. At present there is no evidence for necrotic cell death in the TSE 
diseases, but numerous publications detailing mechanisms of neuronal autophagy and 
apoptosis. 
3.1.2 Neuronal autophagy 
Autophagy is a tightly controlled process required for normal cellular turnover, where 
the target cell or protein is sequestered by autophagic vacuoles resulting in the 
degradation of the cellular constituents. As autophagy is a constitutive process, only 
excessive and misplaced autophagic vacuoles resulting in cell death are the hallmarks 
of a disease state. The characteristic hallmarks of autophagy are: the formation of 
autophagic vacuoles comprised of cytoplasm sequestered with single, double or 
multiple membranes; membranous whorls, residual bodies, multivesicular bodies and 
engulfed organelles. The full mechanisms of autophagy are poorly understood, 
particularly in neurons. Increasing numbers of biological markers are being 
identified, but morphological analysis by electron microscopy remains the major 
technique for identifying autophagy. 
Neuronal autophagy has also been documented as a mechanism for neuronal cell loss 
in the TSE infections and to date has been reported in experimental CJD, scrapie and 
BSE ( Boellaard et al. 1989; Boellaard et al. 1991; Jeffrey et al. 1992; Liberski et al. 
1992). Neuronal autophagy has also been documented in other neurodegenerative 
diseases and their experimental models: in Huntington's disease (Roizon 1974, 1979; 
Kegel 2000; Petersen 2001), in Alzheimer's disease (Cataldo et al. 1994; Cataldo et 
83 Chapter 3: Mechanisms of 
neuronal cell death in TSEs 
al. 1995; Cataldo et al. 1996; Stadelmann et al. 1999) and in Parkinson's disease 
(Anglade et al. 1997). Autophagy and apoptosis appear to have some common 
mechanisms and autophagic independence or inter -dependence with apoptosis needs 
to be further clarified. Both apoptosis and autophagy can be induced by the opening 
of the mitochondrial permeability transition pore (PTP) (Lemasters et al. 1998) and 
the presence of autophagy is associated with an increased tendency for cells to 
undergo apoptosis (Jia et al. 1997). Whether autophagy proceeds independently of 
apoptosis is uncertain, as reports using neuronal cell cultures indicate that autophagy 
induction is sensitive to apoptotic stimuli (Larsen & Sulzer 2002). It is therefore 
conceivable that as evidence for apoptosis and autophagy exists, and that their 
mechanisms appear to interconnect, that both processes could have distinct roles in 
contributing to neuronal cell loss in these diseases. 
3.1.3 Neuronal apoptosis: Caspase- dependent 
Apoptosis is a carefully co- ordinated series of events, and has long been the 
phenotype of programmed cell death (Kerr et al. 1972), and is essential for cell 
development, maturation, normal tissue turnover and regulation of immune systems. 
Apoptosis is co- ordinated by the Fas mediated pathway, the cysteine protease 
(caspase) and Bc1-2 protein families and can be triggered by toxic compounds, 
chemicals, the absence of growth factors, physical stresses including y- and UV- 
irradiation, oxidative stress and heat shock. The activation and suppression of 
apoptotic processes are also mediated by various cell- surface receptors that detect 
physiological changes, where the binding of death ligands to specific receptors 
activates the respective apoptotic mechanism. Apoptosis is thought to be an 
important mechanism of neuronal cell death in TSE infections based upon the 
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detection of cellular and nuclear shrinkage, condensation and fragmentation of 
nuclear chromatin by electron microscopy and biochemically by endonuclease- 
mediated internucleosomal fragmentation of DNA into multiple oligosomal sub -units 
of 180 bp (Giese et al. 1995; Lucassen et al. 1995; Fraser et al. 1996; Jesionek- 
Kupnicka et al. 1997; Dorandeu et al. 1998; Gray et al. 1999; Puig & Ferrer 2001). 
Transgenic mouse models over -expressing Bc1-2 in the nervous system are protected 
from cell death during development, highlighting the anti -apoptotic function of the 
protein (Martinou 1994). Fas is one of the key initiators in the apoptotic cascade; Fas 
ligand (FasL) binds to the Fas receptor (FasR), and this results in the formation of the 
death -inducing signaling complex (DISC). This leads to the activation of initiator and 
effector caspases, mediated through either a mitochondria- dependent or the 
mitochondria- independent pathway (Scaffidi et al. 1998). Upon activation of a death 
signal, a self -amplifying cascade amongst the caspase enzymes occurs, resulting in 
the activation of the relatively inactive caspase zymogens within the cytosol. This 
apoptotic mechanism is mediated by cytochrome c (cyt c). Cytochrome c is translated 
as apopcytochrome c in the cytosol, translocates to the mitochondria, and is converted 
to holocytochrome c following the addition of a haem group in the mitochondria. The 
research of this thesis concentrates on the holocytochrome c isoform, the only isoform 
capable of inducing apoptosis (Yang et al. 1997), and is referred to as cytochrome c 
within the text of this thesis. Cyt e is released from the mitochondria in response to 
oxidative stress, due to elevated levels of extra -mitochondrial Cat +. The redox state 
of cyt c (following cytosolic release) is independent of the apoptotic capabilities of 
the protein, although cyt c is thought to remain in the cytosol in the reduced form 
(Hampton et al. 1998). 
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Anti -apoptotic proteins (Bc1 -2, Bcl -XL) maintain the integrity of mitochondrial 
membranes and prevent cyt c release (Kluck et al. 1997; Yang et al. 1997), and pro - 
apoptotic proteins (e.g. Bax, Bak) result in membrane permeabilisation. The physical 
interactions of Bcl -2 and Bax with proteins of the PTP can result in opening of the 
PTP and translocation of soluble intermembrane proteins via the outer mitochondrial 
membrane. The PTP is thought to be involved in the translocation of Cat+ into the 
mitochondrial matrix and release of cyt c, through a nitric oxide -independent 
mechanism. In Alzheimer's disease and cerebral ischemia, cytosolic Cat+ 
concentrations are pathologically elevated resulting in the release of cyt c and the 
activation of neuronal apoptosis (Schild et al. 2001). However no evidence exists to 
confirm that this occurs in prion diseases. The release of cyt c into the cytosol results 
in the activation of a caspase cascade and apoptotic cell death (Liu et al. 1996). Cyt c 
interacts with Apaf -1 (apoptotic protease activating factor 1) to form the apoptosome 
(a complex consisting of cyt c, ATP, procaspase -9 and Apaf -1), resulting in the 
activation of caspase 9 and downstream effector caspases and therefore apoptotic cell 
death (Zou et al. 1999). Cyt c release is mediated through balanced interactions of 
pro- and anti -apoptotic members of the Bc1 -2 family, which therefore have an 
important role in the mediation of apoptosis. The up- regulation of Fas and Caspases 
as markers for neurodegeneration in prion diseases have been documented for the first 
time in murine 87V scrapie infections (Jamieson et al. 200la), highlighting the 
importance of these caspase- dependent apoptotic markers in the early detection of the 
neurodegenerative pathways associated with prion diseases. 
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3.1.4 Neuronal apoptosis: Caspase- independent 
In addition to the role of caspases in apoptosis, Apoptotis Inducing Factor (AIF) and 
Endonuclease G (EndoG) have emerged as mediators of apoptosis in both the 
presence and absence of caspases (Li et al. 2001; Susin et al. 1999; van Loo et al. 
2001). AIF and EndoG are IMM proteins released to the nucleus and cytosol upon 
permeabilisation of the mitochondrial membrane. Therefore these proteins are 
released from the mitochondria in addition to cyt c, although the sequence and 
apoptotic stimuli resulting in their release has yet to be fully clarified. These proteins 
are also regulated by the Bc1-2 protein family members and their release, or not, 
further determines the fate of the cell. The ability of these proteins to execute 
apoptosis in the absence of caspases represents a novel area of interest in TSEs, and 
their involvement in neurodegenerative models of ischemia and Parkinson's Disease 
has been documented et al. 2003; Wang et al. 2003; Zhu et al. 2003). 
Difficulties in the detection of neuronal loss in vivo have resulted in modest advances 
in the understanding of the neurodegenerative pathways associated with TSEs. The 
research on caspase- independent mechanisms will therefore highlight the roles, if any, 
of these proteins in murine models of TSE disease. 
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Figure 3A Apoptotic functions of some of the inner mitochondria) membrane proteins 
Brief schematic highlighting apoptotic functions of the inner mitochondrial membrane (IMM) 
proteins analysed in this research. Endo G and AIF apoptotic mechanisms are not completely 
clear, however it is thought AIF can be apoptotic in both the presence and absence of 
caspases. Cyt c forms the apoptosome with Apaf -1 and caspase 9 to activate downstream 
effector caspases. Apoptosome formation and IMM protein release is influenced by Hsp70, 
and also by pro- and anti -apoptotic members of the Bcl -2 protein family 
3.1.4.1 Apoptosis -inducing factor 
AIF is a flavoprotein synthesised as a precursor (-67 kDa), directed by an N- terminal 
mitochondrial localisation sequence (MLS) of 100 amino acids for incorporation into 
the IMM. Proteolytic cleavage of the MLS results in mature AIF ( -57 kDa) 
consisting of a nuclear localisation signal, a C- terminal region with high homology to 
eukaryotic and prokaryotic oxidoreductases (consisting of flavin adenine dinucleotide 
(FAD) and nicotinaminde adenine dinucleotide (NAD) binding sites), and a DNA 
binding domain. Mature AIF appears to be expressed ubiquitously from embryonic 
development to the adult stage, specifically localised to the IMM. The precise 
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functions of AIF remain unknown; however, it has both apoptotic and oxidoreductase 
activities. The apoptotic activity is not dependent upon the status of the 
oxidoreductase activity, as full length recombinant AIF (bound and unbound to FAD) 
stimulates apoptosis in purified nuclei (Ye et al. 2002). However, deletion mutants 
within the oxidoreductase domain remove the apoptotic abilities of AIF, indicating 
that at least some of the structural features of the oxidoreductase domain are 
important for apoptotic activities (Susin et al. 1999; Miramar et al. 2001). Some 
evidence suggests that AIF may also act like a free radical scavenger and be involved 
in redox coupling or cycling with NAD (P) H (Klein et al. 2002; Mate et al. 2002). 
AIF has a structure similar to glutathione peroxidase, important in the dismutation of 
hydrogen peroxide and therefore protection against oxidative stress (Mate et al. 
2002). Cerebellar cells expressing low levels of AIF are extremely sensitive to 
peroxide mediated oxidative stress, whereas cells over -expressing AIF are resistant 
(Klein et al. 2002). AIF may therefore function as an antioxidant within the IMM 
under normal physiological conditions, but assuming pro -apoptotic functions 
following release from the IMM. 
Upon the induction of apoptosis, AIF is released from the IMM and translocates to the 
nucleus and cytosol. In the nucleus AIF is thought to directly bind DNA (Ye et al. 
2002) to induce partial chromatin condensation and DNA fragmentation to high 
molecular weighted (HMW) fragments ( -50 kB) but without the oligonucleosomal 
180 -200 bp ladder characteristic of caspase- mediated apoptosis (Susin et al. 1999). 
Cytoplasmic microinjections of recombinant AIF results in the morphological and 
biochemical changes typical of apoptosis even when cells are cultured with the pan 
caspase inhibitor Z- VAD.fmk (Susin et al. 1999). Further evidence for a role of AIF 
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in enabling apoptosis is that AIF null mice die at an early stage of embryogenesis, due 
to the lack of cavitation of embryoid bodies that is essential for normal development 
directed by apoptosis (Joza et al. 2001). The release of AIF from the mitochondria is 
thought to affect the barrier function permeability of the mitochondrial membrane. 
Therefore, AIF released from the IMM will affect the membrane function of other 
mitochondria (Susin et al. 1997). Bc1-2 inhibits the release of AIF from the IMM, but 
if AIF has already been released from the IMM and is present in the nucleus and 
cytosol the cytoprotective effects are lost (Susin et al. 1999). 
Purified nuclear heat -shock protein 70 (Hsp70), a cytoprotective factor, antagonises 
AIF to prevent AIF- induced chromatin condensation (Ravagnan et al. 2001). Hsp70 
has previously been shown to inhibit apoptosis by preventing apoptosome formation 
by binding Apaf -1, therefore preventing caspase -9 activation (Beere et al. 2000; Saleh 
et al. 2000). In Apaf -1 knockout cells, Hsp70 continues to inhibit apoptosis 
indicating the ability to block apoptosis through further mechanisms (Ravagnan et al. 
2001). Hsp70 and AIF interactions have so far been demonstrated in cell -free systems 
and in intact cells (Ravagnan et al. 2001), but a functional relationship has yet to be 
established in vivo. In addition to the release of AIF under apoptotic conditions, AIF 
release has also been demonstrated experimentally in conditions of ATP depletion, 
that lead to a characteristic necrotic phenotype of advanced DNA fragmentation and 
characteristic lack of chromatin condensation (Daugas et al. 2000). Therefore AIF 
appears to be a dual /multi function protein, with one function of that of a caspase- 
independent mitochondrial death effector active in conditions of either necrosis or 
apoptosis. 
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In addition to the existing in vitro studies, recent publications have documented the in 
vivo activities of AIF in neuronal apoptosis. High molecular weight DNA 
fragmentation and localisation of AIF to hippocampal and ipsilateral cortical nuclei 
has been demonstrated following traumatic brain injury in rats (Zhang et al. 2002). 
This HMW fragmentation and AIF translocation has also been found in a rat model of 
transient -global ischemia in CA1 hippocampal neurons (Cao et al. 2003) and also in a 
rat model of hypoxia -ischemia in neonatal animals (Zhu et al. 2003). AIF 
translocation has also been documented in the penumbra following middle cerebral 
artery occlusion in adult rats (Ferrer et al. 2003) and in a mouse model of sporadic 
Parkinson's disease (Wang et al. 2003). 
3.1.4.2 Endonuclease G 
Endo G is a non -specific mitochondrial nuclease ( -30 kDa) that is highly conserved 
between eukaryotes. It is encoded by a nuclear gene and directed to the mitochondria 
by an N- terminal signal sequence which is subsequently cleaved for the incorporation 
of mature Endo G into the mitochondria, where it forms homodimers. Mammalian 
Endo G has been identified not only in the IMM, but also within the mitochondrial 
DNA (mtDNA) complex (Li et al. 2001; van Loo et al. 2001). The lack of a nuclear 
localisation sequence and its preference for GC -rich substrates (which resemble the 
DNA sequences in the mtDNA complex) had led researchers to believe that Endo G 
had a role in mtDNA replication (Cote & Ruiz -Carrillo 1993). However, more recent 
research has identified a role for Endo G in the mediation of caspase- independent 
apoptosis (Wang 2001). Caspase- activated deoxyribonuclease (CAD), also known as 
DNA fragmentation factor 40, is a nuclease which results in HMW DNA 
fragmentation and DNA laddering when cleaved from its inhibitor ICAD/DFF45 by 
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caspase 3. In the absence of caspases in mice lacking CAD/DFF40 and in mice with 
caspase- resistant ICAD /DFF45, HMW DNA fragmentation and DNA laddering still 
occurs, indicating the activity of a caspase- independent nuclease. This nuclease has 
been identified as Endo G (Li et al. 2001; van Loo et al. 2001). 
The majority of Endo G is located in the IMM, remaining inactive until its release and 
translocation to the nucleus. The full mechanisms resulting Endo G activation are 
unknown, but are thought to be under the control of the Bc1-2 family members as 
Bcl -2 over -expression blocks the translocation of Endo G from the mitochondria to 
the nucleus (van Loo et al. 2001). Pro -apoptotic truncated Bid (tBid) has been shown 
to induce the release of Endo G and cyt c from mitochondria in vitro and in vivo, 
resulting in DNA fragmentation. Although Bid is cleaved to tBid (pro -apoptotic) by 
caspase 8 resulting in cyt c release and formation of the apoptosome (Li et al. 1998; 
Luo et al. 1998; Gross et al. 1999), Bid can also be cleaved independently of caspases 
by granzyme B and lysosomal proteases, further indicating that Endo G can be 
activated in a caspase- independent manner (Heibein et al. 1999; Stoka et al. 2001). 
Although partially purified Endo G results in DNA laddering in isolated nuclei, full 
DNA degradation is thought to require the activities of exonucleases and DNaseI 
(Widlak et al. 2001). No evidence yet suggests that AIF and Endo G work together in 
mammalian apoptosis, however homologues of these proteins in Caenorhabditis 
elegans (Wah -1 and csp -6 respectively) suggest that they work synergistically (Wang 
et al. 2002). Therefore, AIF and Endo G are both evolutionarily conserved. Whether 
or not they act synergistically in mammals, they appear to be important in the 
mediation of caspase- independent apoptosis in certain neurological disorders. The 
release of AIF and Endo G therefore represent interesting mechanisms of apoptosis 
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which deserve consideration in TSE diseases and which will be addressed by this 
research. 
The aims of this thesis (Section 1.6) are to investigate the fundamental mechanisms of 
neurodegeneration in the TSEs. As described above, evidence exists for caspase- 
dependent mechanisms of cell death in several TSE diseases and TSE disease models. 
This thesis has concentrated on potential roles of AIF, Endo G and Cyt c in two well 
described murine scrapie models (ME7 /CV and 87V/VM) at the terminal stages of 
disease (Section 1.4.5). As cyt c appears to be involved in both caspase- dependent 
and caspase- independent cell death pathways in other disease models, the 
translocation of Cyt c from the IMM to the cytosol in TSEs would represent a 
relatively upstream marker of neurodegeneration. The analysis of AIF and Endo G 
for similar translocation is a downstream event in the apoptosis cascade, and would 
confirm wheither caspase -independnet mechanisms are involved in the 
neurodegenerative process in the TSE diseases. 
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3.2 Results 
3.2.1 Production of mitochondria -free cytosolic samples 
The creation of mitochondria -free cytosolic samples was essential for the analysis of 
apoptosis -related protein translocation from the inner IMM to the cytosol. Cytosolic 
samples containing 60 and 90µg total protein were probed with the anti- voltage- 
dependent anion channel (VDAC 1) primary antibody, to allow the detection of 
contaminating mitochondria. VDAC1 is an abundant protein of the outer 
mitochondrial membrane found in all eukaryotes. VDAC 1 forms a large voltage - 
gated channel responsible for metabolism, mitochondrial homeostasis and apoptotic 
cell death through the mediation of cyt c release (Shimizu et al. 1999). Mitochondrial 
extracts from identical brain samples confirmed reactivity with VDAC 1. 3T3 or 
K562 cell lysates varied with reactivity with VDAC1, depending on the batch, and 
were poorly reactive as these are cellular lysates. 
Initially, samples created by the sucrose -gradient fractionation protocol (Section 
2.3.1.) revealed the presence of mitochondrial contaminants in the cytosolic fractions. 
Increased centrifugation speeds of 100,000g (50,000rpm) for 60 minutes, and careful 
removal of cytosolic supernatants produced consistently mitochondria -free samples. 
In addition, samples created by the sub cellular fractionation (Calbiochem) protocol 
(Section 2.3.2.2.) were contaminated with mitochondria in the cytosolic fractions. 
Two further final centrifugation steps at 10,000g, each for 10 minutes, greatly 
increased the purity of the fractions. Cytosolic purity was maximised by 
homogenising dissected samples by serial passage through a 19 gauge metal needle 
using 1m1 syringes, in comparison to the samples originally created by 
homogenisation with mini -dounce homogenisers. Cytosolic fractions created by these 
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protocols were consistently free of mitochondria and are ideal for the study of the 
translocation of IMM proteins to the cytosol. 
3.2.2 Primary antibodies and positive controls for analysing IMM protein 
translocation 
Sub -cellular fractionated cytosolic samples were analysed for VDAC1, AIF, Endo G 
and cyt c. Cytosolic samples created from these homogenates were free of 
mitochondria as confirmed by the lack of reactivity with the anti -VDAC 1 antibody. 
Western blot analysis with Hsp70 was also performed for micro -dissected samples, 
but not for sucrose -gradient fractionated samples as this antibody was not available at 
the time of this research. Hsp70 was examined to confirm the presence of protein on 
the membranes as this protein is present in both the mitochondria and cytosol, and 
also because this protein can inhibit both caspase and caspase- independent apoptotic 
pathways (Beere et al. 2000; Ravagnan et al. 2001). The 3T3 cell lysate was 
purchased as a positive control for Endo G (and AIF), and the K562 cell lysate was 
purchased as a positive control for AIF. Both cell lysates cross -reacted strongly with 
the anti -Hsp70 antibody but weakly with the anti -VDAC 1 antibody. Depending upon 
the batch of positive control, the anti -cyt c antibody would recognize either of the cell 
lysates or both. 
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3.2.3 AIF translocation to the cytosol is detected in micro -dissected ME7 /CV 
but not 87VNM samples, or in samples prepared from whole brain 
To investigate caspase- independent mechanisms of neuronal cell death, mitochondria - 
free cytosolic samples were prepared from whole brain homogenates and also from 
micro -dissected pooled hippocampal and thalamic samples from the ME7 /CV and 
87VNM murine scrapie models (Section 1.4.5.). Samples were separated into sub - 
cellular fractions by the whole brain sucrose gradient technique (Section 2.3.1.) and 
analysed by Western blot (Figures 3.2 -3.9). Furthermore, the hippocampi and 
thalamus which are two of the areas presenting TSE pathology in the ME7 /CV 
(Figure 1.2) and 87V /VM (Figure 1.3) models, were micro -dissected, pooled, sub - 
cellular fractionated using the Calbiochem kit (Section 2.3.2.2.) and analysed by 
Western blot (Figures 3.10- 3.17). Apoptosis is notoriously difficult to detect in vivo, 
due to the rapid clearance of apoptotic cells. If neuronal apoptosis is occurring in vivo 
in these murine scrapie models then these micro -dissected areas, which show a 
marked neuronal loss (Jeffrey et al. 2000; Jamieson et al. 2001(a); Jamieson et al. 
2001(b)), should contain a higher proportion of apoptotic to normal cells. Based on 
this evidence, the use of micro -dissected areas would maximise the likelihood of 
detecting apoptosis -related proteins. 
Cytochrome c detection in the tested samples will be discussed in Section 3.2.4. 
Samples containing 30µg of mitochondrial proteins from both the whole brain 
(Figures 3.2/ 3.4/ 3.6/ 3.8) and micro -dissected brain homogenates (Figures 3.10/ 
3.12/ 3.14/ 3.16) always detected AIF, Endo G, VDAC and cyt c (and Hsp70 when 
analysed). Cytosolic samples containing 30µg of total protein from the whole brain 
fractionated samples from both the whole brain (Figures 3.2/ 3.4/ 3.6/ 3.8) and micro - 
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dissected brain homogenates (Figures 3.10/ 3.12/ 3.14/ 3.16) never contained 
detectable AIF, Endo G or VDAC proteins. Hsp70, where tested, was always 
detected and cyt c was occasionally detected in these samples. Cytosollic samples 
containing 60 and 90µg total protein from the whole brain fractionated samples from 
both the whole brain (Figures 3.3/ 3.5/ 3.7/ 3.9) and micro - dissected brain 
homogenates (Figures 3.11/ 3.13/ 3.15/ 3.17) were always free of mitochondria! 
contaminants as determined by the lack of VDAC1 proteins. Endo G was never 
detected in either the 60 or 90µg total protein samples indicating t t this 
endonuclease protein is either not detected or not involved in mediating neuronal cell 
death in murine scrapie disease. AIF was not detected in the 87V/VM or NB/VM 
cytosolic samples containing 60 or 90µg total protein from samples prepared by the 
whole brain (Figures 3.7 and 3.9) or micro- dissesti n fractionation tee l E fines II 
(Figures 3.15 and 3.17). However, AlF was detected in the \IETCV ((but not 
NB /CV) cytosolic samples containing 60 or 90µg total prorein from samples prepared 
by the micro -dissection fractionation technique (Figures 3.113 and 3.17))_ Furthermore. 
AIF was not detected in equivalent ME7 /CV and NB/CV 60 am '" "i wr total protein- 
containing cytosolic samples created by the whole iu rain fractionati 
(Figures 3.3 and 3.5). These results further highlight ill 
II) n 
differences 
i1i'i [Y toed 
illdll .(1 nn Section 
1 between the mechanisms of neuronal cell death in the MET/CV and V/V //V 
mutine scrapie models. In addition, these results indicate 
protocol reduces the dilution effect of non- 
I Ul' the micro-dissection 
ptosing cells to cells potentially 
undergoing apoptosis, and may therefore be a much more suitable tee 
vivo detection of apoptosis. 
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3.2.4 Cytochrome c is detected in the cytosol in terminal stage murine scrapie 
and aged- matched normal brain injected control animals in micro - 
dissected and whole brain homogenates 
Cytosolic samples created from whole mouse brain homogenates (Figures 3.2 -3.9) 
and micro -dissected brain areas (Figures 3.10 -3.17) were also analysed for the 
presence of cyt c. Cytochrome c is an important mediator of intrinsic apoptosis, 
whose presence in the cytosol can initiate the caspase cascade by formation of the 
apoptosome (Liu et al. 1996; Zou et al. 1999). Mitochondrial samples (30µg protein) 
from both the whole brain (Figures 3.2/ 3.4/ 3.6/ 3.8) and micro -dissected brain 
homogenates (Figures 3.10/ 3.12/ 3.14/ 3.16) always contained cyt c protein. It was 
expected that if cyt c were to be detected in the cytosolic fractions it would detected 
only in those brain homogenates prepared from murine scrapie infected mice, if 
neuronal cell death was occurring through apoptotic pathways. However, cytochrome 
c was present in low amounts in almost all of the cytosolic samples (301.1g protein) 
prepared by the micro -dissection fractionation procedure (Figures 3.10/ 3.12/ 3.14/ 
3.16), but not in the cytosol of whole brain fractionated samples except for extremely 
weak bands in samples prepared from NB/VM mice (Figure 3.6). Cytosolic samples 
containing 60 and 901Ag total protein from both the whole brain (Figures 3.3/ 3.5/ 3.7/ 
3.9) and micro -dissected brain homogenates (Figures 3.11/ 3.13/ 3.15/ 3.17) all 
contained larger quantities of the cyt c protein. Visually, cyt c levels in the cytosol of 
normal and scrapie- infected brain homogenates were similar. It was therefore 
impossible to verify if cyt c levels were higher in murine scrapie infected samples (as 
would be expected if intrinsic neuronal apoptosis was occurring), in comparison to 
normal brain injected control samples. The unexpected presence of cyt c in all 
cytosolic samples (60 and 901Ag protein) led to the hypothesis that cyt c may be 
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present in these samples due to the sample preparation procedure or that age- related 
mechanisms may be involved. Samples from younger mice (NB /CV and NB /VM) 
were prepared by both extraction procedures and analysed for the presence of cyt c 
(Section 3.2.5). 
3.2.5 Cytochrome e is not detected in the cytosol of normal brain injected 
animals at 70dpi in micro -dissected nor in whole brain fractionated brain 
homogenates 
Cyt c had been detected in some of the cytosolic samples containing 301Ag protein, 
and in all samples containing 60 and 90µg protein from the ME7 /CV, 87V/VM and 
NB control animals (Section 3.2.4.). To analyse whether cyt c was being detected as 
a consequence of age -related functions (such as mitochondria malfunction) or due to 
the protocols used for fractionating the samples, normal brain injected CV and VM 
mice were analysed at approximately 70 dpi (Figure 3.19). Cytosolic samples were 
created using both the micro -dissected and whole brain fractionation protocols, and 
samples containing 601.1g (Figure 3.19A) and 90µg (Figure 3.19B) protein were 
analysed by Western blot with the anti -cyt c antibody. Cyt c was present both in the 
3T3 and K562 positive controls (Figure 3.19) but absent from wells containing 60 and 
90µg protein for both the micro -dissected and whole brain fractionation techniques. 
Stripping and re- probing the membrane with Hsp70 revealed that protein was 
definitely present in all of the tested samples. Therefore, the presence of cyt c in the 
cytosol is not due to the procedure used to fractionate the samples but appears to be 
due to age- related mechanisms. 
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Figure 3.2 Sub -cellular location of apoptosis- related proteins isolated from whole 
brain homogenates from normal brain infected terminal stage age- matched CV mice 
AIF, Endo G, VDAC1 and cyt c localize to the mitochondria, but are not detected in 
cytosolic fractions. 30pg of each mitochondrial and cytosolic fraction from normal CV 
brains (n =3), and 3pg of K562 and 3T3 positive control cell lysates (Abcam), were loaded to 
each gel. Samples were prepared and analyzed for VDAC1 as described (Sections 2.3.5., 
2.3.6. and 2.3.8.). One blot was used for this analysis, which was stripped and re- probed 
(Section 2.3.9.) for AIF, Endo G and cyt c respectively. Western blots were exposed for 
periods of 1, 5 and 10 mins. Blots shown here were obtained following 5mins exposure. 
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Figure 3.3 Sub -cellular location of apoptosis -related proteins isolated from whole 
brain homogenates from normal brain infected terminal stage age- matched CV mice 
AIF, Endo G and VDAC1 are not detected in cytosolic fractions. Cyt c was detected in both 
6Opg and 90pg cytosolic fractions from the normal CV brains. 6Opg and 90pg of each 
cytosolic fraction from normal CV brains (n =3), and 3pg of K562 and 3T3 positive control 
cell lysates (Abcam), were loaded to each gel. Samples were prepared and analyzed for 
VDAC1 as described (Sections 2.3.5., 2.3.6. and 2.3.8.). One blot was used for this 
analysis, which was stripped and re- probed (Section 2.3.9.) for AIF, Endo G and cyt c 
respectively. Western blots were exposed for periods of 1, 5 and 10 mins. Blots shown 
here were obtained following 5 mins exposure. Some unspecific bands are visible following 
probing with the Endo G and VDAC polyclonal antibodies. 
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Figure 3.4 Sub -cellular location of apoptosis -related proteins isolated from whole 
brain homogenates from ME7 infected terminal stage CV mice 
AIF, Endo G, VDAC1 and cyt c localize to the mitochondria, but are not detected in 
cytosolic fractions. 30pg of each mitochondrial and cytosolic fraction from ME7 /CV brains 
(n =3), and 3pg of K562 and 3T3 positive control cell lysates (Abcam), were loaded to each 
gel. Samples were prepared and analyzed for VDAC1 as described (Sections 2.3.5., 2.3.6. 
and 2.3.8.). One blot was used for this analysis, which was stripped and re- probed 
(Section 2.3.9.) for AlF, Endo G and cyt c respectively. Western blots were exposed for 
periods of 1, 5 and 10 mins. Blots shown here were obtained following 5 mins exposure. 
Some unspecific bands are visible following probing with the Endo G and VDAC polyclonal 
antibodies. 
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Figure 3.5 Sub -cellular location of apoptosis -related proteins isolated from whole 
brain homogenates from ME7 injected terminal stage CV mice 
AIF, Endo G and VDAC1 are not detected in cytosolic fractions. Cyt c was detected in both 
60pg and 90pg cytosolic fractions from the ME7 /CV brains. 60pg and 90pg of each 
cytosolic fraction from ME7 /CV brains (n =3), and 3pg of K562 and 3T3 positive control cell 
lysates (Abcam), were loaded to each gel. Samples were prepared and analyzed for 
VDAC1 as described (Sections 2.3.5., 2.3.6. and 2.3.8.). Two blots were used for analysis, 
which were then stripped and re- probed (Section 2.3.9.) for AIF, Endo G and cyt c 
respectively. Western blots were exposed for periods of 1, 5 and 10 mins. Blots shown 
here were obtained following 5 mins exposure. Some unspecific bands are visible following 
probing with the Endo G and VDAC polyclonal antibodies. 
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Figure 3.6 Sub -cellular location of apoptosis- related proteins isolated from whole 
brain homogenates from normal brain infected terminal stage age- matched VM mice 
AIF, Endo G and VDAC1 localize to the mitochondria, but are not detected in cytosolic 
fractions. Cyt c is detected in the mitochondrial fractions, and low levels are present in 
cytosolic fractions. 30pg of each mitochondrial and cytosolic fraction from normal VM 
brains (n =3), and 3pg of K562 and 3T3 positive control cell lysates (Abcam), were loaded to 
each gel. Samples were prepared and analyzed for VDAC1 as described (Sections 2.3.5., 
2.3.6. and 2.3.8.). Two blots were used for this analysis, which were then stripped and re- 
probed (Section 2.3.9.) for AIF, Endo G and cyt c respectively. Western blots were 
exposed for periods of 1, 5 and 10 mins. Blots shown here were obtained following 5 mins 
exposure. 
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Figure 3.7 Sub -cellular location of apoptosis- related proteins isolated from whole 
brain homogenates from normal brain infected terminal stage age- matched VM mice 
AIF, Endo G and VDAC1 are not detected in cytosolic fractions. Cyt c was detected at both 
60pg and 90pg cytosolic fractions from the normal VM brains. 60pg and 90pg of each 
cytosolic fraction from normal VM brains (n =3), and 3pg of K562 and 3T3 positive control 
cell lysates (Abcam), were loaded to each gel. Samples were prepared and analyzed for 
VDAC1 as described (Sections 2.3.5., 2.3.6. and 2.3.8.). Western blots were exposed for 
periods of 1, 5 and 10 mins. One blot was used for this analysis, which was then stripped 
and re- probed (Section 2.3.9.) for AIF, Endo G and cyt c respectively. Western blots were 
exposed for periods of 1, 5 and 10 mins. Blots shown here were obtained following 5 mins 
exposure. 
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Figure 3.8 Sub -cellular location of apoptosis -related proteins isolated from whole 
brain homogenates from 87V infected terminal stage VM mice 
AIF, Endo G, VDAC1 and cyt c localize to the mitochondria, but are not detected in 
cytosolic fractions. 30pg of each mitochondrial and cytosolic fraction from 87VNM brains 
(n =3), and 3pg of K562 and 3T3 positive control cell lysates (Abcam), were loaded to each 
gel. Samples were prepared and analyzed for VDAC1 as described (Sections 2.3.5., 2.3.6. 
and 2.3.8.). Two blots were used for this analysis, which were then stripped and re- probed 
(Section 2.3.9.) for AIF, Endo G and cyt c respectively. Western blots were exposed for 
periods of 1, 5 and 10 mins. Blots shown here were obtained following 5 mins exposure. 
Some unspecific bands are visible following probing with the VDAC polyclonal antibody. 
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Figure 3.9 Sub -cellular location of apoptosis -related proteins isolated from whole 
brain homogenates from 87V injected terminal stage VM mice 
AIF, Endo G and VDAC1 are not detected in cytosolic fractions. Cyt c was detected in both 
60pg and 90pg cytosolic fractions from the 87VNM brains. 6Opg and 90pg of each 
cytosolic fraction from 87VNM brains (n =3), and 3pg of K562 and 3T3 positive control cell 
lysates (Abcam), were loaded to each gel. Samples were prepared and analyzed for 
VDAC1 as described (Sections 2.3.5., 2.3.6. and 2.3.8.). One blot was used for this 
analysis, which was then stripped and re- probed (Section 2.3.9.) for AIF, Endo G and cyt c 
respectively. Western blots were exposed for periods of 1, 5 and 10 mins. Blots shown 
here were obtained following 5 mins exposure. 
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Figure 3.10 Sub -cellular location of apoptosis- related proteins isolated from the 
micro -dissected hippocampus and thalamus from normal brain injected terminal 
stage age-matched CV mice 
AIF, Endo G and VDAC1 localize to the mitochondria, but are not detected in cytosolic 
fractions. Hsp70 is present in both the mitochondria) and cytosolic fractions. Cyt c 
localizes to the mitochondria, and low levels are present in cytosolic fractions. 30pg of 
each mitochondrial and cytosolic fraction from normal CV brains (n =3), and 3pg of K562 
and 3T3 positive control cell lysates (Abcam), were loaded to each gel. Samples were 
prepared and analyzed for VDAC1 as described (Sections 2.3.5., 2.3.6. and 2.3.8.). Two 
blots were used for this analysis, which were then stripped and re- probed (Section 2.3.9.) 
for AIF, Endo G, cyt c and Hsp70 respectively. Western blots were exposed for periods of 
1, 5 and 10 mins. Blots shown here were obtained following 5 mins exposure. 
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Figure 3.11 Sub -cellular location of apoptosis- related proteins isolated from the 
micro -dissected hi ocam us and thalamus from normal brain in'ected terminal 
stage age-matched CV mice 
AIF, Endo G and VDAC1 are not detected in cytosolic fractions. Hsp70 and cyt c were 
detected in both 60pg and 90pg cytosolic fractions from the normal CV brains. 6Opg and 
90pg of each cytosolic fraction from normal CV brains (n =3), and 3pg of K562 and 3T3 
positive control cell lysates (Abcam), were loaded to each gel. Samples were prepared and 
analyzed for VDACI as described (Sections 2.3.5., 2.3.6. and 2.3.8.). Two blots were used 
for this analysis, which were then stripped and re- probed (Section 2.3.9.) for ALF, Endo G, 
cyt c and Hsp70 respectively. Western blots were exposed for periods of 1, 5 and 10 mins. 
Blots shown here were obtained following 5 mins exposure. Some unspecific bands are 
visible following probing with the VDAC and Endo G polyclonal antibodies. 
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Figure 3.12 Sub -cellular location of apoptosis -related proteins isolated from the 
micro -dissected hippocampus and thalamus from ME7 injected terminal stage CV 
mice 
AIF, Endo G and VDAC1 localize to the mitochondria, but are not detected in cytosolic 
fractions. Hsp70 is present in both the mitochondria) and cytosolic fractions. Cyt c localizes 
to the mitochondria, and low levels are present in cytosolic fractions. 30pg of each 
mitochondrial and cytosolic fraction from ME7 /CV brains (n =3), and 3pg of K562 and 3T3 
positive control cell lysates (Abcam), were loaded to each gel. Samples were prepared and 
analyzed for VDAC1 as described (Sections 2.3.5., 2.3.6. and 2.3.8.). Two blots were used 
for this analysis, which were then stripped and re- probed (Section 2.3.9.) for AIF, Endo G, 
cyt c and Hsp70 respectively. Western blots were exposed for periods of 1, 5 and 10 mins. 
Blots shown here were obtained following 5 mins exposure. 
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Fi ure 3.13 A o tosis- related AIF and c t c translocate to the c tosol in sam les 
prepared from the micro -dissected hippocampus and thalamus from ME7 injected 
terminal stage CV mice 
AIF, Hsp70 and cyt c were detected in both 60pg and 90pg cytosolic fractions from the 
ME7 /CV brains. The presence of AIF and cyt c in the cytosolic fractions represents 
translocation from the mitochondria as a consequence of mitochondrial malfunction. Endo 
G and VDAC1 are not detected in cytosolic fractions. 60pg and 90pg of each cytosolic 
fraction from ME7 /CV brains (n =3), and 3pg of K562 and 3T3 positive control cell lysates 
(Abcam), were loaded to each gel. Samples were prepared and analyzed for VDAC1 as 
described (Sections 2.3.5., 2.3.6. and 2.3.8.). Two blots were used for this analysis, which 
were then stripped and re- probed (Section 2.3.9.) for AIF, Endo G, cyt c and Hsp70 
respectively. Western blots were exposed for periods of 1, 5 and 10 mins. Blots shown 
here were obtained following 5 mins exposure, except that for AIF which was exposed for 
10 mins. Some unspecific bands are visible following probing with the VDAC polyclonal 
antibody. 
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Figure 3.14 Sub -cellular location of apoptosis- related proteins isolated from the 
micro- dissected hippocampus and thalamus from normal brain injected terminai 
stage age- matched VM mice 
AIF, Endo G and VDAC1 localize to the mitochondria, but are not detected in cytosolic 
fractions. Hsp70 is present in both the mitochondriall and cytostlic fractions.. Cyt e 
localizes to the mitochondria, and low levels are present in cytosolic fractions. 30pg of 
each mitochondrial and cytosolic fraction from normal VM brains (n =3). and 3pg of K562 
and 3T3 positive control cell lysates (Abeam). were loaded to each gell. Samples were 
prepared and analyzed for VDAC1 as described (Sections 2.3.5.., 2..3.6. and 2.3.8.x. Two 
blots were used for this analysis, which were then stripped and re- probed (Section 2.3.9 l 
for AIF, Endo G, cyt c and Hsp70 respectively. Western blots were ex_ ».sed for pen sir 
1, 5 and 10 mins. Blots shown here were obtained following 5 mins ex,vssure.. 
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Figure 3.15 Sub -cellular location of apoptosis -related proteins isolated from the 
micro -dissected hippocampus and thalamus from normal brain injected terminal 
stage age- matched VM mice 
AIF, Endo G and VDAC1 are not detected in cytosolic fractions. Hsp70 and cyt c were 
detected in both 60pg and 90pg cytosolic fractions from the normal VM brains. 60pg and 
90pg of each cytosolic fraction from normal VM brains (n =3), and 3pg of K562 and 3T3 
positive control cell lysates (Abcam), were loaded to each gel. Samples were prepared and 
analyzed for VDAC1 as described (Sections 2.3.5., 2.3.6. and 2.3.8.). Two blots were used 
for this analysis, which were then stripped and re- probed (Section 2.3.9.) for AIF, Endo G, 
cyt c and Hsp70 respectively. Western blots were exposed for periods of 1, 5 and 10 mins. 
Blots shown here were obtained following 5 mins exposure. 
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Figure 3.16 Sub -cellular location of apoptosis -related proteins isolated from the 
micro -dissected hippocampus and thalamus from 87V infected terminal stage VM 
mice 
AIF, Endo G and VDAC1 localize to the mitochondria, but are not detected in cytosolic 
fractions. Hsp70 is present in both the mitochondrial and cytosolic fractions. Cyt c 
localizes to the mitochondria, and low levels are present in cytosolic fractions. 30pg of 
each mitochondrial and cytosolic fraction from 87VNM brains (n =3), and 3pg of K562 and 
3T3 positive control cell lysates (Abcam), were loaded to each gel. Samples were 
prepared and analyzed for VDAC1 as described (Sections 2.3.5., 2.3.6. and 2.3.8.). Two 
blots were used for this analysis, which were then stripped and re- probed (Section 2.3.9.) 
for AIF, Endo G, cyt c and Hsp70 respectively. Western blots were exposed for periods of 
1, 5 and 10 mins. Blots shown here were obtained following 5 mins exposure. Some 
unspecific bands are visible following probing with the Endo G polyclonal antibody. 
114 Chapter 3: Mechanisms of 
neuronal cell death in TSEs 
as 
ás 
ss Q © 
... ,... U C.i u s u 1 U cr áa aa mm ta °' á ot s Z. 
áT reD 







Figure 3.17 Sub-cellular location of apoptosiis-reflatedi protteiirms Guru tdhnEmribmi>- 
dissected hippocampus and thalamus from 87Ví iiniectted ttermitivall starre WWI mile 
AJIF,. Endo G and V®AC t are not detected in cytosolüc tTret:trms_ Bf *71, ai o,yt o were 
detected in both 6OIug and 9Otug cytosolli;c fr. oi ros from titre awivirur brains ea1,g arrd'. `I(Tpg of 
each cytcsoihic fraction from 87Nfti1 brains (rr=3)), sordi 314 of K5EZ arrd: a fa ¡xsitiver contra' 
e>rlll lysates (Abeam), were loaded to each . L SaIrplleS were We:par-lad di id analy,,aed fur- 
V®A,C1 as described (Sections 2,3,5,, 2.3.6. and 2..3..3.);.. Two blots were used ftu-ttiis 
arnllysüs which were then stripped and re-probed (Section 2.3.S.)) AlF, F rdrs, , c.y,,t and 
Hsp76 respectively, Western blots were exposed for peniddis cell,. 5 and TG min 
shawl here were obtained following 5 míins exposure.. Satre ,m.44ifiy tIar1ds 
following probing with the VDAC and Endo G poljyddirrall artifadiias.. 
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A 
ME7 /CV (whole brain samples) NB /CV (whole brain samples) 
AIF EndoG VDAC1 CytC AIF EndoG VDAC1 CytC 
Mitochondria ,+ + + + + + + + 
Cytoplasm 
30pg - - - - - - 
Cytoplasm 
60pg - 
+ - - - + 
Cytoplasm 
90pg 
+ _ - - + 
ME7 /CV (subcellular brain samles) NB /CV (subcellular brain samp es) 
AIF EndoG VDAC1 CytC Hsp70 AIF EndoG VDAC1 CytC Hsp70 
Mitochondria + +. + + + + + + + + 
Cytoplasm 
30pg - 
+_ - - - +/- + 
Cytoplasm 
60pg 
+ - + + - - _ + + 
Cytoplasm 
90pg 
+ - + + - - + + 
R 
87VNM (whole brain samples) NBNM (whole brain samples) 
AIF EndoG VDAC1 CytC AIF EndoG VDAC1 CytC 





+ _ _ _ + 
Cytoplasm 
90pg 
+. _ _ _ + 
87VNM (subcellular brain samples) NBNM (subcellular brain samples) 
CytC Hsp70 
+ 
AIF EndoG VDAC1 CytC Hsp70 AIF EndoG VDAC1 
Mitochondria + + +. + + + + + + 
Cytoplasm 
30pg - 
+ - - - +1- + 
Cytoplasm 
60pg - - + 
+ - - - + + 
Cytoplasm 
90pg - - 
+ + _ _ - + + 
Table 3.1 Summary of immunoreactivity of samples analysed by Westerb blot from ME7 /CV and 
87VNM and age- matched control animals at terminal stages of disease 
Mitochondrial and cytosolic samples prepared from whole brain and subcellularly fractionated brain 
samples and analysed by Western blot in Figures 3.2 to 3.17 are summarised in the table above. 
Positive immunoreactivity is denoted with +, whereas those samples with no immunoreactivity are 
shown with -. Samples which were weakly immunoreactive are illustrated with + / -. 
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3.2.6 Analysis of uninfected 70dpi animals for cytochrome e 
The detection of cyt c in normal and scrapie -infected brain samples, from both the 
sucrose- gradient and micro -dissected procedures, required clarification. Samples 
from 70dpi normal -brain injected mice were analysed for cyt c to determine if this 
detection was as a result of sample preparation or through age- related mechanisms. 
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Fi ure 3.19 C tochrome c is not ' resent in the c tosol in oun ' 70d i uninfected 
control mouse brains 
Cyt c was not detected in the cytosol of younger mice, although the presence of Hsp70 
verifies that protein was present in each of the tested samples. Cytosolic samples were 
prepared from 70dpi NB /CV and NB/VM mice (* = sucrose gradient fractionated, A=micro- 
dissected and fractionated). 60pg and 90pg of each cytosolic fraction, and 3pg of K562 
and 3T3 positive control cell lysates (Abcam), were loaded to each gel. Samples were 
prepared and analyzed for cyt c as described (Sections 2.3.5., 2.3.6. and 2.3.8.). One blot 
was used for this analysis, which was then stripped and re- probed (Section 2.3.9.) for 
Hsp70 respectively. Western blots were exposed for periods of 1, 5 and 10 mins. Blots 
shown here were obtained following 10 mins exposure. 
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3.3 Discussion 
Apoptosis is thought to be an important mechanism of neuronal cell death in TSE 
infections based upon the detection of cellular and nuclear shrinkage, condensation 
and fragmentation of nuclear chromatin by electron microscopy and biochemically by 
endonuclease- mediated internucleosomal fragmentation of DNA into multiple 
oligosomal sub -units of 180 bp (Giese et al. 1995; Lucassen et al. 1995; Fraser et al. 
1996; Dorandeu et al. 1998; Gray et al. 1999; Jamieson et al. 2001; Puig & Ferrer 
2001). Apoptosis research within the TSE field has concentrated primarily on 
extrinsic pathways, and the numerous apoptotic proteins thought to be involved 
following exposure to PrP peptides in vitro are detailed in Section 4. Apoptotic 
proteins documented for the ME7 /CV and 87V/VM murine scrapie models in vivo 
include the up- regulation of Fas ligand and activated caspase 3 in the 87V /VM murine 
scrapie model by ICC and Western blot (Jamieson et al. 2001), and the up- regulation 
of several apoptotic proteins in response to mitochondrial and ER oxidative stresses in 
the ME7 /CV model by Affymetrix micro -array analysis (Brown et al. 2005). 
Apoptosis mediated by the caspase- independent IMM protein, AIF, has recently been 
reported in rodent models of transient -global ischemia and hypoxia -ischemia in 
neonatal animals (Cao et al. 2003; Zhu et al. 2003). Translocation of AIF has also 
been detected in rodent models of traumatic brain injury (such as middle cerebral 
artery occlusion) (Ferrer et al. 2003) and in the MPTP model of spontaneous 
Parkinson's disease (Wang et al. 2003). Caspase- independent apoptosis represents a 
novel research area of the mechanisms of neuronal cell death in these diseases. I 
therefore concentrated the research of this thesis on intrinsic mitochondrial apoptotic 
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pathways, in an effort to identify novel apoptotic markers in the ME7 /CV and 
87V/VM murine scrapie models. 
3.3.1 Translocation of apoptosis- related proteins is not evident when analysing 
whole brain samples 
Samples prepared by the whole brain sucrose - gradient fractionation technique were 
prepared to analyse IMM protein translocation to the cytosol. Three ME7 /CV and 
87V/VM, and three respective age -match normal brain injected control animals were 
sacrificed at the terminal stages of disease. Analysis of cytosolic samples containing 
30, 60 and 9011g (and mitochondrial samples containing 30pg) total protein were 
analysed for AIF, Endo G and cyt c by Western blot. Cyt c was detected in all of the 
cytosolic samples, and this is discussed in Section 3.3.3. However, AIF and Endo G 
were not detected in any of the cytosolic samples created by the whole brain 
fractionation procedure (Figures 3.2 -3.9). The lack of detection of AIF and Endo G in 
the cytosolic samples could indicate that these IMM proteins are not involved in 
apoptosis in these murine scrapie models. However, if infected cell populations do 
not display relatively large scale synchronous apoptosis it would be extremely 
difficult to detect single apoptotic cells in vivo. Additionally. the rapid clearance of 
cells with abnormal neuronal functions by apoptosis would further hinder their 
detection. 
Certain neuronal subsets are more sensitive to murine scrapie pathology than others. 
This is particularly evident in the murine hippocampus, where the CAI pyramidal 
neurons are lost during ME7 /CV infections (Scott & Fraser 1984) and the CA2 
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pyramidal cells are damaged during 87VNM infections (Belichenko et al. 2000; 
Jeffrey et al. 2000). Murine scrapie brain samples created by the micro -dissection of 
such pathologically targeted areas, notably the hippocampus and thalamus for these 
models, should contain a higher proportion of apoptotic to normal cells in comparison 
to the samples prepared from whole brain homogenates. The recently published 
micro -dissection technique, developed by the CNS pathogenesis group at IAH 
Edinburgh, has proved to be a valuable technique for the detection of PrPS° (Barr et al. 
2004) and also for the in vivo detection of apoptosis in the CA2 neurons of 87V/VM 
murine scrapie brains (Jamieson et al. 2001a; Jamieson et al. 2001b). Based on this 
evidence, micro -dissected areas were created to maximise the likelihood of detecting 
apoptosis- related proteins in this research. As before three terminal animals from 
each of the ME7 /CV and 87VNM, and NB inoculated aged- matched control animals 
were analysed. After failed initial attempts to develop a scaled down version of the 
whole brain sucrose gradient technique, a commercially available sub -cellular 
fractionation kit (Calbiochem) was purchased and optimised for the analysis of frozen 
mouse brain samples. Mitochondria (containing 30µg) and cytosolic fractions 
containing 30, 60 and 90µg total protein were analysed as before by Western blot 
(Figures 3.10- 3.17). AIF was clearly detected in the cytosolic samples (60 and 90µg 
total protein) created from the ME7 /CV but not NB /CV control animals. The 
relevance of this translocation to neuronal apoptosis in TSE infections will be 
discussed in Section 3.3.2. In summary, AIF translocation was detected in the micro - 
dissected brain samples, but not in the samples prepared from whole brain 
homogenates. Consequently, the micro -dissection of scrapie- infected brain areas has 
proven to be a useful research technique for the in vivo detection of apoptosis -related 
proteins in neurodegenerative disease models. 
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3.3.2 Translocation of apoptosis inducing factor to the cytosol is specific to the 
ME7 /CV murine scrapie model 
The analysis of whole brain fractionated and micro -dissected (hippocampal and 
thalamus) samples revealed that the micro -dissection procedure was much more 
sensitive for the in vivo detection of apoptosis- related proteins (Section 3.3.1). AIF 
and Endo G translocation from the IMM to the cytosol was never detected in samples 
prepared by the whole brain sucrose gradient fractionation technique (Figures 3.2- 
3.9). Furthermore, Endo G was not detected in the micro -dissected cytosolic fractions 
created from the ME7 /CV and 87VNM scrapie models (Figures 3.10 -3.17), implying 
that this protein is not released into the cytosol in response to these murine scrapie 
infections. However, low amounts of AIF were detected in the cytosolic samples 
created from ME7 infected CV animals but not in the NB- inoculated aged matched 
cohorts (Figures 3.13/3.11). AIF was detected in ME7 /CV cytosolic samples 
containing 60 and 90µg total protein (Figure 3.13), but not in cytosol samples 
containing 301.tg protein (Figure 3.12). AIF was not detected in any of the cytosolic 
samples prepared from the 87V infected VM animals (Figures 3.16/.17), or in the NB- 
inoculated aged matched control animals (Figures 3.14/.15). This indicates that the 
release of AIF into the cytosol is a specific event related to infection with the ME7 
murine scrapie isolate. 
The translocation of AIF in the ME7 /CV but not 87VNM model further adds to the 
observed differences in the sequence of neuropathological changes and apparent 
mechanisms of neuronal cell death in these murine scrapie models (described in detail 
in Section 1.4.5). In the 87VNM hippocampus, neuronal damage occurs from 70dpi 
and PrPSO is detected much later at 200dpi indicating that neuronal 
damage in this 
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model is not directly linked to PrPW deposition (Jamieson et at 2001). Caspase 3 
activation and the up- regulation of Fas ligand have been detected in e 87VNM 
murine scrapie model (Jamieson et al. 2001). Furthermore. termin deoxynucleotidyl 
transferase mediated dUTP nick end labelling (TUNEL) a alysis confirmed apoptosis 
in this model by the presence of the characteristic 180 -200óp DNA ladder (Jamieson 
et al. 2001(a); Jamieson et al. 2001(b)). In the ME7 /CV hipp'ocampus. PrP' 
deposition is detected at 70dpi, the loss of neuronal axon term II II .1 s and synapses is 
detected from 100dpi, and significant neuronal loss is detected from 170dpi ((Jetley 
& Fraser 2001; Jeffrey et al. 2001). In contrast to the 87VDVM model_ apoptosis 
involving activated caspase 3 and up- regulation of Fas ligand has not i1NP en cted in 
ME7/CV mice. However, the research of this thesis shows 1P,:1 translocation of Alf' 
is a specific event related to infection with the ME7 scrapie isolate_ The detection of 
AIF and cyt c in the cytosol of terminal stage ME7 infected CV mice indicates 
these intrinsic mitochondrial proteins are likely to contribute to apoptosic cell death.. 
However, it is possible that the preparation of these samples m y have resul the 
disruption of some cells. A high degree of DNA I .e `!Jilin entation (180-2(0460., as 
detected by the TUNEL assay, is not characteristic ofcas]l .,se-independent apo i17tl 
cell death pathways. Therefore future work should attempt to detect IIMW DANA 
fragmentation (-50 kB), as this would confirm that ca . fY ,. se -i m Il ependent aqnnrpri (f)::, i ^% 
contributes to the neurodegenerative process in the ME7/CV model Furthemmoire,. 
ICC analysis would be beneficial as it would allow quantification (( 
protein detection) of apoptosis- related proteins at 
111 IÌ nnuttúlnlle 
e single cael ECC anaIlá sis 
would identify the distribution of AIF and Endo G in these seases however it laas 
not possible to establish ICC protocols due to time constraints ofother experiments_ 
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Ever- increasing evidence confirms that oxidative stress contributes to neuronal cell 
death in experimental TSE infections. This includes: lipid peroxidation by reactive 
oxygen species (ROS) and alterations in mitochondrial Mn SOD enzyme activities in 
263K and 87V murine scrapie infected rodents (Choi et al. 1998; Lee et al. 1999), 
increased sensitivity of Prnpa "' cerebellar neurons to oxidative stresses (Brown et al. 
1996), increased resistance of PC 12 cells over -expressing PrPC to ROS when treated 
with PrP 106 -126 (Brown et al. 1997), and detection of the oxidative stress marker 
heme oxygenase -1 in MET infected murine scrapie brains (Choi et al. 2000). 
Oxidative stress may also be enhanced by the production of ROS by activated 
microglia in response to PrP106 -126 (Brown et al. 1996; Brown et al. 1997). 
Furthermore, it is thought that PrPC protects cells from oxidative stress by 
incorporating copper atoms into the cytosolic Cu9'Zn SOD which is res nsible for the 
dismutation of ROS (Brown et al. 1997; Brown & Besinger 1998; Brown et aL 1999). 
It is possible that PrPC conversion to Prrc during TSE infection may reduce the 
capabilities of such infected cells to withstand oxidative stress ossibly by ame uced 
Cu/Zn SOD activity (Brown et al. 1999). Structural mitochondria) abnormalities, in 
correlation with oxidative stress, have been r rted in Syrian hamsters infected with 
the 263K scrapie isolate (Choi et al. 1998) and also in the 87Vr,'VN1 rumine scr pie 
model (Lee et al. 1999). Therefore the release of AIF and cyt c from the 1M? l to the 
cytosol in the MET /CV model further indicates mitochondrial dysfunction in the ISE 
infections. Evidence for oxidative stress and apoptosis in t n model has recently' 
been published in pre- clinical animals (-170 dpi) (Brown et of 2065)_ a critical time- 
point corresponding to a significant loss (50%) of CA I 
et al. 2000). Several genes involved in mitoc I ndrial an 
ppocampal neurons hJlelflrev 
ER oxidative stress and 
apoptosis are significantly up- regulated, indicting t o utive stress and apoptosis 
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contribute to the neuropathological process in this model (Brown et al. 2005). 
Therefore, the release of IMM apoptosis -related proteins (such as AIF and cyt c) from 
disrupted mitochondria may be due to elevated levels of oxidative stress in the 
ME7 /CV model. Further work investigating the mechanisms resulting in the 
translocation of these proteins could include in situ hybridisation for mtDNA or ICC 
analysis for markers of oxidative damage to DNA and RNA, such as 8- 
hydroxyguanosine/8- hydroxydeoxyguanosine (8- OHG /8- OHdG). 8- OHG /8 -OHdG 
has been found in brain sections taken from individuals diagnosed with sCJD and 
GSS (Guentchev et al. 2002; Petersen et al. 2005). 8 -OHG /8 -OhdG have also been 
used as reliable oxidative stress markers in neurodegenerative diseases such as 
Alzheimer's disease and Down's syndrome (Nunomura et al. 1999), and Parkinson's 
disease (Kikuchi et al. 2002). 
The release of AIF to the cytosol in the ME7 /CV model represents a relatively 
downstream event in the apoptosis cascade. Therefore, future research should 
concentrate not only on mechanisms resulting in the release of IMM proteins (e.g. 
oxidative stress) but also on discovering other apoptosis- related proteins involved in 
this process. As described the release of IMM proteins is carefully controlled by pro - 
and anti -apoptotic members of the Bc1-2 family, and have been reported in human 
neuronal cells treated with the neurotoxic PrP106 -126 peptide (O'Donovan et al. 
2001). Furthermore, other IMM apoptosis -related proteins which may contribute to 
neuronal cell death are the secondary mitochondrial activator of caspases /direct IAP- 
binding protein of low isoelectric point (Smac/Diablo) (Du et al. 2000) and 
HtrA2 /Omi proteins (Suzuki et al. 2001). Following apoptotic stimuli, these proteins 
are also released into the cytosol and either bind to (Smac/Diablo) or cleave (HtrA2) 
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with inhibitor of apoptosis proteins (IAPs). Inactivation of IAP proteins enhances 
caspase -9 activation, and therefore downstream caspases through the enhanced 
formation of the apoptosome. Neurodegeneration involving Smac /Diablo and HtrA2 
has recently been reported in a model of Huntington's disease (Goffredo et al. 2005), 
and the up- regulation of HtrA2 (which cleaves IAPs) has recently been published in 
the ME7 /CV murine scrapie model (Brown et al. 2005). In order to understand the 
role of the mitochondria in mediating intrinsic apoptotic pathways in protein 
misfolding neurodegenerative diseases, future research should include these IMM 
proteins. Research for the TSE field could include; investigations at various time 
points of the incubation period in experimental TSE models and also the 
neurodegenerative model established and described in Section 4 using the neurotoxic 
MoPrP105 -125 peptide. This analysis may therefore result in the development of 
intervention strategies which could limit or inhibit these neurodegenerative 
mechanisms. 
3.3.3 Cytochrome c detection in the cytosol of terminal murine scrapie infected 
and normal aged- matched control animals may represent mitochondrial 
dysfunction with age 
Mitochondria are involved in adenosine triphosphate (ATP) and phospholipid 
synthesis, calcium homeostasis, generation of ROS, and induction of apoptosis. 
Mitochondrial dysfunction, following homeostatic /oxidative stresses and apoptotic 
stimuli, can result in the translocation of IMM proteins (such as AIF, Endo G and 
cyt c) to the cytosol. The apoptotic research for this thesis was conceived to 
investigate the translocation of such IMM proteins to the cytosol in two murine 
scrapie models. IMM protein release can be instigated by the PTP, most likely 
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through balanced interactions with pro- and anti -apoptotic members of the Bc1-2 
protein family (Kluck et al. 1997; Yang et al. 1997). Although there is strong 
evidence for the roles of cyt c in mediating apoptotic cell death (Liu et al. 1996; Zou 
et al. 1999), cyt c has received little attention with respect to TSE disease models. 
However, cytosolic translocation has been reported in human neuronal SH -SY5Y 
cells treated with PrP106 -126 (O'Donovan et al. 2001). Also, the mitochondrial 
chloride channel mtCLIC4, capable of inducing cyt c release and activation of 
apoptosis (Fernandez -Salas et al. 2002), has recently been found to be up- regulated in 
the ME7 /CV murine scrapie model (Brown et al. 2005). 
My initial hypothesis was that if cyt c was involved in apoptosis, then cyt c would be 
detected only in the cytosolic extracts prepared from murine scrapie infected brain 
homogenates, and not in the normal brain -injected control samples. Western blot 
analysis revealed that cyt c was present in all of the cytosolic samples (60 and 901.tg 
protein) created from ME7 /CV and 87V/VM mice, and also in NB control samples, 
created by both the micro -dissection (Figures 3.11/.13/.15/.17) and whole brain 
fractionation (Figures 3.3/.5/.7/.9) techniques. The detection of cyt c in the cytosolic 
fractions from the NB control animals was an unexpected finding as the purity of 
these cytosolic fractions had been confirmed by the absence of the abundant 
mitochondrial membrane protein, VDACI. To assess whether the detection of cyt c 
was as a result of age -related mechanisms or experimental procedures, both 
fractionation procedures were repeated on NB animals sacrificed at -70 days dpi (the 
ages of the normal- injected aged matched controls from the original experiments were 
approximately 250 dpi for the NB /CV and 320 dpi for the NB/VM animals). 
Cytosolic samples containing 60µg total protein from both NB /CV and NB /VM, 
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prepared by both fractionation procedures, were analysed on a single SDS gel (Figure 
3.19A). Similarly, samples containing 90µg total protein from the same samples were 
also analysed on a separate gel (Figure 3.19B). This ensured that samples containing 
the same total protein content, but prepared by different techniques, would be 
comparable to each other by removing possible variations between Western blots. 
Immunoreactivity with the anti -cyt c antibody was confirmed by inclusion of the 3T3 
positive control cell lysate; however, cyt c was not detected in any of the cytosolic 
samples at this time point. Protein content within these samples on the PVDF 
membranes was confirmed by stripping and re- probing the membranes with the anti - 
Hsp70 primary antibody (Tables 3.1A & B). The presence of cyt c in the terminal 
murine scrapie cytosolic samples may therefore be due to age -related mitochondrial 
damage or cell death, and not the sub -cellular fractionation procedures. 
Disruptions to the mitochondrial membrane potential, such as elevated concentrations 
of cytosolic Cat +, are responsible for cyt c release and induction of apoptosis in 
Alzheimer's disease thus further indicating oxidative stress in the activation of 
apoptosis (Schild et al. 2001). In age -related protein misfolding diseases, it is unclear 
whether apoptosis is due to the accumulation of misfolded proteins or due to the 
accumulation of ROS. Oxidative stress caused by fluctuations in cytosolic Cat+ levels 
have been reported following exposure of neuronal cells to the PrP106 -126 peptide 
(Thellung et al. 2000; Taylor et al. 2001), however, this has not been observed in 
vivo. The biological mechanisms of ageing are poorly understood, however, ROS 
generation is thought to contribute to mitochondrial dysfunction as an organism ages 
(Harman 1973). ATP generation, by electron transfer along the respiratory complex, 
generates excess superoxide anions which are normally dismutated to hydrogen 
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peroxide by SOD enzymes and free radical scavengers. The mechanisms resulting in 
disruptions to the homeostatic controls, which normally prevent the accumulation of 
excess ROS as an organism ages, are unknown. It is thought that the constant 
exposure of mtDNA to ROS results in the accumulation of mutations and therefore 
mitochondrial dysfunction with age. Oxidative stress is one of the key apoptosis- 
inducing stimuli, and may connect ageing CNS mitochondria and apoptosis in age - 
related neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease 
and amyotrophic lateral sclerosis. There is also strong evidence indicating that 
oxidative stress may be involved in neuronal cell death in the TSE infections, as 
discussed in Section 3.3.2, and therefore may be responsible for the release of both 
AIF and cyt c in these models. Since the loss of mitochondrial cristae has been 
observed in some experimental murine scrapie models (Choi et al. 1998; Lee et al. 
1999), it is possible that higher levels of cyt c may be present in the cytosols of 
scrapie infected mice. Future work would have to quantitatively determine (e.g. using 
an Enzyme Linked ImmunoSorbent assay -ELISA) cytosolic cyt c to determine if 
concentrations are higher in murine scrapie- infected animals in comparison to the 
age- matched control mice. 
For the work of this thesis; the presence of cytosolic cyt c in infected and uninfected 
animals, but absence in younger animals ( -70 dpi), implies its release is influenced by 
age related mechanisms. The effects of the ageing process on CNS mitochondrial 
protein expression have just been published in normal mice (C57B16; 2 and 12 
months) (Manczak et al. 2005), of similar age to those chosen for the research in this 
thesis. ICC analysis revealed an increase in cyt c release in 12 month old mice when 
compared to 2 month old mice, particularly within the pyramidal neurons (CA1 -CA3) 
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of the hippocampus. Mitochondrial dysfunction is thought to be responsible for this 
release due to increased detection of 8 -OHG. Therefore, these results are 
complementary to the observations of cytosolic cyt c release in older mice in the 
research presented in this thesis. However, the release of cytosolic cyt c may not 
necessarily stimulate apoptosis, as it is believed a threshold concentration must be 
exceeded prior to the initiation of apoptosis. It was recently reported that cyt c release 
is proportional to the degree of CNS mitochondrial dysfunction in a rat model of 
Parkinson's disease (Clayton et al. 2005). This study also demonstrated sub -threshold 
levels of cytosolic cyt c release, which were not sufficient to induce apoptosis in 
cortical neurons. The presence of cyt c in the cytosolic fractions analysed in this 
thesis research does therefore not necessarily mean that apoptosis will be activated in 
all samples. In vitro research has shown that physiological cytosolic concentrations 
of K+ (the most abundant cytosolic ion) prevent the activation of apoptosis (Bortner et 
al. 1997; Hughes et al. 1997), and inhibit cyt c formation of the apoptosome (Cain et 
al. 2001). Decreases in cytosolic K+ concentrations occur prior to the induction of 
apoptosis, and are sufficient to allow the activation of apoptotic mechanisms of cell 
death (Hughes et al. 1997). Abnormalities in Cat + -activated K+ currents have been 
reported in the ME7 /CV murine scrapie model (in which both AIF and cyt c were 
detected in this thesis) (Johnston et al. 1998), in PC 12 cells treated with the 
neurotoxic PrP106 -126 peptide (Taylor et al. 2001), and also in Prnp "0 cerebellar 
Purkinje cells (Herms et al. 2001). Interruptions to these Cat +dependent K+ currents 
in experimental TSE models may be sufficient to abolish the control of K+ in 
inhibiting activation of apoptosis. Reduced concentrations of intracellular K+ in 
scrapie- infected neurons may therefore allow activation of cyt c- mediated apoptosis, 
which may not occur in non -infected cells if K+ concentrations are at physiological 
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concentrations. More research is therefore required to determine the effects of 
infection with TSE agents in combination with enhanced cytosolic cyt c 
concentrations in aged mice. Future work should quantitatively monitor cyt c and K+ 
levels at various stages of the incubation period of murine scrapie infected mice, in 
addition to the other IMM apoptosis- related proteins discussed in Section 3.3.2. 
These factors could also be monitored by immunofluorescence and FACS analysis 
using in vitro models, such as the PrP105 -125 model established in Section 4. Future 
research will therefore have to determine the potential contributions of mitochondrial 
dysfunction, age and misfolded PrPsc in contributing to neuronal cell death in the TSE 
diseases. 
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Chapter 4: Synthetic PrP peptides 
4.1 GSS and synthetic PrP peptides 
TSE amyloid peptides were first successfully isolated from cases of the GSS Indiana 
kindred (carrying a phenylalanine to serine substitution at 198) (Ghetti et al. 1989), 
identifying a large proportion of 11 kDa peptide fragments within the amyloid plaque 
deposits (Tagliavini et al. 1991). Also present were polymers of the 11 kDa peptides, 
and a number of larger PrP fragments with intact N- termini of smaller molecular 
mass. Subsequent analysis of amyloid proteins from GSS patients with different 
mutated alleles (alanine to valine substitution at 117) identified 7 kDa peptide 
subunits (Tagliavini et al. 2001). These smaller peptides spanned amino acids 81- 
150, and were truncated at both the C- and N- termini. Sequencing of the 11 kDa 
(amino acids 58 -150) and 7 kDa peptides (amino acids 81 -150) revealed that these 
peptides correspond to the N- terminal region of PrPres (PrP27 -3o) (Prusiner et al. 1983). 
This is an essential region of the PrP molecule, as deletions within this region inhibit 
the generation of PrPs° molecules (Muramoto et al. 1996). This sequence represents 
the most conserved region of the PrP protein across all tested species, and contains the 
hydrophobic palindrome amino acid sequence AGAAAAGA (found within the 
PrP106 -126 peptide). This amino acid sequence is thought to be important in 
mediating the transmission of TSE disease through hypothesised interactions of PrPC 
with PrPSC (Muramoto et al. 1996; Supattapone et al. 1999; Norstrom & Mastrianni 
2005). Ablation of this palindromic sequence has also been shown to affect the 
fibrillogenic and neurotoxic properties of synthetic peptides in vitro (Jobling et al. 
1999). The primary and secondary structures of synthetic peptides containing this 
sequence therefore represent in vitro models relevant to the study of the 
neurodegenerative processes associated with TSE infections. 
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These findings were in agreement with synthetic Syrian hamster PrP peptide studies 
identifying the high propensity of this region to form stable 13-sheet, and the It is 
thought that limited in vivo proteolytic cleavage of PrP molecules results in the 
formation of these amyloidogenic peptides, capable of polymerising into insoluble 
fibrillar structures. The synthesis of numerous peptides based upon the 7 kDa 
amyloid fragments (amino acids 81 -150), revealed that these peptides harboured 
fibrillogenic and neurotoxic properties (Forloni et al. 1993; Tagliavini et al. 1993). 
The sequence representing amino acids 106 -147 was found to be central to the 
fibrillogenic properties of this sequence and that several peptide sequences within this 
region formed distinct fibrillar structures (PrP106 -126, PrP106 -114, and PrP124 -147) 
(Tagliavini et al. 1993). PrP106 -126, was found to be neurotoxic to rat hippocampal 
cultures, and will be discussed in Section 4.2. 
4.2 PrP106-126 
4.2.1 PrP106 -126 primary structure 
PrP 106 -126 (Appendix I) consists of an N- terminal hydrophilic head (KTNMKHM -) 
followed by a hydrophobic tail (- AGAAAAGAVVGGLC), containing the previously 
mentioned palindrome sequence (AGAAAAGA) important for the conversion of PrP° 
to PrPSO. PrP106 -126 conformation is influenced by a number of factors including 
solvent composition, ionic strength, pH, the presence of membranes and mutations to 
specific amino acids. Structural analysis by circular dichroism revealed that PrP 106- 
126 forms a high proportion of stable /3-sheet in ionic acid environments (pH 5), and 
also in the presence of liposomes (De Gioia et al. 1994). However, when dissolved in 
non -ionic or neutral pH environments, the peptide adopts more random coil and less 
/3-sheet structures. The structural plasticity of the peptide in different environments is 
132 Chapter 4: Synthetic PrP peptides 
thought to be influenced significantly by protonation of the Histidine (His 111), 
located between the hydrophilic head and hydrophobic tail segments. Unlike the 
other amino acid residues in the sequence, the ionisation of Hisl 11 is enhanced in 
acidic, but not neutral, pH conditions (De Gioia et al. 1994; Ragg et al. 1999). The 
substitution of L -His 111 with D -His 111 reduces the formation of I3-sheet structure and 
eliminates the influence of pH on the peptide structure, thought to be due to the steric 
hindrance of D -His 111 with the neighbouring residues (Salmona et al. 1999). 
Substituting His 111 with a non -ionisable hydrophobic amino acid such as alanine, 
reduces the solubility of the peptide. Therefore, the ionisable side chain of His 111 is 
thought to be extremely important in mediating the structural conformations of 
PrP106 -126. However, a PrP106 -126 peptide homologue containing methylated 
His 111 has comparable neurotoxicity to the normal sequence indicating that His 111 
does not influence the toxicity of the peptide to murine cerebellar cultures (Brown 
2000). The conformation and accessibility of the PrP106 -126 sequence in vivo is 
potentially important for the generation of PrP`eS molecules, as normal physiological 
processes cleave PrP° but not PrPCeS molecules between Lysine 110 and His 111 (Chen 
et al. 1995). The sequence spanning PrP106 -126 contains two pathogenic point 
mutations responsible for GSS disease. These point mutations represent an alanine to 
valine substitution at 117 (Wu et al. 1987), and the more recently discovered glycine 
to valine substitution at 114 in members of a Uruguayan family (Rodriguez et al. 
2005). A synthetic PrP106 -126 peptide homologue containing the Al17V mutation 
has an enhanced I3-sheet content and neurotoxicity compared to the normal peptide, 
however, this change to the primary sequence abolishes the requirement for PrP° 
expression for toxicity (Brown 2000). The primary structure of PrP106 -126 is clearly 
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important in modulating the secondary structure, and consequentially, the toxicity of 
this sequence in vitro. 
4.2.2 PrP106 -126 secondary structure and biochemical properties 
PrP106 -126 is sparingly soluble in distilled water, aggregating to produce straight 
fibrils 0.1 -1µm in length and with a diameter range of 4 -8 nm (similar to those 
identified in GSS amyloid plaques) (Forloni et al. 1993). Peptide aggregates present 
the characteristic birefringence of amyloid deposits, and the peptide is neurotoxic in a 
dose -dependent manner to rat hippocampal cultures (Forloni et al. 1993). PrP106 -126 
shows partial resistance to proteinase -K digestion (Selvaggini et al. 1993), requires 
the neuronal expression of PrP° for neurotoxicity (Brown et al. 1994; Brown et al. 
1996), has a high I3-sheet content (Selvaggini et al. 1993; De Gioia et al. 1994), and 
stimulates astrocytes and microglial cells (Forloni et al. 1994; Brown et al. 1996). 
PrP106 -126 therefore shares many of the biochemical properties of PrP50 (Table 1.2.), 
further reflecting the relevance of this peptide for the in vitro modelling of the 
proposed conversion of PrPc to PrPs°, and also for the in vitro modelling of TSE 
related neurodegeneration. 
The fibrillogenic properties of PrPl06 -126 aggregates appear to result from the 
primary structure, as a random scrambled sequence of the same amino acids fails to 
form fibrillar structures and also lacks the neurotoxic properties of the normal 
sequence. However, the toxicity of PrPl06 -126 is not due solely to the formation of 
amyloid fibrils, as other fibrillogenic peptide sequences (PrP106 -114, PrP127 -147) 
fail to exhibit neurotoxic effects when added to rat hippocampal cells (Forloni et al. 
1993). Furthermore, amidation of the C- terminus of PrP 106 -126 with NH2 results in a 
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non -fibrillar random -coil structure with toxicity comparable to that of the normal 
peptide sequence (Salmona et al. 1999). However, amidation of PrP106 -126 abolishes 
astrocyte proliferation in comparison to the normal peptide. Consequently, astrocyte 
proliferation by PrP106 -126 appears to be due to the indirect effect of the presence of 
fibrillar amyloidogenic peptide deposits, and not due to direct effects of the peptide. 
Therefore the primary structure appears to be important in mediating both the 
formation of amyloid fibrils and the toxicity of the normal PrP106 -126 peptide, but 
this toxicity is not due solely to the formation of these amyloid fibrils. A recent study 
revealed that PrP 106 -126 peptides containing G114A and G119A substitutions form 
protofibrillar structures (but not mature fibrils), are more soluble, and are more 
neurotoxic than the normal sequence to human neuroblastoma cells (Florio et al. 
2003). The mechanisms by which the mutated and normal PrP106 -126 peptides 
elicited their neurotoxic responses were identical, indicating that these substitutions 
did not alter the mechanisms by which the peptides interacted with the cells. 
Therefore, the neurotoxic properties of PrP 106 -126 may be controlled by a fine 
balance between the solubility /insolubility and structural properties. Protofibrillar or 
pre -amyloid forms of PrP have in some cases been associated with selective damage 
to axon terminals and dendritic spines in the 87V/VM murine scrapie model (Jeffrey 
et al. 1997). Therefore, the formation of soluble protofibrillar structures prior to the 
appearance of mature fibrils, may contribute to the neurotoxicity of PrP106 -126. This 
thesis aims to further clarify such structure /toxicity relationships using the PrP 106- 
126 murine homologous peptide, PrP105 -125. 
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4.2.3 PrP106 -126 neurotoxicity 
The first report of the neurotoxic properties of PrP 106 -126 identified apoptosis as the 
mechanism of cell death following chronic exposures of the peptide to rat 
hippocampal cultures (Forloni et al. 1993). This was based upon the typical cell 
morphology and condensation of nuclear chromatin, and also the detection of the 
characteristic DNA ladder (180- 200bp) (Section 3). Subsequent neurotoxicity studies 
revealed that PrP106 -126 was responsible for apoptotic cell death when added to 
mouse cerebellar neurons (Brown et al. 1996), rat pituitary cells (Florio et al. 1998), 
and human neuroblastoma cells (O'Donovan et al. 2001; Florio et al. 2003). 
Apoptotic cell death has also been confirmed in vivo, following intraocular 
inoculations of PrP106 -126 into rat retinal cells (Ettaiche et al. 2000; Bergstrom et al. 
2005). In addition to the morphological changes and fragmentation of DNA, 
numerous biochemical markers of apoptosis and membrane dysfunction have been 
detected in vitro following exposure to PrP106 -126. Enhanced Annexin V binding 
and activation of caspases -3, -6, and -8 have been reported following the exposure of 
PrP 106 -126 to mouse cortical neurons (White et al. 2001). Pre -treating cells with the 
pan -caspase inhibitor (Z -VAD -FMK) marginally reduced the peptide's toxicity, 
whereas a caspase -3- specific inhibitor (Z -DEVD -FMK) did not, suggesting the 
involvement of further cell death mechanisms. Similarly, these caspase inhibitors 
also failed to protect human neuroblastoma cells following the detection of activated 
caspase -3 as a consequence of chronic exposures to PrP106 -126 (Thellung et al. 
2002). These authors reported the activation of p38 MAP kinases, which may be 
activated as a consequence of mitochondrial depolarisation. The p38 MAP kinase 
pathway has been reported by other researchers (Florio et al. 2003), as has 
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mitochondrial membrane potential disruption of human neuroblastoma cells 
(O'Donovan et al. 2001). 
The upstream events responsible for the induction of apoptosis, following exposure to 
PrP106 -126, are thought to include disruptions to intracellular calcium levels and 
oxidative stress. Intracellular accumulations of calcium are capable of inducing 
apoptosis (Section 3.1.3.), and disruptions to calcium homeostasis have been reported 
(Florio et al. 1996; Florio et al. 1998; O'Donovan et al. 2001). The neurotoxic effects 
of PrP106 -126 are enhanced in conditions with decreased anti -oxidant enzymes such 
as Cu/Zn SOD (Brown et al. 1997; Brown et al. 1997) and also by the production of 
ROS from activated microglia (Brown et al. 1996). One postulated role of PrPc is that 
of an anti -oxidant similar to a SOD, as Prnp °I'0 mouse cerebellar cells are more 
sensitive to oxidative stress from ROS than wild -type cells (Brown et al. 1996). 
These authors believe that indirect interactions of PrP106 -126 with Cu/Zn SOD 
enzymes result in the decreased dismutation of ROS, and therefore decreased 
protection from oxidative stresses. If PrPc does possess SOD activities, these may be 
compromised by interactions with PrP106 -126. 
However, there is conflicting evidence as to the role, if any, of microglia in mediating 
the toxicity of PrP 106 -126. The co- culture of PC 12 cells with microglia has been 
reported to be vital for the toxicity of PrP 106 -126 (Brown et al. 1997), however, the 
dependence of microglia for toxic effects have been disputed by other researchers 
using the PC 12 cell culture system (Hope et al. 1996). Microglial stimulation to 
release ROS may contribute to the neurotoxicity, but does not appear to be essential. 
The research detailed in this thesis does not include a co- culture of microglia and 
137 Chapter 4: Synthetic PrP peptides 
PC12 cells however, the effects of the naive and neuronal phenotypes of PC12 cells 
were tested with different morphologies of PrP105 -125 peptides (Section 4.2.4.). 
4.2.4 Murine PrP105 -125 
The murine PrP105 -125 peptide, homologous to the human PrP106 -126 peptide 
sequence, was synthesised for the research described in this thesis. The murine 
PrP105 -125 peptide differs by two amino acids from the homologous region within 
the human genome (Appendix I) and is identical in sequence to the same region 
within the rat genome. This peptide sequence therefore removes potential species 
barrier effects, in comparison to previous studies using the human PrP106 -126 peptide 
for the purposes of correlating the structure /toxicity effects of this peptide in a rat 
PC12 cell culture system. The MoPrP105 -125 peptide represents a novel feature of 
the work of this thesis for this purpose. 
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4.3 Results 
4.3.1 Electron microscopic analysis of MoPrP105 -125 and scrambled 
MoPrP105 -125 at various aggregation times and buffer conditions 
The ability of the MoPrP105 -125 and scrambled MoPrP105 -125 peptides to form 
fibrillar structures was checked by negatively staining peptide solutions with sodium 
phosphotungstate, and analysing by transmission electron microscopy (Section 
2.4.5.). For the normal peptides, EM photomicrographs are representative of the 
fibrils present within that grid. For the scrambled peptide samples, the 
photomicrographs show what was actually present on the grids. These samples 
contained sparse amorphous aggregated material. Initial studies using 200mM citrate 
(pH7), distilled water (GibcoBRL) and 10mM MES (pH7) buffers with incubation at 
room temperature for 48 hours revealed that all buffers permitted the MoPrP105 -125 
peptides to form fibrillar structures. Although fibrillar -like structures were found in 
the scrambled equivalents, these structures were distinctly different to those formed 
by the normal peptides. MoPrP105 -125 dissolved in 200mM citrate (pH7) buffer 
(Figure 4.1.A.) formed frequent long straight fibrils. In the same conditions, the 
scrambled peptide formed smaller straight fibril -like structures (Figure 4.1.B.). The 
normal peptide dissolved in distilled water formed highly branched straight fibrils 
(Figure 4.1.C.), whereas the scrambled equivalent (Figure 4.1.D.) formed occasionally 
small fibril -like structures which were also highly branched. The normal peptide 
formed very frequent long straight fibrillar structures, which were often branched, 
when dissolved in 10mM MES (Figure 4.1.E.). However, the scrambled peptide 
(Figure 4.1.F.) formed infrequent fibril -like structures which were also distinctly 
different from those formed by the normal peptide. 
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Based on the observations of the incompatibility of the 200mM citrate buffer for 
FTIR analysis (Section 4.3.3.) and the poor amyloidogenic properties of the peptides 
when dissolved in distilled water (Section 4.3.2.), a series of factors were manipulated 
to alter the amyloidogenic and secondary structural properties of the peptides when 
dissolved in the remaining buffer (10mM MES). These changes involved altering the 
NaCI concentration (0, 50, 200mM), analysing the buffers at two different pH values 
(pH 5 and 7), performing this analysis over a longer time scale of up to 14 days, and 
increasing the incubation temperature to 37 °C. The EM photomicrographs in Figure 
4.2 (10mM MES, pH 7) and Figure 4.3 (10mM MES, pH 5) were taken following 
incubations at 37 °C for 5 and 14 days respectively. These time points were chosen 
based upon the amyloidogenic properties of these peptides as monitored by the 
Thioflavin -T binding assay, as it was apparent that maximum aggregation had 
occurred at these time points in these buffers (Section 4.3.2.). 
MoPrP105 -125 dissolved in 10mM MES pH7 (Figure 4.2.) formed frequent straight 
fibrils in this buffer. The morphology of these fibrils altered with NaCI concentration; 
fibrils formed in the absence of NaC1 formed a dense mat of fibrils, these fibrils were 
distinctly longer and straight in the presence of 50mM NaCl. Fibrils formed in the 
presence of 200mM were found in dense bundles of straight fibrils; although these 
were less compact than at lower NaC1 concentrations. The scrambled peptides 
dissolved in these buffers did not form any fibrillar structures. MoPrP105 -125 
dissolved in 10mM MES pH5 (Figure 4.3.) formed dense networks of straight fibrils. 
The fibrils became slightly larger with increasing concentrations of NaCI, and were 
also less compact at 200mM NaCI. The grid containing fibrils created in 50mM NaC1 
was a dense mass of fibrils, which were frequently overlapping. In the presence of 
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200mM NaCl the quality of the staining was poorer in comparison to the other 
samples, but these fibrils were long and overlapping. The fibrils formed in the 
presence of 50mM and 200mM NaCl had slight bending in comparison to the much 
straighter fibrils within those networks. In the samples containing the scrambled 
equivalents fibrillar structures were absent in the samples with OmM and 50mM 
NaCl. However; fibrillar structures were present in the 200mM NaC1 samples, 
although these were distinctly different from the normal peptide as these were 
extremely short and infrequently observed. 
4.3.2 Amyloidogenic properties of MoPrP105 -125 and scrambled 
MoPrP105 -125 measured by Thioflavin -T binding assay 
The amyloidogenic /aggregation properties of the MoPrP 105 -125 and scrambled 
MoPrP105 -125 peptides were monitored by incubating aliquots of these peptides with 
molar excesses of Thioflavin -T (Section 2.4.3.). Initial studies tested the effects of 
10mM MES (pH7), distilled water and 200mM citrate buffer (pH7) on the 
amyloidogenicity (tendency to form fibrils) of the normal and scrambled peptides 
following incubation at room temperature for 48 hours. Thioflavin -T binding is a 
specific assay for the formation of fibrils, where binding alters the excitation maxima 
to -480nm. Figure 4.4 shows the Thioflavin -T binding profiles of the buffers 
described above for the normal and scrambled peptide sequences. Scrambled peptides 
in these tested conditions never bound to Thioflavin -T, indicating that the scrambled 
sequences do not possess amyloidogenic properties. The normal peptide dissolved in 
200mM citrate buffer (pH7) had the highest propensity to form amyloid fibrils, 
whereas the normal peptide in 10mM MES had relatively low Thioflavin -T binding in 
comparison. Furthermore, the normal peptide dissolved in distilled water had 
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negligible fibril forming properties. Although the normal peptide dissolved in 
200mM citrate buffer was the favoured choice for future studies at this stage, it was 
found that this buffer was incompatible with FTIR analysis (Section 4.3.3.). 
Therefore, the compatibility of the MES buffer with all tested techniques concentrated 
the following studies on variations of the MES buffer (described in Section 4.3.1.) in 
efforts to enhance the fibril forming properties. Furthermore, the fluorimeter slit 
width for emitting fluorescent light was found to be optimal at 4nm for Thioflavin -T 
binding in comparison to the 2nm slit width used in the above mentioned research. 
Figure 4.5. shows the Thioflavin -T binding of normal and scrambled MoPrP 105 -125 
peptides (10mM MES, pH7) at serial time points at increasing concentration of NaCI 
(0, 50 or 200mM) (immediately dissolved t =0, 0.5, 1, 24 and 120 hours). Scrambled 
peptides never bound to Thioflavin -T, demonstrating the lack of fibril forming 
abilities of these samples. Fibril formation was highest in normal peptides created in 
the 50mM NaCI buffer, although fibril formation was only marginally higher than 
those samples prepared in the presence of 200mM NaCl. The buffer lacking NaCI 
had even lower amyloidogenic properties than the other tested NaC1 concentrations. 
However, maximum formation of fibrils had occurred by 24 hours incubation as 
Thioflavin -T binding was relatively unchanged following 120 hours (5 days) 
aggregation. Figure 4.6. shows the Thioflavin -T binding of normal and scrambled 
MoPrP105 -125 peptides (10mM MES, pH5) at serial time points at increasing 
concentration of NaC1 (0, 50 or 200mM) (immediately dissolved t =0, 0.5, 1, 24,120, 
168, 240 and 336 hours). Correlating with the scrambled sequences from MES pH7, 
scrambled peptides in these buffer conditions never bound to Thioflavin -T and 
therefore were also non -amyloidogenic. Normal peptide samples created in the 
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presence of 200mM NaC1 had an extremely low tendency to form fibrils, and samples 
without NaC1 were only slightly more amyloidogenic. However, 50mM NaCI buffers 
had a high tendency to form amyloid fibres and a plateau for Thioflavin -T binding 
was achieved following 240 -336 hours (10 -14 days) incubation. Therefore, normal 
peptide sequences created in MES buffers at pH5 had a lower propensity to form 
fibrils than samples created at pH7. Also, the highest Thioflavin -T binding was 
reached following incubations of 240 -336 hours (10 -14 days) in comparison to the 
rapid binding of 24 -120 hours (1 -5 days) observed at pH 7. 
4.3.3 Secondary structure analysis of MoPrP105 -125 and scrambled 
MoPrP105 -125 by Fourier transform infrared spectroscopy 
FT -IR was used to analyse the effects of the vehicle buffers on the secondary structure 
of the MoPrP105 -125 and scrambled MoPrP105 -125 peptides (Section 2.4.4.). 
Secondary structure analysis by FTIR concentrated primarily on the amide I region 
(1600- 1700cm 1), although the amide II region was also analysed as this can provide 
additional information on the aggregation state of tested samples. Initial studies using 
200mM citrate @H 7) revealed that this buffer formed highly aggregated fibrillar 
structures when analysed by EM and Thioflavin -T binding (Sections 4.3.1. and 
4.3.2.), although the strong carbonyl bonds in the citrate buffer prevented secondary 
structure analysis by FTIR within the amide I region. Coupled with the poor 
amyloidogenic properties of the normal peptide in distilled water (Section 4.3.2.), it 
was decided to discontinue studies using these buffers. Since the normal peptide in 
MES was amyloidogenic and formed dense fibrillar networks (Section 4.3.1. and 
4.3.2.), it was decided to continue further studies with this buffer as it was also 
compatible with FTIR. 
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The FTIR spectra displayed in Figure 4.7. (MES pH 7, 50mM NaC1) and Figure 4.8. 
(MES pH 5, 50mM NaC1) were from aliquots of peptide samples incubated at 37 °C 
for 5 and 14 days respectively . Secondary structure analysis of these samples was 
coupled with the amyloidogenic properties (Section 4.3.2.) and the fibrillar structures 
following EM analysis (Section 4.3.1) at these time points. Based upon the fibrillar 
and amyloidogenic profiles of the normal peptide samples supplemented with 50mM 
NaCl (Figures 4.2.C. & 4.5. for pH 7, and Figures 4.3.C. & 4.6. for pH 5), these 
peptide solutions were analysed by FTIR and their cytotoxicities measured using the 
alamarblue reduction assay (Section 2.5.11.2.). Although FTIR analysis concentrates 
primarily on the amide I (1600- 1700cm 1) region, in the absence of aggregated 
structures, complete hydrogen/deuterium exchange occurs and the amide II peak 
appears as amide II'. However, amide II peaks remain for both the MoPrP105 -125, 
but not scrambled, peptide conformations (Figures 4.7. and 4.8.). This is indicative of 
highly aggregated structures in the normal peptide solutions which prevent complete 
deuterium exchange. Highly aggregated fibrillar structures are present in both normal 
peptides as detected by EM (Section 4.3.1.) and Thioflavin -T analysis (Section 
4.3.2.). Although I performed the sample preparation, acquisition and majority of the 
analysis; secondary structural curve fitting using the Grams software (Thermo 
Corporation, California) was performed by Dr. Matt Hicks (University of Warwick). 
Using this information, I was then able to assign secondary structures to each of the 
normal and scrambled peptide solutions. Secondary structure assignments for the 
normal and scrambled peptides (10mM MES +50mM NaC1 pH7) are described in 
Tables 4.1 and 4.2 respectively. The normal peptide sequence has a high proportion 
of I3-sheet (69.21%) in comparison to the scrambled peptide (32.61%). The normal 
peptide also consists of 11.05% a -helix and 19.74% [3-turn; whereas the scrambled 
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peptide contains 21.94% a -helix and a large proportion (45.45%) fi-turn, The 
secondary structure assignments for the normal and scrambled peptides (i (r i i i 
MES +50mM NaCl pH5) are described in Tables 4.3 and 4.4 respeetii4e13, °.. he 
normal peptide sequence also has a high proportion of 13 -sheet (61.11%) in 
comparison to the scrambled peptide (combined 0-sheet - 42.08%). "D'6nc rtnmrnpall 
peptide also consists of 17.51% a -helix and 21.38% fi -turns whereas the scrambled 
peptide contains 19.12% a- helix, 16.71%13-turn and 22.09% random coiill. 
4.3.4 Secondary structure overview of the MoPrPI05-125 and scrambled 
peptides chosen for cytotoxicity analysis 
Peptide solutions chosen for the cytotoxicity analysis were &rimed tram the 
accumulation of information relative to the sec 
peptide solutions under different conditions. Two 
ry stnat= psofgettiies dame 
1,.t sollmttiimns mare awes kw 
this analysis, in addition to their non -aggregating seranntbiali ills aarntstsv.. CNtte 
first peptides (normal and scrambled) chosen were ilhio e created iitm ill[ 
MES+50mM NaC1 (pH 7) pre- incubated for 5 days art 37/9C'.. Under theavinskitikatu 
the normal peptide formed distinctly long strati 
frequently on the EM grid (Figure 4.2.C.), ' This 
iftitiiAs vbrozte Damara 
IOC i jilt aka asca the lhúukfte,tt 
propensity to form amyloid fibrils of all of the tested t l W in kit arils notlitnih, ass 
measured by Thioflavin -T binding (Figure 4.5.).. Tine ,,c40010o10 stlnrttiar<rte atully/§edi 
within the amide 1(1600-1700cm4) region; consisted of 119741% Paling, llll.M% ffa- 
heláX. and 6921% I3-sheet (Figures 4,7. T 4.1 4. lfiu aanquiisriA, t&r gazanitilttil 
peptide did not form any fibrillar grottoes (firm 4.2D.4, anti wzus man- 
aanylmjiidog:enic (Figure 4.5.). The secondary swam online staruntirlieril Inl& 
1146 .7lrrpxtor Igjrtdhiztá ilivpxttá&ss 
consisted of 45.45%13-turn, 21.94% a- helix, and 32.61%13-sheet (Figures 4.7. & 
Table 4.2.). 
The second set of peptides (normal and scrambled) chosen for cytotoxicity analysis 
were those created in 10mM MES +50mM NaCl (pH 5) pre- incubated for 14 days at 
37 °C. Under these conditions the normal peptide formed an extremely dense network 
of fibrils which were shorter than those created at pH 7. These fibrils were so 
frequent that they often over -lapped and some fibrils appeared to slightly bend (Figure 
4.3.C.). This normal peptide also had a high propensity to form amyloid fibrils, 
although this was slightly lower than that of the other normal peptide described above 
(Figure 4.6.). The secondary structure, as analysed within the amide I region (1600 - 
1700cm 1), comprised 21.38% n -turn, 17.51% a- helix, and 61.11% 13 -sheet (Figures 
4.8. and Table 4.3.). In comparison the scrambled peptide control did not form 
fibrillar structures (Figure 4.3.D.), and was non -amyloidogenic (Figure 4.6.). The 
scrambled peptide had a secondary structure consisting of 16.71%13-turn, 19.12% a- 
helix, 22.09% random coil, and 42.08% combined 13 -sheet (Figures 4.8. and Table 
4.4.). 
4.3.5 Treatment of PC12 cells with nerve growth factor differentiates cells to 
the neuronal phenotype 
The PC12 cell line can be reversibly differentiated into a neuronal phenotype when 
cultured on collagen IV coated surfaces in the presence of NGF (Section 1.5.3.). 
PC12 cells were cultured with 100ng/ml NGF and analysed following exposure for 7 
and 14 days in comparison to untreated (naive) cell cultures. Phase contrast 
microscopic analysis shows that naive PC12 cells (Figure 4.9.A.) are round with a 
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tendency to grow in small clumps. PC12 cells exposed to NGF for 7 days (Figure 
4.9.B.) are more isolated from each other, and dendritic processes start to develop and 
extend to neighbouring cells. 14 day NGF -differentiated PC12 cells (Figure 4.9.C.) 
have enlarged cell bodies and extended mature neuritic processes in comparison to 
naive and 7 day NGF- differentiated PC12 cells. Neuronal differentiation of the PC12 
cell cultures was confirmed by FACS analysis (Section 2.5.10.2.) using the anti - 
neurofilament protein primary antibody (Table 2.1.). Figures 4.10 -4.13 are 
concearned with the expression of PrP° by PC12 morphologies and are discussed in 
Section 4.3.6. Neurofilament proteins, the major structural subunits of mammalian 
neurons, exist in three subunits; NF -L (- 68kDa), NF -M (- 145kDa) and NF -H 
(-200kDa) where NF -L forms heterodimers with either NF -M or NF -H (Lee & 
Cleveland 1996). PC12 cell NF -L mRNA increases significantly following 
differentiation with NGF (Lindenbaum et al. 1998), and has been shown to be reliable 
in quantitatively determining PC12 cell differentiation to the neuronal phenotype 
(Schimmelpfeng et al. 2004). FACS analysis with the anti -NF -L primary antibody 
confirmed that naive cells express negligible amounts of the NF -L subunit (1.61 %) 
(n =4, SEM =0.2) (Figures 4.14.A. and 4.14.B.). In contrast, 16.05% (n =4, SEM =0.76) 
of cells expressed NF -L following exposure to NGF for 7 days (Figures 4.14.0 & D). 
This increase in NF -L protein expression was highly significant (p <0.005) in 
comparison to the naive cell cultures. Furthermore, 14 day differentiated PC 12 cells 
were much larger and more complex than the naive and 7 day differentiated 
counterparts, as confirmed by forward and side scatter analysis. NF -L expression by 
14 day differentiated cell cultures increased by almost 20 -fold in comparison to naive 
cells, with 31.04% (n =4, SEM =0.33) of cells expressing the neuron -specific protein 
(Figures 4.14.E. and 4.14.F.). This increase in NF -L expression was also highly 
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significant (p<0.005) in comparison to 7 day differentiated cultures. PC12 cells 
differentiated for 14 days were deemed to be neuronal, and were used for the 
cytotoxicity analysis of conformational phenotypes of the MoPrPI05 -125 peptide. 
The cytotoxicity analysis further confirmed the neuronal phenotype, as these 
differentiated PC12 cells were much more sensitive to the TMT compound than naive 
non -NF -L expressing cultures. TMT, a neurotoxic compound, was chosen as a 
positive control for the Alamarblue cytotoxicity assay (Section 2.5.11.2.). Although 
hippocampal pyramidal and dentate gyrus cells are particularly sensitive to TMT; the 
compound is also toxic to glial cells. The mechanisms of TMT toxicity are unclear, 
but are thought to be influenced by the expression of stannin and are thought to be 
mediated by apoptosis. Naive and neuronal PC12 cells were both sensitive to the 
neurotoxicity of TMT, but neuronal PC12 cells were more susceptible. The mean 
viability of naive PC12 cells, as measured by Alamarblue reduction, was 65.45% of 
the positive untreated growth control (i.e. TMT inhibited viability by 34.55 %) after 24 
hours exposure (Figure 4.15.). Naive PC12 cells which were chronically exposed for 
7 days (Figure 4.15.) had a mean viability of 39.68% (or inhibited by 60.32 %). In 
contrast, the mean viability of neuronal PC12 cells exposed to TMT for 24 hours was 
45.53% (or inhibited by 54.47 %) when compared to the positive growth control 
(Figure 4.17.). This mean viability was decreased further to 10.68% (or inhibited by 
89.32 %) following chronic exposure for 7 days (Figure 4.17.). Therefore 14 day 
NGF- differentiated PC12 cells not only express neuronal -specific proteins (i.e. NF -L), 
morphologically resemble neurons, but they also respond like neurons in the presence 
of neurotoxic TMT. Naive and neuronal (14 day NGF- differentiated) PC12 cells 
were used for monitoring the structure /toxicity relationships of MoPrP105 -125 in this 
thesis. 
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4.3.6 PrP` expression by PC12 cells increases following differentiation with 
nerve growth factor 
To analyse the possible effects of PrPc upon the toxicity of MoPrP105 -125, the 
expression of PrP° was analysed in naive, 7- and 14 day -NGF differentiated PC12 cell 
cultures. Preliminary immunofluorescence and FACS analysis revealed that the anti - 
PrP 8H4 monoclonal primary antibody (Table 2.1.) was superior in recognizing rat 
PrP °, in comparison to the anti -PrP 6H4 (Table 2.1.) monoclonal and 1B3 (Farquhar 
et al. 1989) (kindly donated by K. Brown and C. Farquhar) polyclonal antibodies. 
8H4 was therefore used for the immunofluorescence and FACS studies detailed in this 
thesis. The PrPc expression by naive and neuronal PC12 cells was attempted using 
the Western blot techniques described using these anti -PrP antibodies (Section 2.5.9.); 
however, these studies were unsuccessful and are not discussed further. It is possible 
that the Western Blot techniques were not sensitive enough for detecting the low 
levels PrPc expressed in naive PC12 cultures or that the methods for removing the 
naive PC12 cells damaged the cell surface PrPc. Immunofluorescence analysis 
revealed that PrPc expression was increased according to the differentiation status of 
the PC12 cells. Naive PC12 cells expressed low levels of PrPc (Figures 4.10.A. and 
4.10.C.), which was restricted to the cytosol and cell membrane. PrPc expression 
increased following differentiation for 7 days (Figures 4.11.A. and 4.11.C.); 
expression levels were higher again in PC 12 cells fully differentiated after 14 days 
(Figures 4.12.A. and 4.12.C.). 
FACS analysis corroborates the immunofluorescence results, as 9.02% of naive PC12 
cells express PrPc when labelled with the 8H4 monoclonal antibody (n =4, SEM =0.27) 
(Figures 4.13.A. and 4.13.B.). After 7 days of NGF- differentiation, 30.18% of cells 
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express PrPe (n =4, SEM =0.59) (Figures 4.13.C. and 4.13.D.), representing a highly 
significant increase in PrPc expression (P <0.005). The number of cells expressing 
PrPc is increased further to 42.22% (n =4, SEM =0.7) following differentiation for 14 
days (Figures 4.13.E. and 4.13.F.), representing over a 4 -fold increase in PrPc 
expression in comparison to naive cells which is also highly significant in comparison 
to 7 day differentiated cultures (p <0.005). The apparent higher detection of PrPc in 
the immunofluorescence images in comparison to the FACS data could be due to 
inadequate permeabilisation of the PC12 cells during FACS analysis, or possible 
damage to cell surface PrPc during procedures to harvest the cells for analysis. 
4.3.7 MoPrP105 -125 toxicity 
MoPrP105 -125 peptide conformations (Section 4.3.4.) were added at concentrations 
of 50, 80, 100 or 150µM to naive or neuronal PC12 cells. Neither of the MoPrP 105- 
125 peptides, nor their scrambled counterparts (Section 4.3.8.), were toxic to naive 
PC12 cell cultures (Figures 4.15. -4.16. and 4.19.- .4.20.). However, both of the 
MoPrP105 -125 conformations were toxic to neuronal PC12 cell cultures (Figures 
4.17. -4.18. and 4.21.- 4.22.). Balanced two -way ANOVA analysis showed that 
toxicity on neuronal cells was highly significant in comparison to the naive cell 
cultures (p <0.005), and also that this toxicity was dependent on the normal and not 
scrambled peptide (p <0.005). There is therefore a highly significant relationship that 
requires the neuronal phenotype for the peptide conformations to be toxic. 
To analyse the effects of short and longer exposure times of MoPrP105 -125 peptides 
on neuronal PC12 cells, alamarblue cytotoxicity assays were performed at exposures 
of 24, 48, and 72 hours and also 5 and 7 days (Section 2.5.11.2.). Exposure time for 
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both peptides was statistically highly significant (p <0.005), and there was a highly 
significant two -way relationship between exposure time and cell type. This indicates 
that the presence of neuronal PC12 cells and the duration of peptide exposure are 
extremely important variables, as such toxicity is not observed for the naive cell 
cultures. Analysis of the alamarblue reduction values across all concentrations shows 
that the maximum toxicity of both normal peptides is observed following exposure for 
5 days. It is likely that toxicity would increase even further with increased peptide 
exposure times, although this was not analysed for the research of this thesis. 
Analysis of the secondary structure of these normal peptides shows that the I3-sheet 
content is similar (Tables 4.1. and 4.3.), although the fibrillar structures are very 
different (Figures 4.2. and 4.3.). The I3-sheet content of the normal peptide created at 
pH 7 is 69.21 %, and analysis of fibrillar morphology shows that these fibrils are very 
straight along in comparison to all other peptide solutions. At pH 5 the I3-sheet 
content is 61.11%, and EM analysis revealed a dense mass of fibrils, which were 
small, occasionally bent and frequently overlapping. It was hypothesised that the 
toxicities of morphologically distinct fibrillar structures would not have such 
comparable neurotoxic properties. Possible reasons for such similar toxicities are 
discussed in Section 4.4. 
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4.3.8 Scrambled MoPrP105 -125 is non -toxic to naive PC12 cells, but 
moderately toxic to neuronal PC12 cells following chronic exposure 
A randomly generated scrambled sequence of the human PrP106 -126 synthetic 
peptide has been widely demonstrated to be non -neurotoxic in comparison to the 
normal peptide sequence (Forloni et al. 1993). A scrambled version of MoPrP105- 
125 was synthesised and analysed as a non -aggregating (Section 4.3.2.) control which 
had the same amino acid composition as the normal peptide sequence (Appendix I). 
Cytotoxicity of the scrambled peptide was monitored by alamarblue reduction in 
contrast to non -treated positive growth controls, and compared to cultures treated with 
equivalent volumes of vehicle buffer lacking peptide. The scrambled peptide 
sequence, of the two tested peptide conformations, was non -toxic to naive PC12 
cultures at all of the tested time points (Figures 4.16. and 4.20.). However; when 
neuronal cells were treated for 5/7 days (Figures 4.18. and 4.22.), viability was 
slightly decreased in comparison to the vehicle treated control cells. The toxicity of 
these two scrambled peptides is therefore comparable after 7 days exposure to 
neuronal PC12 cells, but not as remarkable as that observed in the normal peptide 
experiments. Therefore, the MoPrP105 -125 peptides tested in this thesis are much 
more toxic than their scrambled counterparts. 
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4.3.9 Analysis of apoptosis in MoPrP105 -125 treated neuronal PC12 cells 
Two approaches were chosen in an attempt to identify apoptosis in the normal 
peptide- treated neuronal PC12 cells. Annexin V and anti -active caspase -3 antibodies 
were used to search for apoptotic markers. Analysis included replicates of cells 
treated with; the two normal peptide conformations, TMT, and untreated controls. 
Staining with Annexin V proved problematic as it stained non -specifically in all of the 
cell replicates. It is thought that the procedures used to remove adherent cell cultures 
may damage the neuritic processes, which may therefore account for the non -specific 
binding of annexin V (Schutte et al. 1998). Further work would have to optimise the 
cell harvesting procedures and/or techniques to block non -specific binding. 
Therefore, annexin V binding as a marker of early apoptosis could not be used to 
obtain results for this thesis. The in vitro and in vivo detection of active caspase 3, 
following exposure of neuronal cells to PrP106 -126 and in the 87V /VM murine 
scrapie model, represented a downstream marker of apoptosis which should be 
analysed in this thesis. However, reactivity of the anti -caspase 3 antibody could also 
not be confirmed in any of the cell cultures. These studies were the final experiments 
of the research of this thesis, and due to considerable time constraints could not be 
optimised or studied further. 
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Figure 4.1 Electron micrographs of MoPrP105 -125 and scrambled MoPrP105 -125 prepared in 
200mM citrate buffer (pH7), distilled water, and 10mM MES buffer (pH7) after 48 hours incubation 
at room temperature 
MoPrP105 -125 and scrambled MoPrP105 -125 samples (5pl) were dried onto carbon /formvar 200 mesh 
grids and negatively stained with 2% sodium phosphotungstate (Section 2.4.5). (A) normal peptide in 
200mM citrate pH 7 (B) scrambled peptide in 200mM citrate pH 7 (C) normal peptide in distilled water 
(D) scrambled peptide in distilled water (E) normal peptide in 10mM MES pH 7 (F) scrambled peptide in 
10mM MES pH 7. Magnifications: x45,000 (A, C, E) and x15,000 (B, D, F). 
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Figure 4.2 Electron micrographs of MoPrP105 -125 and scrambled MoPrP105 -125 prepared in 
10mM MES buffer (pH 7) at increasing NaCI concentrations after 5 days incubation at 37 °C 
MoPrP105 -125 and scrambled MoPrP105 -125 samples (5pl) were dried onto carbon /formvar 200 
mesh grids and negatively stained with 2% sodium phosphotungstate (Section 2.4.5). (A) normal 
peptide and (B) scrambled peptide with OmM NaCI, (C) normal peptide and (D) scrambled peptide 
with 50mM NaCI, (E) normal peptide and (F) scrambled peptide with 200mM NaCI. Magnifications: 
x45,000 (A, C, E) and x15,000 (B, D, F). 
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Figure 4.3 Electron micrographs of MoPrP105 -125 and scrambled MoPrP105 -125 prepared in 
10mM MES buffer (pH 5) at increasing NaCI concentrations after 14 days incubation at 37 °C 
MoPrP105 -125 and scrambled MoPrP105 -125 samples (5p1) were dried onto carbon /formvar 200 
mesh grids and negatively stained with 2% sodium phosphotungstate (Section 2.4.5). (A) normal 
peptide and (B) scrambled peptide with OmM NaCI, (C) normal peptide and (D) scrambled peptide 
with 50mM NaCI, (E) normal peptide and (F) scrambled peptide with 200mM NaCI. Magnifications: 
x45,000 (A, C, E) and x15,000 (B, D, F). 
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Figure 4.7 Attenuated FT-1R spectra of MoPrP105 -125 and scrambled 
MoPrP105 -125 dissolved at 2mq /ml in 10mM MES pH7 (+ 50mM NaCI), aggregated at 
37 °C for 5 days 
MoPrP105 -125 (- ) and scrambled MoPrP105 -125 (- ) peptide secondary 
structure analysis by FT -IR spectroscopy (Section 2.4.4) were collected following a 
20 minute period of hydrogen/deuterium exchange. Secondary structure assignments 
for the normal and scrambled peptides, derived from the amide I region (1600 - 
1700cm I), are detailed in Tables 4.1 - 4.2. The peak in the Amide II region in the 
MoPrP105 -125 peptide indicates the presence of highly aggregated fibrillar 
structures, preventing complete hydrogen/deuterium exchange (Amide II'). Such 
aggregated structures are present in this peptide sample (Figures 4.2.0 and 4.5), and 
are absent in the scrambled peptide sample (Figures 4.2.D and 4.5) 









1662 -1682 13-turn 19.74 
1645 -1662 a -helix 11.05 
1637 -1645 Random coil 0 
1613 -1637 r3-sheet (low) 69.21 
Table 4.1 FT -IR assigned secondary structures for MoPrP105 -125 dissolved at 
2mq /ml in 10mM MES pH7 (+ 50mM NaCI), aggregated at 37 °C for 5 days 
Secondary structure assignment from the amide I region (1600- 1700cm -1) of the normal 
MoPrP105 -125 displayed in Figure 4.7 
Wave number 
cm 
Secondary structure % secondary 
structure 
1689 -1682 (3-sheet (high) 0 
1662 -1682 I3-turn 45.45 
1645 -1662 a -helix 21.94 
1637 -1645 Random coil 0 
1613 -1637 (3-sheet (low) 32.61 
Table 4.2 FT -IR assigned secondary structures for scrambled MoPrP105 -125 
dissolved at 2mq /mI in 10mM MES pH7 (+ 50mM NaCI), aggregated at 37 °C for 5 days 
Secondary structure assignment from the amide I region (1600- 1700cm -1) of the scrambled 
MoPrP105 -125 displayed in Figure 4.7 
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Wave number cm' 
Figure 4.8 Attenuated FT -IR spectra of MoPrP105 -125 and scrambled 
MoPrP105 -125 dissolved at 2mq /ml in 10mM MES pH5 (+ 50mM NaCI), aggregated at 
37 °C for 14 days 
MoPrP105 -125 (- ) and scrambled MoPrP105 -125 (- ) peptide secondary 
structure analysis by FT -IR spectroscopy (Section 2.4.4) were collected following a 
20 minute period of hydrogen/deuterium exchange. Secondary structure assignments 
for the normal and scrambled peptides, derived from the amide I region (1600 - 
1700cm 1), are detailed in Tables 4.3 - 4.4. The peak in the Amide II region in the 
MoPrP 105 -125 peptide indicates the presence of highly aggregated fibrillar 
structures, preventing complete hydrogen/deuterium exchange (Amide II'). Such 
aggregated structures are present in this peptide sample (Figures 4.3.0 and 4.6), and 
are absent in the scrambled peptide sample (Figures 4.3.D and 4.6) 








13 -sheet (high) 
1662 -1682 f3-turn 21.38 
1645 -1662 a -helix 17.51 
1637 -1645 Random coil 0 
1613 -1637 13-sheet (low) 61.11 
Table 4.3 FT -IR assigned secondary structures for MoPrP105 -125 dissolved at 
2mq /ml in 10mM MES pH5 (+ 50mM NaCI), aggregated at 37 °C for 14 days 
Secondary structure assignment from the amide I region (1600- 1700cm-1) of the normal 
MoPrP105 -125 displayed in Figure 4.8 
Wave number 
cm 1 
Secondary structure % secondary 
structure 
1689 -1682 13 -sheet (high) 10.96 
1662 -1682 13 -turn 16.71 
1645 -1662 a -helix 19.12 
1637 -1645 Random coil 22.09 
1613 -1637 ß -sheet (low) 31.12 
Table 4.4 FT -IR assigned secondary structures for scrambled MoPrP105 -125 
dissolved at 2m /ml in 10mM MES H5 + 50mM NaCI), aggregated at 37 °C for 14 days 
Secondary structure assignment from the amide I region (1600- 1700cm-1) of the scrambled 
MoPrP105 -125 displayed in Figure 4.8 
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Figure 4.9 Inverted microscopic analysis of rat pheochromocytoma PC12 cells at various 
stages of differentiation with nerve -growth factor 
Naive PC12 cells were grown on collagen IV coated T -25cm2 flasks and treated with 100ng /m1 of 
murine NGF (Section 2.5). Morphological analysis using an inverted microscope (Zeiss) was 
performed daily, and images of cells at various stages of differentiation were captured using a digital 
camera (Nikon). (A) Naive PC12 cell cultures prior to NGF treatment. Cells are round /oval in shape 
and tend to grow in dense clusters. (B) PC12 cells following 7 days differentiation with NGF have 
some dendritic processes, grow more distant from neighbouring cells and some cells have slightly 
larger cell bodies. (C) 14 day differentiated cells have a dense network of dendritic processes, grow 
more independently from clusters, and have enlarged cell bodies. The majority of cells are fully 
differentiated, however, some cells ( -- *) do not morphologically resemble neurons 
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B 
D 
Figure 4.10 Immunoreactivity of naive PC12 cells with the anti -PrP 8H4 
monoclonal primary antibody 
Naive PC12 cells were grown on collagen IV coated coverslips (Section 2.5.2) and 
stained according to the described protocol (Section 2.5.8). Images were captured using 
the confocal microscope (Zeiss) and the Axioskop 2 camera software at magnifications 
of x40 (A & B) and x63 (C & D). Naive PC12 cells express PrP at low levels (A & C), 
which is restricted to the cytosol. B and D show the negative control samples, where 
8H4 was replaced with normal mouse serum to demonstrate the specificity of the 8H4 
immunoreactivity. 
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Figure 4.11 Immunoreactivity of 7 day NGF- differentiated PC12 cells with the 
anti -8H4 monoclonal primary antibody 
Naive PC12 cells were grown on collagen IV coated coverslips (Section 2.5.2), 
cultured for 7 days (Section 2.5), and stained according to the described protocol 
(Section 2.5.8). Images were captured using the confocal microscope (Zeiss) and 
Axioskop 2 camera software at magnifications of x40 (A & B) and x63 (C & D). 7 day 
differentiated PC12 cells express PrP at higher levels (A & C), which is restricted to 
the cell body. Cell bodies of 7 day NGF- differentiated cells are larger than those of the 
naive cultures (Figure 4.10) and dendritic processes begin to form. B and D show the 
negative control samples, where 8H4 was replaced with normal mouse serum to 
demonstrate the specificity of the 8H4 immunoreactivity. 





Figure 4.12 Immunoreactivity of 14 day NGF- differentiated PC12 cells with the 
anti -8H4 monoclonal primary antibody 
Naive PC12 cells were grown on collagen IV coated coverslips (Section 2.5.2), 
cultured for 14 days (Section 2.5), and stained according to the described protocol 
(Section 2.5.8). Images were captured using the confocal microscope (Zeiss) and 
Axioskop 2 camera software at magnifications of x40 (A & B) and x63 (C & D). 14 day 
differentiated PC12 cells express PrP at very high levels (A & C), which is restricted to 
the cell body. Cell bodies of 14 day NGF- differentiated cells are even larger than 
those of the 7 day differentiated cultures (Figure 4.11) and have extensive dendritic 
processes. B and D show the negative control samples, where 8H4 was replaced 
with normal mouse serum to demonstrate the specificity of the 8H4 immunoreactivity. 
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Figure 4.13 FACS analysis for the expression of PCP` by differentiating PC12 cells 
Naive, 7 day and 14 day differentiated PC12 cells were analysed for PrP° expression with 
the 8H4 monoclonal antibody (Figure 2.1) by FACS analysis (Section 2.5.9). Cells were 
analysed (in quadruplicate, n =4) at the naive (A & B), 7 day NGF- differentiated (C & D), and 
14 day NGF- differentiated phenotypes (E & F). Cells were gated as shown (A, C, E). 
Histograms for control cells, treated with secondary but no primary antibodies, are shown by 
an unfilled purple histogram. Cells staining positively for PrP° are represented by the solid 
red coloured histograms. The mean PrP° expression significantly increases from naive 
9.02% (SEM= 0.27), 7 day 30.18% (SEM= 0.59) to 14 day 42.22% (SEM= 0.7) treated 
PC12 cells. 
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Figure 4.14 FACS analysis for the expression of neurofilament protein by 
differentiating PC12 cells 
Naive, 7 day and 14 day differentiated PC12 cells were analysed for NF -L expression with 
the neurofilament (light sub -unit) monoclonal antibody (Figure 2.1) by FACS analysis 
(Section 2.5.9). Cells were analysed (in quadruplicate, n =4) at the naive (A & B), 7 day 
NGF- differentiated (C & D), and 14 day NGF- differentiated phenotypes (E & F). Cells were 
gated as shown (A, C, E). Histograms for control cells, treated with secondary but no 
primary antibodies, are shown by an unfilled purple histogram. Cells staining positively for 
NF -L are represented by the solid red coloured histograms. The mean NF -L expression 
significantly increases from naive 1.61% (SEM= 0.2), 7 day 16.05% (SEM= 0.76) to 14 day 
31.04% (SEM= 0.33) treated PC12 cells. 








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Naive PC12 % Reduction % Reduction 
48 hours 
97.00 












(SEM = 0.85) 
cells 24 hours 
50pM 93.26 
MoPrP105 -125 (SEM = 1.27) 
80pM 86.93 
MoPrP105 -125 (SEM = 1.01) 
99.21 
(SEM = 2.15) 
94.59 
(SEM = 1.16) 
95.59 
(SEM = 2.16) 
91.32 
(SEM = 1.22) 
100pM 93.64 
MoPrP105 -125 (SEM = 2.95) 
98.97 
(SEM = 0.20) 
85.44 
(SEM = 1.14) 
98.93 
(SEM = 1.44) 
92.13 
(SEM = 1.95) 
150pM 80.38 
MoPrP105 -125 (SEM = 2.71) 
95.97 
(SEM = 0.38) 
88.60 
(SEM = 1.01) 
87.73 
(SEM = 1.45) 
75.46 
(SEM = 3.40) 
400pM 64.45 
TMT SEM = 1.58 
Differentiated % Reduction 
57.50 




(SEM = 2.56) 
48.46 




(SEM = 2.45) 
45.98 




(SEM = 0.90) 
39.68 




(SEM = 1.32) 
PC12 cells 24 hours 
50pM 92.69 
MoPrP105 -125 (SEM = 0.91) 
80pM 91.11 
MoPrP105 -125 (SEM = 1.02) 
82.84 
(SEM = 1.10) 
51.11 
(SEM = 1.19) 
88.39 
(SEM = 4.82) 
44.92 
(SEM = 0.39) 
100pM 87.53 
MoPrP105 -125 (SEM = 0.84) 
86.01 
(SEM = 1.18) 
99.43 
(SEM = 3.10) 
74.01 
(SEM = 2.23) 
63.67 
(SEM = 2.32) 
150pM 81.78 
MoPrP105 -125 (SEM = 1.45) 
75.17 
(SEM = 0.75) 
95.37 
(SEM = 1.49) 
61.51 
(SEM = 1.95) 
70.25 
(SEM = 1.59) 
400pM 45.53 
TMT (SEM = 0.41) 
20.87 
(SEM = 0.69) 
22.16 
(SEM = 0.42) 
9.34 
(SEM = 0.12) 
10.68 
(SEM = 1.44) 
Table 4.5 Summary of mean % Alamarblue reduction compared to positive growth controls for 
naive and 14 day differentiated PC12 cells, treated with MoPrP105 -125 (10mM MES+ 50mM NaCI, 
pH 7, 5 days prior incubation at 37 °C) 
PC12 cells (800cells /well) (n =3), naive or differentiated with NGF for 14 days, were exposed to normal 
peptides at concentrations of; 50, 80, 100, or 150pM. Peptide exposure was maintained for periods of 
24, 48, 72 hours, 5 or 7 days. Alamarblue toxicity was related to untreated control PC12 cultures (n =3). 
Reproducibility was confirmed by treating parallel cultures (n =3) with 400pM TMT. The reduction of 
Alamarblue is expressed as a percentage of the growth control (untreated, n =3) PC12 cells to monitor 
the toxixtiy of normal peptides to tested cell cultures. 
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Naive PC12 % Reduction % Reduction 
48 hours 
92.69 












SEM = 2.62 
cells 24 hours 
50pM 84.42 
MoPrP105 -125 SEM = 1.36 
80pM 86.40 
MoPrP105 -125 SEM = 1.27 
86.61 
SEM = 2.03) 
89.59 
SEM = 2.33 
94.30 
SEM = 1.49 
88.28 
SEM = 1.61 
100pM 84.65 
MoPrP105 -125 (SEM = 1.46) 
86.81 
(SEM = 2.40) 
96.27 
(SEM = 2.96) 
88.92 
(SEM = 1.98) 
86.15 
(SEM = 1.31) 
150pM 75.35 
MoPrP105 -125 SEM = 0.89 
400pM 64.45 
TMT SEM = 1.58 
89.22 
SEM = 1.55 
57.50 




SEM = 0.42) 
80.68 
SEM = 1.14 
48.46 




SEM = 0.70 
89.44 
SEM = 1.99 
45.98 




SEM = 0.46 
77.39 
SEM = 1.09 
39.68 




SEM = 0.34 
Differentiated % Reduction 
PC12 cells 24 hours 
50pM 90.54 
MoPrP105 -125 SEM = 3.14 
80pM 76.07 
MoPrP105 -125 SEM = 2.20 
80.41 
SEM = 3.44 
60.65 
SEM = 1.24 
72.76 
SEM = 0.21 
70.42 
SEM = 2.51 
100pM 79.11 
MoPrP105 -125 SEM = 2.40 
71.07 
SEM = 0.64 
63.67 
SEM = 2.54 
54.05 
SEM = 3.19 
51.03 
SEM = 0.95 
150pM 70.73 
MoPrP105 -125 SEM = 0.60 
400pM 45.53 
TMT SEM = 0.41 
61.56 
SEM = 1.15) 
20.87 
SEM = 0.69 
50.37 
SEM = 2.30 
22.16 
SEM = 0.42 
66.21 
SEM = 2.28 
9.34 
SEM = 0.12 
42.02 
SEM = 0.54 
10.68 
SEM = 1.44 
Table 4.6 Summary of mean % Alamarblue reduction compared to positive growth controls for 
naive and 14 day differentiated PC12 cells, treated with MoPrP105 -125 (10mM MES+ 50mM NaCI, 
pH 5, 14 days prior incubation at 37 °C) 
PC12 cells (800cells /well) (n =3), naive or differentiated with NGF for 14 days, were exposed to normal 
peptides at concentrations of; 50, 80, 100, or 150pM. Peptide exposure was maintained for periods of 
24, 48, 72 hours, 5 or 7 days. Alamarblue toxicity was related to untreated control PC12 cultures (n =3). 
Reproducibility was confirmed by treating parallel cultures (n =3) with 400pM TMT. The reduction of 
Alamarblue is expressed as a percentage of the growth control (untreated, n =3) PC12 cells to monitor 
the toxixtiy of normal peptides to tested cell cultures. 
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4.4. Discussion 
The misfolding of proteins into insoluble aggregates is associated with a number of 
neurodegenerative diseases, including TSEs, Alzheimer's, Huntington's, and 
Parkinson's diseases. These insoluble aggregates are formed from disruptions to the 
normal tertiary structure, resulting in the exposure of normally buried hydrophobic 
regions of the protein and a toxic gain of function of the misfolded proteins 
(Muchowski 2002). These hydrophobic regions (such as the AGAAAAGA 
palindrome sequence found within the PrP106 -126 peptide) then interact with similar 
hydrophobic regions to form fibrillar structures. These fibrillar structures range from 
short protofibrillar structures, to mature amyloid plaques observed in Alzheimer's 
disease and some of the TSE infections. Misfolded aggregates are characterised by a 
high content of I3-sheet structure, and the binding to histopathologic dyes such as 
Thioflavin -T and Congo red. 
Neuronal cultures exposed to synthetic PrP peptides have been developed to model, in 
vitro, TSE- mediated neurodegeneration. Of particular interest is the PrP106 -126 
peptide, corresponding to the most highly conserved portion of the PrP protein, found 
within the 7 kDa peptides (amino acids 81 -150) isolated in vivo from GSS amyloid 
plaques (Tagliavini et al. 2001). The PrP 106 -126 peptide contains the hydrophobic 
palindrome sequence (AGAAAAGA) thought to be important not only for the 
conversion of PrP° to PrPSO (Muramoto et al. 1996; Norstrom & Mastrianni 2005), but 
also for conferring the toxic properties of the synthetic peptide (Jobling et al. 1999). 
The synthetic peptide was found to be neurotoxic following exposures to rat 
hippocampal cultures (Forloni et al. 1993). Furthermore, the peptide shares many of 
the biochemical and physical properties of PrPsc. Peptide aggregates exhibit the 
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birefringence of amyloid deposits when bound to Thioflavin -T or Congo red, have 
partial resistance to proteinase -K digestion (Selvaggini et al. 1993), require the 
neuronal expression of PrP° for neurotoxicity (Brown et al. 1994; Brown et al. 1996), 
have a high f3 -sheet content (Selvaggini et al. 1993; De Gioia et al. 1994), and 
stimulate astrocytes and microglial cells (Forloni et al. 1994; Brown et al. 1996). 
The PrP106 -126 peptide represents the minimal amino acid sequence capable of 
replicating the properties of PrP' in vitro, and is also more practical for research 
purposes due to the insoluble nature of PrPSO isolated in vivo. The homologous 
sequence of this peptide in mice, PrP105 -125, was synthesised to establish a model of 
neurodegeneration and also to remove potential species barrier effects in this model. 
This is because this sequence is identical between MoPrP105 -125 and rat PC12 cells, 
whereas the human PrP106 -126 differs by two amino acids (Appendix I). As it is 
well known that even a single amino acid difference can dramatically alter the 
susceptibility to infection with TSEs in vivo (Hsiao et al. 1990; Manson et al. 1999), 
this peptide sequence represents a better in vitro model of neurodegeneration. The 
long incubation periods of the TSE diseases, and the difficulties in identifying 
apoptosis in vivo (as discussed in Section 3), reiterate the importance of establishing 
such an in vitro model to clarify the as yet unknown mechanisms of neuronal loss in 
these fatal diseases. 
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4.4.1 Secondary structure of MoPrP105 -125 is influenced by pH, NaCI 
concentration and aggregation time 
The secondary structural properties, including 3 -sheet content, of HuPrP106 -126 are 
hugely influenced by a number of factors including solvent composition, ionic 
strength, pH, the presence of membranes and mutations to specific amino acids 
(Section 4.2.1.). The mouse sequence differs by two amino acids to the homologous 
sequence of the human PrP106 -126 peptide (Appendix I). These amino acids 
differences (in place of methionine in the human sequence) are leucine and valine at 
positions 108 and 111 respectively. These amino acids only moderately increase the 
hydrophobicity of the mouse peptide (hydroplot analysis; 
http: / /www. innovagen. se/ custom -peptide- synthesis /peptide- property- 
calculator/ peptide -property -calculator.asp) in comparison to the human sequence, as 
these amino acids are also non -polar and non -charged like methionine. Therefore, the 
factors which influence the human peptide were expected to similarly affect the 
secondary structure of the homologous MoPrP105 -125 peptide. Prior to testing the 
neurotoxic properties of the MoPrP 105 -125 in the PC 12 cell culture system, I felt that 
the detailed analysis of the secondary structures in each buffer must be performed. 
The main objective was to create peptide solutions containing a large proportion of (3- 
sheet and with altered fibrillar morphologies. This was because the secondary 
structure of PrP50 consists of a large proportion of I3-sheet (43 %), in comparison to 
PrPc which has a low proportion of f3-sheet (3 %) (Caughey et al. 1991; Safar et al. 
1993). Also, in vitro studies had previously correlated the toxicity of PrP106 -126 
with E3-sheet content (Forloni et al. 1993; Brown et al. 1998) and the morphologies of 
fibrillar structures may alter the toxicity of these peptide solutions. 
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Initial experiments analysed the propensity of the MoPrP105 -125 and scrambled 
equivalents to form fibrils in the presence of different buffers. This amyloidogenicity 
was monitored by binding to Thioflavin -T and morphologically by EM analysis. 
Amyloid fibrils bind to Thioflavin -T (and Congo red) in a mechanism that is specific, 
but poorly understood. It has recently been proposed that Thioflavin -T binding 
occurs along alternate residues on the alternate sides of the I3-sheet (i.e. channels) of 
amyloid fibrils (Krebs et al. 2005). This binding is thought to maintain Thioflavin -T 
in a short flat structure when in close proximity to such tightly packed f3-sheet 
structures present within amyloid fibrils. The EM images of the scrambled peptide 
samples represent the small amounts of amorphous aggregates that were actually 
present on the EM grids (Figures 4.2/4.3). Thioflavin -T analysis (Figures 4.4 -4.6) 
revealed that these structures formed from the scrambled peptide were non -fibrillar 
and are not discussed further in this section. 
The ability of the normal peptide to form amyloid fibrils was in the order: 200mM 
citrate pH 7 < 10mM MES pH 7 < distilled water, as analysed by Thioflavin -T 
binding. EM analysis revealed that the normal peptides formed distinctly different 
fibrillar structures in all buffers. FTIR was the only technology available for the 
secondary structure analysis; however, it was apparent that the citrate buffer was 
incompatible with the FTIR due to the presence of strong carbonyl bonds. Further 
research concentrated on the 10mM MES buffer, altering the secondary structures by 
changing the pH (5 & 7), NaCl and incubation time. Initial studies using the citrate, 
MES buffers and distilled water were analysed over a 48 hour period. Aggregation 
periods for this additional research were extended for periods up to 14 days. 
Additionally; salt concentration is known to affect the morphology of PrP fibrils 
183 Chapter 4: Synthetic PrP peptides 
(Apetri & Surewicz 2003), therefore a range of NaC1 concentrations was applied to 
each of the murine peptide samples. In summary, the MoPrP105 -125 peptide was 
dissolved in 10mM MES at pH7 or pH5 (containing 0, 50, or 200mM NaC1) and 
incubated at 37 °C. 
Thioflavin -T binding revealed that regardless of the NaC1 concentration, the samples 
dissolved at pH 7 were much more aggregated than equivalent samples dissolved at 
pH 5. Maximum aggregation occurred much more quickly at pH 7 (5 days, Figure 
4.5) than at pH 5 (14 days, Figure 4.6). At pH 7, salt concentrations of OmM had the 
lowest propensity to form fibrils but these levels were similar to the maximum 
aggregation which was obtained at pH 5 when supplemented with 50mM NaCl. Salt 
concentrations of 50mM NaC1 were found to maximise the formation of fibrils in both 
of the tested pH environments, therefore highlighting the importance of ionic strength 
in influencing the aggregation state. The slow aggregation of the peptide dissolved at 
pH 5 therefore represents an opportunity for future research to isolate soluble 
protofibrils, which are now believed to be more toxic than mature insoluble 
aggregated fibrils (discussed in Section 4.4.4.). This research therefore shows that the 
ability of the murine PrP 105 -125 peptide sequence is greatly influenced by 
differences of pH within the same buffer conditions. The differences attributed to 
these differences in pH can be modified further by altering the salt concentration and 
aggregation period. These factors were also found to modify the morphology of the 
mature aggregated fibrils. Generally, fibrils formed in the presence of increasing 
NaC1 concentration (in both tested pH environments) were found to be less dense and 
less compact than samples lacking NaCl. These findings are in strong agreement with 
a recent report which noted similar morphologies of recPrP in MES buffer when 
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incubated with increasing NaC1 concentrations (Kazlauskaite et al. 2005). For the 
research of this thesis; fibrils formed at pH 7 were all found to be straight, although 
fibril morphology was altered with different NaC1 concentrations. At OmM NaCI; 
fibrils were long, straight and present in dense layers. Fibrils formed at 50mM NaCI 
were distinctly longer, although appeared shorter when incubated with 200mM NaCI. 
Fibrils formed from incubating the peptide at pH 5 were straight, however, slight 
curving of fibrils was observed at concentrations of 50mM and 200mM NaC1 and 
fibrils appeared to slightly increase in length with increasing NaCI concentration. 
Based on the highest levels of aggregation in the tested buffers, samples chosen for 
toxicity analysis were the 10mM MES buffers at pH 5 and pH 7 supplemented with 
50mM NaCl. The mature fibrils were distinctly different in the two samples, as the 
fibres were very long and straight at pH 7 but were much shorter with slight bending 
of some fibrils in the extremely dense network of fibrils observed at pH 5. 
The FTIR analysis presented was from the two samples described above which were 
chosen for the neurotoxicity analysis. The f3 -sheet content of the normal peptides was 
69.21% at pH 7, and 61.11% at pH 5. Previous studies using the HuPrP 106 -125 
peptide have shown that a larger proportion of f3-sheet is obtained at pH 5 in 200mM 
phosphate buffer (Selvaggini et al. 1993). This research has found that the 13 -sheet 
content was slightly higher at pH 5 in the MES buffer, however this may be due to the 
two amino acid differences in the mouse peptide (in comparison to the human 
peptide). This suggestion is based on the observation that amino acid substitutions, 
representative of the A117V GSS mutation in the HuPrP106 -126, have comparable 
quantities of I3-sheet at both pH 5 and pH 7 (Salmona et al. 1999). There are 
therefore highly complex interactions between the pH, salt concentration in 
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influencing the development and morphology of aggregated amyloid fibrils of 
MoPrP105 -125. More detailed secondary structure analysis could be performed to 
help understand the relationships of these variables with the amino acid composition 
and primary structure of the MoPrP 105 -125. These factors will influence the 
secondary structure of dissolved peptides and may therefore influence the toxicity of 
tested peptides. This knowledge will enable the effects of secondary structure 
(including protofibrillar and mature fibrillar morphologies) to be correlated with 
toxicity, and therefore lead to a better understanding of the neurodegeneration 
associated with these diseases. 
4.4.2 PC12 cells cultured with NGF adopt a neuronal phenotype 
The rat pheochromocytoma cells were used to model the neurodegenerative potential 
of the MoPrP 105 -125 peptides, following the unsuccessful attempts to establish 
murine organotypic hippocampal slice cultures for this thesis (Section 1.5.1.). 
However, the PC12 cells represent a good model for such research as they are 
believed to be early progenitor cells of neural cleft origin which differentiate to the 
neuronal phenotype in vitro in the presence of NGF (Greene & Tischler 1976). NGF 
in vivo is believed to cause the neuronal differentiation of stem cells migrating from 
the neural cleft (Bjerre & Bjorklund 1973). Differentiation of PC12 cells to the 
neuronal phenotype depends on the presence of a collagen IV coated matrix, NGF 
concentration, differentiation time, and also the initial density of plated cells (Greene 
& Tischler 1976). The morphology of differentiating cells was monitored daily up to 
14 days by inverted microscopic analysis. The expression of NF -L mRNA increases 
significantly in NGF- differentiated cells and has been proven to be reliable as a 
quantitative measure of differentiation in PC12 cells (Lindenbaum et al. 1998; 
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Schimmelpfeng et al. 2004). Although PrP' is expressed by a number of cells 
(Section 1.2.2.), the highest levels of PrPc are expressed by neurons of the CNS 
(Manson et al. 1992). PrP° expression by PC 12 cells has been shown to increase 
following differentiation with NGF (Wion et al. 1988; Lazarini et al. 1994), and was 
therefore examined by immunofluorescence and FACS analysis. 
Microscopic analysis showed that naive PC 12 cultures were rounded and grew 
optimally when in close contact with other cells (Figure 4.9.A.). FACS analysis for 
NF -L protein showed that the mean expression of naive cells was 1.61%, confirming 
that these cells were not neuronal (Figures 4.14.A. -.B.). Immunofluorescence 
analysis confirmed low level expression of PrPC restricted to the cell membrane and 
cytosol (Figures 4.10.A. & .C.). Quantitative analysis by FACS analysis showed that 
9.02% of cells express PrP° (Figures 4.13.A. -.B.). Following 7 days NGF- exposure; 
the cell bodies of some cells were extended, cells were present in much lower 
proximities to each other and neuritic processes extended between some cells (Figure 
4.9.B.). The cells were morphologically immature in their neuronal status, but FACS 
analysis showed that the mean increase in NF -L expression was highly significantly at 
16.05% in comparison to naive cell cultures (Figures 4.14.C. -.D.). 
Immunofluorescence analysis showed that PrP° expression was increased greatly 
following 7 days NGF treatment (Figures 4.11.A. & .C.). FACS analysis confirmed 
this, as 30.18% of these cells expressed PrP° (Figures 4.13.C. -.D.) 14 day 
differentiated cells had larger cell bodies and mature neuritic processes extending to 
neighbouring neuronal cells (Figure 4.9.C.). Forward and side scatter analysis 
revealed that these cells were larger and more complex than the naive cells (Figures 
4.13. and 4.14.). These cells resembled mature neurons and the mean NF -L protein 
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expression was 31.04% (Figures 4.14.E. -.F.); this increase was highly significant and 
represented a 20 -fold increase in comparison to the non -neuronal naive cultures. PrP° 
expression in these cultures was higher again as confirmed by immunofluorescence 
(Figures 4.12.A. & .C.) and FACS analysis (42.22 %) (Figures 4.13.E. -.F.). FACS dot 
plots for naive, 7 day and 14 day differentiated cultures showed that the two 
populations observed in the naive PC12 cell analysis had virtually disappeared 
following exposure to NGF for 14 days (Figures 4.13. and 4.14.). The full 
differentiation by NGF correlates with the cessation of mitosis in neuronal cells 
(Greene & Tischler 1976), therefore the combined evidence of this research classified 
these cells as neuronal. Furthermore, the research of this thesis is strengthened since 
the relative increases in PrP° and NF -L protein expression are in line with previous 
reports using neuronal PC12 cells (Wion et al. 1988; Lindenbaum et al. 1998). 
In addition to the observations that 14 day NGF- differentiated PC12 cells were 
morphologically neuronal and expressed neuron specific proteins, these cells also 
responded like neurons to the neurotoxic TMT (as measured by alamarblue 
cytotoxicity assay). TMT was included as a positive control of cell death and also to 
monitor the reproducibility of the alamarblue assays, as these assays were performed 
over a four week period. Although TMT treatments induced cell death in the naive 
PC12 cultures, toxicity was significantly enhanced in the neuronally differentiated 
cells. These results further confirmed that the 14 day NGF- differentiated PC12 cells 
developed for this thesis were neuronal. This is extremely important as the 
establishment of a reproducible in vitro neuronal model was a central aim of the work 
described in this thesis. Therefore, the neuronal PC12 cells established here 
morphologically resemble and express neuronal specific proteins, in addition to 
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responding like neurons when exposed to neurotoxic substances (i.e. TMT). These 
neuronal cells therefore represent a very suitable in vitro model for studying the 
neurodegenerative mechanisms associated with the TSE diseases. 
4.4.3 Neuronal, but not naive, PC12 cell cultures are sensitive to toxic 
conformations of MoPrP105 -125 
The research of this thesis concentrated on establishing an in vitro model for the 
neurodegenerative mechanisms associated with the TSE diseases. Initial research 
plans of this thesis included the HuPrP106 -126 peptide (and its scrambled equivalent), 
as the novelty of using the mouse peptide sequence represented an uncertainty in 
terms of whether it too would be neurotoxic. However, secondary structural analysis 
of the normal and scrambled mouse peptides became so extensive that the human 
peptides had to be removed from the research plan. 
Neurotoxicity of MoPrP105 -125 was confirmed by alamarblue reduction assay 
(Section 2.5.11.2.); however, toxicity was restricted to PC12 cells exhibiting the 
neuronal phenotype. In the work presented in this thesis, normal mouse peptides had 
negligible effects on naive PC12 cells (Figure 4.15.), whereas neuronal cells were 
highly susceptible to the toxicity of the normal mouse peptides (Figures 4.18). Both 
MoPrP 105 -125 peptide preparations were toxic to neuronal PC12 cells in comparison 
to scrambled peptides, and also their vehicle buffer control equivalents. There was a 
highly significant relationship between exposure time and the neuronal cell status (i.e. 
neuronal morphology, p <0.005, two -way ANOVA) (Tables 4.5 & 4.6), and also 
between the cell status (i.e. neuronal morphology) and normal peptides (p <0.005, 
two -way ANOVA). Therefore, the susceptibility of neuronal PC12 cells could be due 
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to mechanisms specific to the neuronal phenotype. One such observation of the 
neuronal phenotype is the significant enhanced expression of PrP`' in comparison to 7 
day differentiated (p <0.005) or naive (p<0.005) cultures (Section 4.3.6.). It is well 
known that PrPc expression is essential for toxicity of PrP106 -126 and also for the 
development of TSE disease in vivo. PrPc expression levels have previously been 
shown to affect the susceptibility of cell cultures to the human PrPI06 -126 peptide 
(Hope et al. 1996). Neuronally differentiated PC12 cells were not included in this 
study by Hope et al., however; naive PC12 cells, which express low levels of PrPc, 
were relatively unaffected by PrP106 -126 peptides and therefore this is in agreement 
with the results of this thesis. However, these observations disagree with a recent 
paper analysing PrP106 -126 (Fioriti et al. 2005), which found PrP106 -126 was 
comparably toxic to naive and neuronal PC12 cells. In contrast, it has also been 
reported that naive and neuronal PC12 cells are resistant to PrP 106 -126 unless co- 
cultured with microglial cells (Brown et al. 1997). It is likely that neuron -specific 
factors in partially differentiated cells in these two studies, such as PrPc expression 
levels, would be different to the neuronal PC12 cell cultures investigated in this 
thesis. Furthermore, secondary structure analysis of the peptide solutions in these 
studies was not tested. This is an extremely important variable as; (1) [3-sheet content 
has been shown to correlate with infectivity in vivo (Wille et al. 2000), and (2) 
PrP106 -126 solutions containing high quantities of (3-sheet have been shown to be 
more toxic in vitro (Brown et al. 1998). Therefore, the 13 -sheet content and 
fibrillogenic properties of the peptides in these studies were unknown, which would 
account for differences in toxicity. Therefore the results of this thesis, demonstrating 
the vulnerability of neuronal PC12 cells to the toxic effects of fibrillogenic peptides 
(Figures 4.17. and 4.21.) containing a large proportion of [3-sheet (Figures 4.7.- Table 
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4.4.), represents positive progress in developing an in vitro model for analysing the 
mechanisms of cell death which in vivo is also restricted to neuronal populations. 
Future work arising from this thesis could determine if the observed differences in the 
susceptibility of neuronal and naive PC12 cells was due to differences in PrP° 
expression levels, or due to other neuron specific traits. The creation of PrP° 
knockout and PrPC over -expressing PC12 cells, would allow for such analysis in naive 
and neuronal PC12 cells. Brown et al. have already shown increased neurotoxic 
effects of PrP 106 -126 in cultured cerebellar neurons over -expressing PrP°; however, 
microglial cells were thought to be important in assisting this toxicity (Brown 1998). 
Even though the cell culture system established in this thesis does not require 
microglia for PrP105 -125 toxicity, future research could establish a co- culture system 
with PC12 cells to see if toxicity is indirectly enhanced by the presence of microglial 
cells. Since microglial activation occurs prior to neuronal loss in murine scrapie 
models and that PrPsc toxicity is enhanced by microglial cells (Giese et al. 1998; Bate 
et al. 2001), the development of such a model would better replicate the in vivo 
neurodegenerative process. The release of ROS by activated microglia, in response to 
PrP peptides, would allow further analysis for the role of oxidative stress in mediating 
neurodegeneration (as discussed in Chapter 3). Furthermore; this research had 
originally planned to include the human PrP106 -126 peptide, created in the conditions 
tested for the mouse peptides, to analyse toxicity on rat PC12 cells in relation to the 
mouse peptide containing the identical sequence to that in the rat genome. Future 
research could include the human peptide to test its toxicity in relation to the mouse 
peptide on rat PC12 cells. In summary; the observations that neuronal and not naive 
PC 12 cells are susceptible to the in vitro neurotoxicity of MoPrP 105 -125 peptides is 
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therefore an illustration of the selective vulnerability of neurons in vivo, when 
exposed to TSE agents. The complete development of an in vitro neurodegeneration 
model could therefore lead to strategies to interrupt the mechanisms of neuronal cell 
loss in these diseases, which would be beneficial due to the prolonged incubation 
periods required when performing such analysis using animal TSE models. 
4.4.4 Neurotoxicity of MoPrP105 -125 in relation to secondary structural 
properties 
Toxicity analysis in this thesis concentrated on the creation of highly aggregated 
mature fibrils containing a large proportion of ß -sheet ( >60 %), as HuPrP 106 -126 
peptides containing a large proportion of ß -sheet are more toxic to neuronal cell 
cultures (Forloni et al. 1993; Tagliavini et al. 1993). The mature fibrils formed by 
MoPrP105 -125 were very toxic and this was highly statistically significant with 
respect to the independent variables of the normal peptide (p <0.005), concentration 
(p <0.005), time (p <0.005) and the presence PC12 cells with the neuronal morphology 
(p <0.005). There were significant two -way relationships between the presence of 
neuronal cells and the normal peptide (p <0.05), and also the presence of neuronal 
cells and the exposure time (p <0.05). The f3-sheet contents of the two normal 
peptides were relatively similar (Tables 4.1. and 4.3.) however the fibrils were 
morphologically different (Figures 4.2.- 4.3.). Fibrils formed in 10mM MES pH 7 
( +50mM NaCl) were very long and straight, whereas fibrils formed in the 10mM 
MES pH 5 ( +50mM NaCI) buffer were much shorter, over -lapping and some fibrils 
had slight bending. Interestingly, increasing evidence suggests that soluble 
intermediates, even in non -disease associated proteins, are more toxic than mature 
fibrils (Bucciantini et al. 2002). Mature fibrils created from PrP peptides are toxic in 
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vitro however the toxicity of mature fibrillar plaques (containing PIT') is less clear in 
vivo, for a number of reasons including; (1) amyloid plaques are characteristic of 
some but not all TSE infections, (2) infectivity does not appear to correlate with PrPsc 
(Telling et al. 1995; Dorandeu et al. 1998; Foster et al. 2001), (3) diseases such as 
Alzheimer's disease, which also contains brain amyloid deposits, are not 
transmissible. 
Future work should try to identify soluble intermediates formed during the growth of 
murine PrP peptides into mature fibrils. Such soluble intermediates have been 
described in the 87V/VM murine scrapie model in vivo; Jeffrey et al. described the 
presence of accumulated pre -amyloidogenic PrP in association with selective damage 
to axon terminals and dendritic spines (Jeffrey et al. 1997). Investigations by Brown 
et al. showed that maximum toxicity of the HuPrP106 -126 peptide was obtained in 
the presence of both highly aggregated and soluble conformations of the peptide 
(Brown et al. 1998). Highly toxic protofibrillar structures were obtained following 
G114A and G119A mutations in HuPrP106 -126 which reduced the ability of the 
peptide to aggregate (Florio et al. 2003). Soluble intermediate protofibrillar structures 
which are rich in 0-turn structure have recently been created in vitro, from recPrP 
molecules in lipid raft membranes, and have been shown to be more toxic than more 
mature insoluble aggregated fibrils (Kazlauskaite et al. 2005). Therefore, future 
research could attempt to identify protofibrillar conformations of MoPrP 105 -125, and 
analyse the neurotoxic mechanisms of these structures on neuronal PC 12 cells. 
Protofibrillar conformations are more likely to be obtained using the 10mM MES pH 
5 ( +50mM NaC1) buffer, as fibril formation is a much slower process in this reaction 
as observed by Thioflavin -T binding (Figure 4.6.), than at pH 7 (Figure 4.5.) which 
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aggregates immediately upon being dissolved. The formation of mature fibrillar 
structures appears to be a much slower process at pH 5, and I believe this would allow 
for the identification of soluble intermediate protofibrillar structures. Therefore the 
observations that the amyloid formation in 10mM MES pH 5 may prove to be very 
important for future analysis to identify protofibrillar intermediated in the reaction 
leading to mature amyloid fibrils. Due to constraints of not having our own EM 
facilities, EM analysis in this research could only be performed at critical points as 
determined by Thioflavin -T analysis. Analysis of peptide conformations at much 
earlier time points would have to be performed in order to identify protofibrillar 
structures in this system. The identification of soluble toxic PrP species may help in 
identifying the infectious agent and explain the transmissibility of these diseases. 
Therapeutic strategies to interrupt the neuronal loss can only be developed by these 
studies which increase our knowledge of the neurodegenerative process by different 
fibrillar forms of PrP. The findings of this thesis that mature amyloid fibrils have 
comparable toxicities even though they are structurally very distinct, therefore 
contributes to the theory that soluble intermediates (such as in the conversion reaction 
of PrP° to PrPS°) may be more neurotoxic and may even represent the infectious agent 
(Caughey & Lansbury 2003). 
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4.4.5 Scrambled MoPrP105 -125 peptides are moderately toxic following 
prolonged exposures 
As discussed in Section 4.3.3., the toxicity of normal peptides was restricted to the 
neuronal phenotype. The differences in toxicity between the scrambled and normal 
peptides (highly toxic) were highly significant (p<0.005), as was the presence of 
PC12 cells with the neuronal morphology in comparison to naive cultures when 
treated with normal peptides (p <0.005), as analysed by two -way ANOVA analysis. 
These alamarblue reduction assays confirmed that the scrambled peptide 
conformations had negligible effects on naive PC12 cells (Figures 4.16. and 4.20.). 
However; when added to the neuronal PC12 cells for periods of 5 or 7 days, 
scrambled peptide treated cells had slightly reduced mean reduction values in 
comparison to buffer equivalent treated cells (Figures 4.18. and 4.22.). However, the 
differences between the mean reduction values for buffer and scrambled peptide 
treated neuronal cells, was much less remarkable than that observed for the normal 
peptide experiments (Figures 4.17. and 4.21.). Analysis of the tested concentrations 
shows that mean alamarblue reduction values for pH 7 created scrambled peptides fell 
from 88.28% after 24 hours to 71.38% after exposure for 7 days (Figure 4.18.). In 
comparison, the mean alamarblue reduction values for pH 5 created scrambled 
peptides fell from 84.79% after 24 hours to 71.08% after 7 days exposure (Figure 
4.22.). The observed reduction in viability was due to the presence of the scrambled 
peptides, as the mean alamarblue reduction values for vehicle buffer treated cells were 
fairly constant and unaffected by exposure time (Figures 4.18. and 4.22.). The 
toxicity of the scrambled peptides after 7 days exposure is much less than that 
observed for the normal peptides (Figures 4.17. and 4.18. compared to Figures 4.21 
and 4.22.). The scrambled peptide conformations have different secondary structure 
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compositions (Tables 4.2 & 4.4), but similar mean alamarblue reduction values as 
described above. The observed toxicities of scrambled peptides may be; (1) due to 
the similar quantities of ß -sheet (32.61% and 31.12% in pH 7 and pH 5 respectively) 
as recorded by FTIR spectroscopy, or (2) non -specific due to prolonged exposures of 
the neuronal PC12 cells to misfolded, but non -fibrillar (Figures 4.2.- 4.3.), scrambled 
peptides. Larger quantities of f3-sheet have been shown to increase the toxicity of the 
normal PrP106 -126 peptide (Brown et al. 1998), and also has become widely 
accepted that the misfolding of proteins, even from non -disease related proteins, can 
result in the formation of toxic species (Bucciantini et al. 2002). Therefore the 
evidence I have gathered indicates that the actual presence of these misfolded 
insoluble aggregates, containing a relatively large proportion of ß- sheet, could 
account for the small toxicities observed with these scrambled peptides. The neuronal 
phenotype contributes to the mechanisms of this toxicity, as naive PC12 cultures are 
resistant to the mildly toxic effects of these scrambled peptides. The mechanisms for 
the increased sensitivity of neuronal, in comparison to naive, PC12 cells are unclear. 
However, to analyse the relationship between toxicity and the proportion of I3-sheet in 
the scrambled peptides, these peptide solutions could be incubated with 13 -strand 
breakers (Soto et al. 2000). Toxicity could then be analysed by alamarblue reduction 
over the same time scale in comparison to untreated scrambled peptide solutions. 
Therefore the slight neurotoxicity of the misfolded scrambled peptides in this thesis 
correlate with observations that the misfolding of any protein into soluble non -fibrillar 
aggregates will be cytotoxic ( Bucciantini et al. 2002). 
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4.4.6 Mechanisms of neuronal cell death following MoPrP105 -125 exposure 
have yet to be clarified 
Neuronal PC 12 cells cultured in the presence of MoPrP 105 -125 peptides were 
analysed biochemically for the presence of apoptosis- related markers. Annexin V 
staining was attempted to identify early signs of apoptosis such as changes to the 
plasma membrane, and activation of caspase 3 was analysed to monitor more 
downstream events. FACS analysis using Annexin V staining could not be 
monitored, as annexin V was found to bind non -specifically to all cells (Section 
4.3.9). Damage to neuritic processes, whilst harvesting adherent neuronal cells for 
FACS analysis, is the most likely explanation for the non -specific binding of annexin 
V (Schutte et al. 1998). Therefore, further research is required to optimise annexin V 
staining protocols for the identification of early -stage apoptosis. The activation of 
caspase 3 in vitro (with PrP106 -126) and caspase 3 and Fas ligand in vivo (87V /VM 
model) represented obvious starting points for the identification of biochemical 
markers of apoptosis (Jamieson et al. 2001a; White et al. 2001). Unfortunately, an 
antibody recognising the Fas ligand in rats (for FACS analysis) arrived after this 
research ended and could not be included in this analysis. Furthermore, the antibody 
chosen for the FACS analysis failed to recognise activated caspase 3 in any of the 
peptide or TMT treated samples. These experiments represented the final research 
area of this thesis, and unfortunately further attempts at identifying neurodegenerative 
mechanisms could not be performed. The required differentiation period of PC 12 
cells for 14 days, then treatment durations of up to 7 days, meant that considerable 
time constraints were fixed into such analysis. 
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The time consuming process of completing the secondary structure analysis of 
MoPrPl05 -125 and the long cell culture conditions required, was disappointing as 
planned work to investigate apoptosis -related proteins in vitro could not be 
performed. Future research should analyse mechanisms of neurodegeneration, 
following treatments of PC12 cells with protofibrillar conformations of human and 
mouse normal peptides (Section 4.4.4.). The optimisation of active caspase 3 and Fas 
ligand protocols for FACS analysis would not prove to be time consuming, as FACS 
protocols for PC12 cells have now been established. Furthermore, the co- culture of 
cells with specific or pan caspase inhibitors, in addition to toxic normal peptide 
species, would have provided detailed analysis of the roles of these proteases in the 
mechanisms of neuronal cell death in this model. The cytosolic translocation of AIF 
in the ME7 /CV murine scrapie model (Chapter 3), and cyt c in fractions from scrapie- 
infected and normal brain, represented an opportunity to investigate mitochondrial 
dysfunction in this in vitro system. The sub -cellular fractionation kit (Calbiochem) 
used for separating brain homogenates (Section 3), was purchased as it was also 
compatible with adherent cell cultures. Western blot analysis of the separated 
fractions would allow similar analysis to be investigated in this model. Furthermore, 
the roles of the Bc1-2 family proteins in controlling the release of the IMM proteins 
(Section 3) could also be investigated. This analysis could also include FACS, 
immunofluorescence, and an ELISA (e.g. for cyt c) which would allow much more 
detailed analysis of the role of apoptotic proteins in mediating neuronal cell death in 
the TSEs and other neurodegenerative diseases. With increasing publications 
investigating mechanisms of cell death, it is becoming clearer that the classifications 
of apoptosis, autophagy and necrosis are not as distinct as was previously thought. 
With respect to the caspase- independent pathways included in this thesis; AIF has 
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also been shown to interact with PARP (Yu et al. 2003), which had historically been 
considered to be specific to necrotic cell death. Furthermore; although the release of 
IMM proteins (such as AIF and Endo G) is caspase- independent, it is thought that 
once released these proteins may also interact with proteins which influence the 
activation of the caspase cascade (e.g. by interrupting Hsp70 /Apaf -1 binding) 
(Ravagnan et al. 2001). These are only two examples of apparent cross -talk between 
the different "classes" of neuronal cell death. Furthermore evidence of cell death 
displaying characteristic features of apoptosis and necrosis, termed aponecrosis, has 
been described (Formigli et al. 2000). Therefore the complexity and apparent cross- 
talk between apoptosis and necrosis, and evidence that inhibition of one can lead to 
domination of the other (Pohl et al. 1999), means that approaches to modulate cell 
death in the TSE diseases should be taken with extreme caution. Further research 
may reveal the precise mechanisms of neuronal cell death in TSE diseases, and lead to 
the development of therapeutic treatments to inhibit the neurodegenerative process or 
to delay /prolong the process to a period beyond the natural lifespan of the infected 
host. The investigations of these pathogenic mechanisms of neuronal cell death in 
this thesis are therefore of direct relevance to the development of future intervention 
and therapeutic strategies to combat the fatal neurodegenerative processes in the 
TSEs. 
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Chapter 5: Final conclusions and future work 
The research described in this thesis was designed to obtain a better understanding of 
the mechanisms leading to and resulting in the characteristic neurodegeneration of the 
TSE diseases. Infection with TSEs results in a number of pathological changes in the 
brain, including the deposition of PrP" and, in several cases, the presence of dense 
amyloid plaques composed of accumulated PrP" molecules. These diseases occur 
following the misfolding of normal host encoded PrPc, via intermediate 
conformations, and result in the deposition of PrPse. PrPSC remains the most reliable 
biomarker in verifying TSE infection; however, confirmation that PrPsc represents the 
infectious agent has yet to be obtained. Therefore, research is required to show which 
conformation of PrP is the most neurotoxic and also verify if this conformation 
represents the infectious agent, and not just a pathological by- product of the disease 
process. The mechanisms resulting in TSE neurodegeneration must be identified if 
successful therapeutic strategies are to be developed. 
The occurrence and sequence of pathological changes following infection with TSE 
agents are strongly influenced by the infecting agent and the host genotype 
combination (Bruce et al. 1976). TSE agents also selectively target neuronal 
populations; however, the mechanisms resulting in such targeting are unknown. 
Therefore, the mechanisms associated with the pathological changes which occur 
during the course of infection with TSE agents are poorly understood and the 
mechanisms of cell death may also differ in accordance with the infecting TSE agent 
and the genotype of the infected host. This research was designed to address the 
mechanisms leading to the activation and also subsequent execution of neuronal cell 
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death pathways. This research was accomplished using (1) an in vitro model to 
analyse the structure /toxicity relationships of a PrP peptide which stimulates neuronal 
cell death and (2) analyse the precise mechanisms of neuronal cell death in vivo using 
two well characterised murine scrapie models. 
The synthetic murine PrP105 -125 peptide, homologous to the neurotoxic human 
PrP106 -126 peptide, was developed to model the activation of TSE related 
neurodegeneration in vitro. This region represents the most highly conserved region 
of the PrP protein in all tested species, and peptides isolated from amyloid deposits of 
GSS patients also contain this neurotoxic sequence (Tagliavini et al. 2001). This 
sequence is also believed to be essential for the conversion of PrP° to PrPSO, and in 
vitro shares many of the biochemical properties of PrPS° (as discussed in Section 4). 
These factors therefore verify its suitability as an in vitro model of TSE 
neurodegeneration. Conformations of this peptide containing different secondary 
structures were created and were found to be toxic specifically to neuronal cell 
cultures. The primary amino acid sequence of MoPrP105 -125 peptides was essential 
for this toxicity, as a scrambled version of this peptide was not toxic. Peptide samples 
containing mature amyloidogenic fibrils, but with distinct conformations, were 
analysed to assess secondary structure /toxicity relationships. This research revealed 
that differences in the structure of mature amyloid fibrils had no discernable effects 
on toxicities. Studies by other researchers, published during the course of the work 
described in this thesis (and also described in Section 4), reported that protofibrillar 
structures caused by the misfolding of even non -disease associated proteins can be 
toxic (Bucciantini et al. 2002). protofibrillar structures have been reported using 
synthetic PrP peptides, including HuPrP106 -126 and recPrP (Florio et al. 2003; 
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Kazlauskaite et al. 2005), and Jeffrey et al. described the association of pre - 
amyloidogenic PrP with selective damage to axon terminals and dendritic spines in 
vivo in the 87V /VM murine scrapie model (Jeffrey et al. 1997). The research of my 
collaborators on the peptide work of this thesis found that the protofibrillar 
intermediates of recPrP were more toxic than more mature insoluble aggregated 
fibrils (Kazlauskaite et al. 2005). Therefore, protofibrillar conformations of the 
MoPrP105 -125 peptides may also prove to be the more toxic species, and the mature 
amyloid fibrils may be a by- product of the misfolding reaction. The poor correlation 
of PrPSO and infectivity in some TSE disease models (Dorandeu et al. 1998; Foster et 
al. 2001) further strengthens the hypothesis that another fibrillar form of PrP may 
represent the infectious agent, and also that PrPSO may correspond to a pathological 
disease by- product. Future research should prepare protofibrillar structures of 
MoPrP 105 -125 peptides and analyse toxicity in relation to the mature amyloid fibrils 
in the PC 12 neuronal cell culture model. These protofibrillar structures may well 
more accurately represent the infectious disease process during the conversion of PrP° 
to PrPse; therefore, future work should monitor both in vivo and in vitro the 
stimulation and downstream pathways of neuronal cell death. This research will be 
important in assessing the effects of protofibrillar PrP in the neuropathological 
changes which occur in the TSEs, in the identification of the infectious agent, and 
explain the transmissibility of these diseases. Therapeutic strategies to interrupt the 
neuronal loss may be developed by studies which increase our knowledge of the 
neurodegenerative process by different fibrillar forms of PrP, or better still prevent the 
misfolding of such disease -related proteins. 
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To understand the mechanisms which result in neuronal cell death in response to 
misfolded PrP, two well characterised murine scrapie models (ME7 /CV & 87V /VM) 
were analysed at the terminal stages of disease. The targeting and sequence of 
pathological changes differs between these two models; this is particularly evident in 
the murine hippocampus, where the CA1 pyramidal neurons are lost during ME7 /CV 
infections (Scott & Fraser 1984) and the CA2 pyramidal cells are damaged during 
87VNM infections (Belichenko et al. 2000; Jeffrey et al. 2000). Whole brains 
infected with either scrapie agent, and age- matched controls, were separated into 
mitochondrial and cytosolic fractions. Additionally, neuropathologically restricted 
areas of the brain, such as the hippocampus and thalamus, were micro -dissected and 
subcellularly fractionated into mitochondrial and cytosolic samples. This proved to 
be a more suitable technique for the in vivo analysis of apoptosis, as these samples 
contained a higher proportion of apoptotic to normal cells in comparison to the 
samples prepared from the whole brains. AIF was released from the IMM to the 
cytosol in the ME7 /CV scrapie model, but not in 87VNM or normal age- matched 
control animals. The release of AIF is therefore specific to infection with the ME7 
murine scrapie strain, confirming that the mechanisms of neurodegeneration differ in 
these two models. The stimulation of different mechanisms of cell death may be due 
to the targeting of these scrapie agents to distinct neuronal populations, which may 
therefore activate different cellular receptors. Future work is required to identify the 
upstream events which result in the release of AIF in the ME7 /CV model; the 
mechanisms of neurodegeneration in the ME7 /CV clearly involve caspase- 
independent proteins, however, it is highly likely that caspase- mediated apoptosis will 
also be involved. Future research should therefore concentrate on identifying proteins 
which activate neuronal apoptosis both prior to and following the release of AIF. The 
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identification of these pathways will aid in the identification of mechanisms of 
neurodegeneration in other TSEs. 
This research inadvertently revealed mitochondrial damage in animals at the terminal 
stages of the incubation period, which was absent in young mice, and which was also 
independent of infection with murine scrapie strains. The release of cyt c from the 
IMM indicates increased mitochondrial permeability in aged animals, correlating with 
evidence reporting mitochondrial dysfunction in other rodent TSE disease models 
(Choi et al. 1998; Lee et al. 1999). The effects of this age -related deterioration on the 
progression of TSE disease are unclear and future research should analyse the effects 
of cyt c release on the activation and/or release of downstream caspase dependent and 
independent proteins. As discussed in Section 3, the release of cyt c may not be 
sufficient to stimulate apoptosis due to physiological interactions with K+ ions. 
However, if a threshold is exceeded (e.g. due to elevated cyt c release or fluctuations 
in K+ ion concentrations) apoptosis can be activated (Bortner et al. 1997; Hughes et 
al. 1997). Such fluctuations in K+ ions have been observed in various in vitro and in 
vivo TSE models, including the ME7 /CV murine scrapie model described here. 
Therefore, reduced physiological concentrations of K+ in scrapie -infected neurons 
may therefore allow activation of cyt c- mediated apoptosis. The incorporation of ICC 
analysis into future research will allow the detection of apoptotic proteins at the single 
cell level. 
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and future work 
The in vitro model of neurodegeneration established in this thesis would provide a 
population of apoptotic cells which could be analysed following treatments with 
neurotoxic conformations of PrP peptides. As previously discussed the protofibrillar 
conformations of these peptides may prove to be the more toxic species, and the 
mature amyloid deposits may be a by- product of the protein misfolding reaction. The 
mechanisms of cell death induced by these protofibrillar conformations could be 
analysed for apoptotic proteins such as AIF. The use of this in vitro model would 
enhance the detection of apoptotic cells and will therefore aid in the understanding of 
neuronal cell death pathways. Such analysis had been planned for this thesis, but due 
to time constraints these studies could not be performed. A wide range of techniques 
could be used to analyse neurodegenerative mechanisms in the in vitro system; the 
identification of apoptosis -related proteins could then be analysed complementary in 
the in vivo models. FACS and immunofluorescence analysis of neuronal PC12 cells 
could be used to analyse the translocation of ions such as K+ and Cat +, which are 
known to control the activation of apoptotic pathways (as discussed in Section 3). 
Furthermore, sub -cellular fractionation of neuronal PC12 cells could also be 
performed to analyse the roles of other IMM proteins, such as Smac/Diablo and 
HtrA2 which have been reported respectively in a model of Huntington's disease and 
ME7 /CV murine scrapie (Brown et al. 2005; Goffredo et al. 2005). The complexity 
and cross -talk between neuronal cell death pathways in these diseases could also be 
investigated using caspase -inhibitor proteins to identify potential roles of specific 
caspases in mediating cell death. Future research will also have to determine the roles 
of mitochondrial dysfunction, age and misfolded PrP in contributing to neuronal cell 
death in these fatal infectious neurodegenerative diseases. 
205 Chapter 5: Final conclusions 
and future work 
The identification of the precise mechanisms of neuronal cell death in TSE diseases 
may lead to the development of therapeutic treatments to inhibit the 
neurodegenerative process or to delay /prolong the process to a period beyond the 
natural lifespan of the infected host. These therapeutic strategies could include; (1) 
preventing TSE- specific cell death activation by the successful identification of the 
neurotoxic /infectious agent, or (2) blocking the activated pathways using specific 
inhibitory molecules. The research of this thesis is therefore of direct relevance to the 
future development of potential therapeutic strategies for TSEs, and may also have 
wider implications for the treatment of other amyloidogenic neurodegenerative 
diseases. 
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